当前位置:首页 > 产品中心 > 试剂/标准品/对照品 > USP标准品 > USP美国药典标准品
详细介绍
Catalog # | Description | Current Lot | Previous Lot(Valid Use Date) | CAS # | NDC # | Special Restriction |
1000408 | Abacavir Sulfate(200 mg) | R028L0 | F1L487(31-DEC-2016) | 188062-50-2 | N/A | |
1000419 | Abacavir Sulfate Racemic (20 mg)(4-[2-amino-6-(cyclo propylamino)-9H-pur in-9yl]-2-cyclopenten e-1-methanol sulfate (2:1)) | F0G248 | 188062-50-2 | N/A | ||
1000420 | Abacavir Related Compound A (20 mg) ([4-(2,6-diamino-9H- purin-9-yl)cyclopent- 2-enyl]methanol) | F1L311 | F0H284(31-OCT-2013) | 124752-25-6 | N/A | |
1000437 | Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9--9H-purine-2,6-diamine) | F0M143 | N/A | N/A | ||
1000441 | Abacavir Related Compound B (20mg) ([4-(2,5-diamino-6-c hloropyrimidin-4-yla mino)cyclopent-2-en yl]methanol) | F1L318 | F0H283(31-OCT-2013) | N/A | N/A | |
1000452 | Abacavir Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl] methanol hydrochloride) | F1L322 | F0H285 (30-SEP-2013) | 172015-79-1 | N/A | |
1000485 | Abacavir Related Compounds Mixture(15 mg) | R039P0 | F0J094 (30-NOV-2016) | N/A | N/A | |
1000496 | Abacavir Stereoisomers Mixture (15 mg) | R044D0 | F0J102 (28-FEB-2017) | N/A | N/A | |
1000500 | Abacavir System Suitability Mixture(15 mg) | F0J097 | N/A | N/A | ||
1000521 | Acarbose (200 mg) (COLD SHIPMENT REQUIRED) | F0M160 | 56180-94-0 | N/A | ||
1000532 | Acarbose System Suitability Mixture (2mg) (COLD SHIPMENT REQUIRED) | F0L204 | N/A | N/A | ||
1000554 | Acamprosate Calcium (200 mg) | F0M484 | 77337-73-6 | N/A | ||
1000565 | Acamprosate Related Compound A (15 mg) (3-aminopropane-1- sulfonic acid) | F0M499 | 3687-18-1 | N/A | ||
1000576 | Acamprosate Related Compound B (20 mg) | F04090 | N/A | N/A | ||
1000601 | Acebutolol Hydrochloride (125 mg) | F005N2 | F-1 (31-JUL-2015) | 34381-68-5 | N/A | |
1000612 | Acebutolol Related Compound A (20 mg) (N-(3-acetyl-4-hydro xyphenyl) but*) | F1G041 | F0G041 (31-JUL-2015) | 40188-45-2 | N/A | |
1000623 | Acebutolol Related Compound B (20 mg) (N-acetamide) | F005G0 | 22568-64-5 | N/A | ||
1000699 | Acebutolol Related Compound I (20 mg) (N-buty ramide) | F005H0 | 441019-91-6 | N/A | ||
1000818 | Abiraterone Acetate (200 mg) | F029L0 | 154229-18-2 | N/A | ||
1000829 | Abiraterone System Suitability Mixture (20 mg) | F01710 | N/A | N/A | ||
1001003 | Acenocoumarol (200 mg) | G0D300 | F (31-OCT-2005) | 152-72-7 | N/A | |
1001502 | Acepromazine Maleate (250 mg) | R003N0 | F-2 (31-OCT-2015) | 3598-37-6 | N/A | |
1002505 | Acesulfame Potassium (200 mg) | G0H082 | F0C136 (30-JUN-2009) | 55589-62-3 | N/A | |
1002811 | Acetaldehyde (3 x 1.1 mL) | F037R0 | 75-07-0 | N/A | ||
1003009 | Acetaminophen (400 mg) | K2M244 | K0I244 (30-APR-2017) | 103-90-2 | N/A | |
1003010 | Acetaminophen Related CompoundA (15 mg) (4-(acetylamino)phe nyl acetate) | F0J252 | 2623-33-8 | N/A | ||
1003027 | Acetaminophen Related Compound B (30 mg) (N-(4-hydroxyphenyl )prop*) | R012P0 | F1M245 (31-AUG-2015) | 1693-37-4 | N/A | |
1003031 | Acetaminophen Related Compound C (50 mg) (N-(2-hydroxyphenyl )acetamide) | R00920 | F1M247 (31-AUG-2015) | 614-80-2 | N/A | |
1003042 | Acetaminophen Related Compound D (50 mg) (N-phenylacetamide ) | R01300 | F0L221 (30-SEP-2016) | 103-84-4 | N/A | |
1003064 | Acetaminophen Related Compound F (50 mg) (p-nitrophenol) | F0M236 | 100-02-7 | N/A | ||
1003100 | Acetaminophen Related Compound J (50 mg) (N-(4-chlorophenyl)a cetamide) | R00310 | F0L222 (31-JUL-2015) | 539-03-7 | N/A | |
1004001 | Acetanilide Melting Point Standard (1g) (Approximay 114 degrees) | M1M285 | M0A029 (30-SEP-2014) | 103-84-4 | N/A | |
1005004 | Acetazolamide (2 g) | K1J032 | K0J032 (31-MAY-2017) | 59-66-5 | N/A | |
1005048 | Acetazolamide Related Compound D (25 mg) (5-Ami,3,4-thiad iazole-2-sulfonamide ) | F025E0 | 14949-00-9 | N/A | ||
1005059 | Acetazolamide Related Compound E (25 mg) (5-Acetamido-1,3,4-t hiadiazole-2-sulfonic acid potassium salt) | F025H0 | N/A | N/A | ||
1005706 | Glacial Acetic Acid (1.5 mL/ampule; 3 ampules) | R038A0 | I0M342 (31-JUL-2017) | 64-19-7 | N/A | |
1006007 | Acetohexamide (250 mg) | H | G-1 (30-JUN-1999) | 968-81-0 | N/A | |
1006506 | Acetohydroxamic Acid (200 mg) | F-1 | F (31-MAR-2003) | 546-88-3 | N/A | |
1006801 | Acetone (1.5mL/ampule; 3 ampules) | I0M548 | H0K208(31-MAR-2017) | 67-64-1 | N/A | |
1008002 | Propoxyphene Related Compound B (50 mg) (alpha-d-2-Acetoxy- 4-dimethylami,2 -diphenyl-3-methylb utane) | I0I291 | H0D012 (30-NOV-2011) | 53990-51-5 | N/A | |
1008501 | Acetylcholine Chloride (200 mg) | R023K0 | H0F091 (30-SEP-2015) | 60-31-1 | N/A | |
1009005 | Acetylcysteine (200 mg) | K0K294 | J0I282 (30-NOV-2012) | 616-91-1 | N/A | |
1009479 | 2-Acetylpyridine (1 g) | F0K307 | 1122-62-9 | N/A | ||
1009901 | Acetyltributyl Citrate (3 x 200 mg) | R053A0 | H0I337 (31-AUG-2017) | 77-90-7 | N/A | |
1009923 | Acetyltriethyl Citrate (500 mg) | R041M0 | H0I339 (31-JAN-2017) | 77-89-4 | N/A | |
1009978 | N-Acetyl-D,L-Methio nine (100 mg) | F03580 | 1115-47-5 | N/A | ||
1010022 | N-Acetylglucosamin e (200 mg) | F0L512 | 7512-17-6 | N/A | ||
1010081 | N-Acetyl-L-Leucine (100 mg) (Acetyl-L-leucine) | F046G0 | 1188-21-2 | N/A | ||
1010106 | N-Acetyl-L-Tyrosine (100 mg) | F0I085 | 537-55-3 | N/A | ||
1010208 | Acetyl Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)- 8-{2-[(2R,4R)-4-(ace toxy)-6-oxotetrahydr o-2H-pyran-2-yl]ethy l}-3,7-dimethyl-1,2,3, 7,8,8a-hexahydrona phthalen-1-yl 2,2-dimethylbutanoa te) | F00660 | 145576-25-6 | N/A | ||
1011007 | Acitretin (200 mg) | R04460 | F0E266 (31-JAN-2017) | 55079-83-9 | N/A | |
1011018 | Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4- methoxy-2,3,6-trimet hylphenyl)-3,7-dimet hylnona-2,4,6,8-tetra enoic acid) | F0E264 | 69427-46-9 | N/A | ||
1011029 | Acitretin Related Compound B (20 mg) (ethyl(all-E)-9-(4-methoxy-2,3,6-trimethylpheny l)-3,7-dimethylnona- 2,4,6,8-tetraenoate) | F0E265 | 54350-48-0 | N/A | ||
1011709 | Adapalene (200 mg) | R03020 | F0L117 (31-JUL-2016) | 106685-40-9 | N/A | |
1011710 | Adapalene Related Compound A (50 mg) (Methyl 6-bromo-2-naphthoa te) | F0K418 | 33626-98-1 | N/A | ||
1011721 | Adapalene Related Compound B (50 mg) (Methyl 6-[3-(1-adamantyl)-4 -methoxyphenyl]-2-n aphthoate) | F0K419 | 106685-41-0 | N/A | ||
1011732 | Adapalene Related Compound C (25 mg) (2-(adamant-1-yl)me thoxybenzene) | R065K0 | F0L078 (31-DEC-2017) | 43109-77-9 | N/A | |
1011743 | Adapalene Related Compound D (25 mg) (4,4'-dimethoxy-3,3'- di(adamant-1-yl)biphenyl) | F0L079 | 932033-57-3 | N/A | ||
1011754 | Adapalene Related Compound E (25 mg) (2,2'-binaphthyl-6,6'- dicarboxylic acid) | R066R0 | F0L080 (30-SEP-2017) | 932033-58-4 | N/A | |
1011878 | Adrenalone Hydrochloride (25 mg) (3',4'-Dihydroxy-2-( methylamino)acetop henone hydrochloride) | F032A0 | 62-13-5 | N/A | ||
1011889 | Advantame (200 mg) | F034R0 | 714229-20-6 | N/A | ||
1011890 | Advantame Acid (20 mg) (N-[N-[3-(3-hydroxy- 4-methoxyphenyl)pr opyl]aspartyl]phenyl alanine) | F034S0 | 713524-95-9 | N/A | ||
1012032 | Actein (20 mg) | F0H264 | 18642-44-9 | N/A | ||
1012054 | Acyclovir Related Compound F (50 mg) (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6, 9-dihydro-1H-purin-2 -yl]acetamide) | F1M502 | F0L515 (29-FEB-2016) | 110104-37-5 | N/A | |
1012065 | Acyclovir (300 mg) | K0L516 | J1G366 (31-MAY-2015) | 59277-89-3 | N/A | |
1012076 | Acyclovir Related Compound A (50 mg) (2-[(2-amino-6-oxo-1 ,6-dihydro-9H-purin- 9-yl)methoxy]ethyl acetate) | R023H0 | I0M125 (31-JUL-2016) | 102728-64-3 | N/A | |
1012087 | Acyclovir Related Compound G (50 mg) (2-ethyl acetate) | F0L510 | 75128-73-3 | N/A | ||
1012101 | Adenine (200 mg) | I0M090 | H0I348 (31-MAY-2014) | 73-24-5 | N/A | |
1012112 | S-Adenosyl-L-Homo cysteine (50 mg) | R02130 | F0G241 (30-SEP-2016) | 979-92-0 | N/A | |
1012123 | Adenosine (200 mg) | I0M365 | H0J390 (31-JUL-2015) | 58-61-7 | N/A | |
1012134 | Ademetionine Disulfate Tosylate(500 mg) (S-Adenosyl-L-Methi onine Disulfate Tosylate) | F0D073 | 97540-22-2 | N/A | ||
1012145 | Agigenin (25 mg) | F | 55332-76-8 | N/A | ||
1012156 | Aflatoxins (1 mL) (International Restricted Sales Item)(COLD SHIPMENT REQUIRED) | F0K319 | N/A | N/A | International Restricted Sales Item - Cold Shipment Required | |
1012178 | 5'-Adenylic Acid (500 mg) | F0J204 | 61-19-8 | N/A | ||
1012190 | Adipic Acid (100 mg) | F0D318 | 124-04-9 | N/A | ||
1012203 | Agnuside (25 mg) | F0D397 | 11027-63-7 | N/A | ||
1012214 | Agar (500 mg) | F0K137 | N/A | N/A | ||
1012495 | Beta Alanine (100 mg) | R033Y0 | F0F111 (31-AUG-2016) | 107-95-9 | N/A | |
1012509 | L-Alanine (200 mg) | H0M400 | G1J091(31-DEC-2014) | 56-41-7 | N/A | |
1012517 | L-Alanyl-L-Glutamin e (200 mg) | F004H0 | 39537-23-0 | N/A | ||
1012531 | L-Alanyl-L-Alanine (200 mg) | F0M225 | 1948-31-8 | N/A | ||
1012553 | Albendazole (200mg) | R02690 | H1K275(30-NOV-2015) | 54965-21-8 | N/A | |
1012595 | rAlbumin Human (6 mg) (Recombinant Human Albumin) (COLD SHIPMENT REQUIRED) | R04600 | G0M268 (31-DEC-2016) | N/A | N/A | Cold Shipment Required |
1012600 | Albuterol (200 mg) | I | H (31-DEC-2000) | 18559-94-9 | N/A | |
1012633 | Albuterol Sulfate (200 mg) | K0G284 | J (28-FEB-2009) | 51022-70-9 | N/A | |
1012644 | Albuterol Related Compound A (25 mg) (4-[2-[(1,1-dimethyle thyl)amino]-1-hydrox yethyl]-2-methylphe nol sulfate) | F0H223 | 18910-68-4 | N/A | ||
1012655 | Albuterol Related Compound B (10 mg) (2-(tert-butylamino)- 1-[4-hydroxy-3-(hydr oxymethyl)phenyl]et hanone) | F0M123 | 156547-62-5 | N/A | ||
1012688 | Alcohol Determination--Alco hol (5 mL/ampule; 5ampules) | G0M024 | F0C399 (31-MAY-2015) | 64-17-5 | N/A | |
1012689 | Albuterol Related Compound E (10 mg) (2,2'-oxybis(methyle ne)bis diacetate) | F0M127 | N/A | N/A | ||
1012699 | Alcohol Determination--Acet onitrile | F0C419 | N/A | N/A | ||
1012746 | Alclometasone Dipropionate Related Compound A (20 mg) (11beta,17,21-trihyd roxy-16alpha-methyl pregna-1,4-diene-3, 20-dione 17,21-dipropionate) | F0K017 | N/A | N/A | ||
1012757 | Alclometasone Dipropionate (300mg) | I0C302 | H (30-SEP-2007) | 66734-13-2 | N/A | |
1012768 | Alcohol (1.2 mL/ampule; 5 ampules) | G0L460 | F0D030 (30-NOV-2014) | 64-17-5 | N/A | |
1012772 | Dehydrated Alcohol (1.2 mL/ampule; 5ampules) | G0M292 | F0D031 (31-JUL-2015) | 64-17-5 | N/A | |
1012780 | Alendronate Sodium (200 mg) | H0H004 | G0D288 (31-AUG-2009) | 121268-17-5 | N/A | |
1012799 | Aleuritic Acid (50 mg) | F02300 | 533-87-9 | N/A | ||
1012848 | Alitame (250 mg) | F0J259 | 99016-42-9 (hydrate); 80863-62 | N/A | ||
1012859 | Alitame - Alanine Amide Impurity (25 mg) (N-(2,2,4,4-tetramet hyl-3-thietanyl)-D-al animamide) | F0M119 | 80875-07-6 | N/A | ||
1012871 | Alfuzosin System Suitability Mixture A (25 mg) (Alfuzosin Hydrochloride containing Impurity A, Impurity D, and Impurity E) | F0L107 | N/A | N/A | ||
1012906 | * Hydrochloride CII (500 mg) | G1J037 | G0J037 (31-MAR-2016) | 70879-28-6 | 0021697370 1 | Controlled |
1012917 | AlfuzosinHydrochloride (150 mg) | F1H162 | F0H162(31-JAN-2018) | 81403-68-1 | N/A | |
1012928 | Alfuzosin System Suitability Mixture (15 mg) | F0H067 | N/A | N/A | ||
1012939 | Allantoin (200 mg) | G1H207 | G0H207 (29-FEB-2016) | 97-59-6 | N/A | |
1012950 | Alliin (25 mg) | F2L004 | F1L004 (30-NOV-2016) | 556-27-4 | N/A | |
1013002 | Allopurinol (250 mg) | R05890 | J0C186 (31-DEC-2017) | 315-30-0 | N/A | |
1013013 | Allopurinol Related Compound B (25 mg) (5-(formylamino)-1H -pyrazole-4-carboxa mide) | R02700 | G0J139 (30-SEP-2016) | 22407-20-1 | N/A | |
1013024 | Allopurinol Related Compound A (25 mg) (3-Amino-4-carboxa midopyrazole Hemisulfate) | I0M517 | H0K282 (31-MAY-2015) | 27511-79-1 | N/A | |
1013035 | Allopurinol Related Compound C (25 mg) (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4- carboxamide) | R00780 | G0J066 (30-APR-2015) | N/A | N/A | |
1013046 | Allopurinol Related Compound D (35 mg) (ethyl 5-amiH-pyrazol e-4-carboxylate) | F0G085 | 6994-25-8 | N/A | ||
1013057 | S-Allyl-L-cysteine (25 mg) | F | N/A | N/A | ||
1013068 | Allopurinol Related Compound E (25 mg) (ethyl 5-(formylamino)-1H- pyrazole-4-carboxyl ate) | R014H0 | G0M120 (30-SEP-2015) | 31055-19-3 | N/A | |
1013079 | Allopurinol Related Compound F (25 mg) (ethyl-(E/Z)-3-(2-car bethoxy-2-cyanoeth enyl)amiH-pyra zole-4-carboxylate) | R028V0 | G0J148 (30-NOV-2014) | 321571-07-7 | N/A | |
1013206 | Almond Oil (1 g) | F0L399 | 8007-69-0 | N/A | ||
1013512 | Almotriptan Malate (200 mg) | F0J054 | 181183-52-8 | N/A | ||
1013523 | Almotriptan RelatedCompound A (20 mg) ({3-[2-(Dimethylamin o)ethyl]-5-[(pyrrolidin e-1-yl)sulfonylmethyl ]-1H-indol-1-yl}meth anol) | F0J055 | 1018676-02-2 | N/A | ||
1013534 | Almotriptan System Suitability (20 mg) (Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog) | F0K134 | N/A | N/A | ||
1013545 | Almotriptan Related Compound B (15 mg) (2-ethanamin e hemifumarate) | F0M508 | 1246860-65-0 | N/A | ||
1013556 | Almotriptan Related Compound C (15 mg) (N-methyl-2-ethanamine) | F0M513 | 334981-12-3 | N/A | ||
1013567 | Almotriptan Related Compound D (15 mg) (1-[({3-[2-(dimethyla mino)ethyl]indol-5-yl }methyl)sulfonyl]pyrr olidine N-oxide hydrochloride) | F0M532 | N/A | N/A | ||
1013727 | Aloin (25 mg) | F0M265 | 1415-73-2 | N/A | ||
1013909 | Alpha-Lactalbumin (400 mg) (COLD SHIPMENT REQUIRED) | F0K015 | 9051-29-0 | N/A | Cold Shipment Required | |
1014005 | Alphaprodine Hydrochloride CII (250 mg) | F | 561-78-4 | 0021601030 6 | Controlled | |
1015008 | Alprazolam CIV (200 mg) | I0G195 | H1C133 (30-SEP-2008) | 28981-97-7 | 0021601040 5 | Controlled |
1015019 | Alprazolam Related Compound A (30 mg) (2-(2-acetylhydrazin o)-7-chloro-5-phenyl -3H-1,4-benzodiaze pine) | F0H056 | 28910-89-6 | N/A | ||
1016000 | Alprostadil (25 mg) | H1F110 | H (30-JUN-2007) | 745-65-3 | N/A | |
1017105 | Altretamine (500 mg) | G0D184 | F (31-MAY-2008) | 645-05-6 | N/A | |
1017364 | Aluminum Sulfate (2 g) (AS) | F0D342 | 17927-65-0 | N/A | ||
1017502 | Dried Aluminum Hydroxide Gel (200 mg) | R05580 | H0M005 (30-NOV-2017) | 21645-51-2 | N/A | |
1018505 | Amantadine Hydrochloride (200 mg) | R049P0 | I0J377 (30-SEP-2017) | 665-66-7 | N/A | |
1018516 | Amantadine Related Compound A (25 mg) (1-Chloroadamantan e) | F014D0 | 935-56-8 | N/A | ||
1018527 | Amantadine Related Compound B (25 mg) (N-(Adamantan-1-yl) acetamide) | F014J0 | 880-52-4 | N/A | ||
1019202 | Amcinonide (200 mg) | I0M261 | H0D346 (30-NOV-2014) | 51022-69-6 | N/A | |
1019406 | Amifostine (150 mg) | F0F075 | 112901-68-5; 20537-88-6 (anhyd | N/A | ||
1019417 | Amifostine Disulfide (100 mg) | G0J274 | F0C152 (20-APR-2011) | 112901-68-5 | N/A | |
1019428 | Amifostine Thiol (50 mg) (2-[(3-aminopropyl)a mino]ethanethiol, dihydrochloride) | F0F078 | 14653-77-1 | N/A | ||
1019494 | Amikacin Sulfate (100 mg) | R04820 | F0L324 (30-JUN-2017) | 39831-55-5 | N/A | |
1019508 | Amikacin (300 mg) | R015H0 | K0I162 (30-SEP-2015) | 37517-28-5 | N/A | |
1019701 | Amiloride Hydrochloride (500 mg) | H1G197 | H (30-NOV-2008) | 17440-83-4 | N/A | |
1019712 | Amiloride Related Compound A (30 mg) (Methyl 3,5-diamino-6-chloro pyrazine-2-carboxyl ate) | F1E287 | F0E287 (30-JUN-2016) | 1458-01-1 | N/A | |
1019756 | Aminobenzoate Potassium (200 mg) | F026H2 | F-1 (31-MAR-2016) | 138-84-1 | N/A | |
1019767 | Aminobenzoate Sodium (200 mg) | F | 555-06-6 | N/A | ||
1019803 | Aminobenzoic Acid(200 mg) (p-aminobenzoic acid) | R021P1 | R021P0(28-FEB-2017) | 150-13-0 | N/A | |
1019870 | 4-Aminobenzoylglut amic Acid (50 mg) | F0M031 | 4271-30-1 | N/A | ||
1020008 | Aminobutanol (500 mg) (1-Butanol, 2-amino-, (+/-)-) | R049T0 | H0G256 (28-FEB-2017) | 96-20-8 | N/A | |
1020023 | Gamma-Aminobutyri c Acid (50 mg) | F0L111 | 56-12-2 | N/A | ||
1021000 | Aminocaproic Acid (200 mg) | I0M248 | H0K201 (31-DEC-2015) | 60-32-2 | N/A | |
1021204 | 4-Aminophenol (100 mg) | R009S0 | G0I308 (30-JUN-2015) | 123-30-8 | N/A | |
1021292 | Aminotriazinone (300 mg) (3-Ami,2,4-triazi n-5(2H)-one) | F053C0 | 1121-90-0 | N/A | ||
1021703 | Nitrofurantoin Related Compound A (20 mg) (N-(Aminocarbonyl)- N-[([5-nitro-2-furanyl ]-methylene)-amino]- glycine) | R045T0 | H0M496 (31-JUL-2017) | N/A | N/A | |
1022808 | 2-Amino-5-chlorobenzophenone (25 mg) | J0F197 | I (30-SEP-2007) | 719-59-5 | N/A | |
1023403 | Diazepam Related Compound B (25 mg) (3-Amino-6-chloro-1- methyl-4-phenylcarb ostyril) | R01830 | K0H414 (31-MAR-2017) | 5220-02-0 | N/A | |
1025205 | Aminoglutethimide (200 mg) | F | 125-84-8 | N/A | ||
1025307 | m-Aminoglutethimid e (100 mg) | G | F (31-MAY-2001) | N/A | N/A | |
1025351 | Aminohippuric Acid (200 mg) | G0E338 | F-1 (30-APR-2008) | 61-78-9 | N/A | |
1025602 | Amino Methacrylate Copolymer (1.5 g) | F0G005 | 24938-16-7 | N/A | ||
1025715 | Aminolevulinic Acid Hydrochloride (200 mg) | F013Q0 | 5451-09-2 | N/A | ||
1025726 | Aminolevulinic Acid Related Compound A (25 mg) (3,3'-(Pyrazine-2,5-d iyl)dipropionic acid) | F017Y0 | 77479-02-8 | N/A | ||
1025737 | Aminolevulinic Acid Related Compound B (25 mg) (Methyl 5-(1,3-dioxoisoindoli n-2-yl)-4-oxopentan oate) | F01800 | 109258-71-1 | N/A | ||
1025806 | 2-[3-Amino-5-(n-met hylacetamido)-2,4,6- triiodobenzamido]-2- deoxy-d-glucose (25 mg) | F | N/A | N/A | ||
1025908 | Aminopentamide Sulfate (200 mg) | F0B273 | 20701-77-3 | N/A | ||
1026004 | m-Aminophenol (300 mg) | G0J290 | F (31-MAR-2012) | 591-27-5 | N/A | |
1026401 | Aminosalicylic Acid (125 mg) | G1J177 | G0J177 (31-OCT-2015) | 65-49-6 | N/A | |
1026605 | 3-Amino-2,4,6-triiod obenzoic Acid (50 mg) | G | 3119-15-1 | N/A | ||
1027007 | 5-Amino-2,4,6-triiod o-N-methylisophthal amic Acid (50 mg) | F-1 | 2280-89-9 | N/A | ||
1027302 | Amiodarone Hydrochloride (200 mg) | H0M435 | G0G340 (30-JUN-2016) | 19774-82-4 | N/A | |
1027346 | Amiodarone Related Compound D (20mg) ((2-butylbenzofuran- 3-yl)(4-hydroxy-3,5- diiodophenyl)metha none) | F1J007 | F0J007 (30-JUN-2016) | 1951-26-4 | N/A | |
1027357 | Amiodarone Related Compound E (25 mg) ((2-butylbenzofuran- 3-yl)(4-hydroxyphen yl)methanone) | F1I150 | F0I150 (30-JUN-2016) | 52490-15-0 | N/A | |
1027380 | Amiodarone Related Compound H (20 mg) (2-chloro-N,N-diethyl ethanamine hydrochloride) | F0I367 | 869-24-9 | N/A | ||
1028000 | Amitraz (200 mg) (COLD SHIPMENT REQUIRED) | H0K161 | G0F313 (30-JUN-2010) | 33089-61-1 | N/A | |
1028019 | Amitraz Related Compound A (40 mg) (N-(2,4-Dimethylphe nyl)formamide) | F03850 | 60397-77-5 | N/A | ||
1028028 | Amitraz Related Compound B (40mg) (N'-(2,4-Dimethylphe nyl)-N-methylformimi damide) (COLD SHIPMENT REQUIRED) | F03860 | 33089-74-6 | N/A | ||
1028032 | Amitraz Related Compound C (40 mg) (N,N'-Bis(2,4-dimeth ylphenyl)formimidam ide) (COLD SHIPMENT REQUIRED) | F03870 | 16596-04-6 | N/A | ||
1029002 | Amitriptyline Hydrochloride (200 mg) | K0L010 | J0A004 (31-MAY-2013) | 549-18-8 | N/A | |
1029013 | Amitriptyline Related Compound A (25 mg) (dibenzosuberone) | G0K409 | F0F310 (30-JUN-2013) | 1210-35-1 | N/A | |
1029024 | Amitriptyline Related Compound B (25 mg) (5-[3-(dimethylamino)propyl]-10,11-dihydr o-5H-dibenzo[a,d]-cyclohepten-5-ol) | G0K369 | F0F317 (31-JAN-2013) | 1159-03-1 | N/A | |
1029501 | Amlodipine Besylate (350 mg) | H0I102 | G0F133 (31-AUG-2010) | 111470-99-6 | N/A | |
1029512 | Amlodipine Related Compound A (15 mg) (3-Ethyl, 5-methyl [2-(2-aminoethoxym ethyl)-4-(2-chloroph enyl)-6-methyl-3,5-p yridinedicarboxylate] fumarate) | H0M312 | G0L172 (31-JUL-2014) | 113994-41-5 (base) | N/A | |
1029534 | Amlodipine Related Compound C (25 mg) (Dimethyl 4-(2-chlorophenyl)-2 ,6-dimethyl-1,4-dihy dropyridine-3,5-dicar boxylate) | F012R0 | 43067-01-2 | N/A | ||
1029545 | Amlodipine Related Compound D (25 mg) (3-Ethyl-5-methyl-4-(2-chlorophenyl)-2--6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | F012S0 | 88150-62-3 | N/A | ||
1029614 | Amlodipine Related Compound K (25 mg) (Ethyl 6-(2-chlorophenyl)-8 -methyl-3,4,6,7-tetra hydro-2H-benzo[b][1 ,4]oxazine-5-carbox ylate) | F012V0 | N/A | N/A | ||
1029909 | Ammonio Methacrylate Copolymer Type A (500 mg) | G0G291 | F-1 (30-JUN-2009) | 33434-24-1 | N/A | |
1029910 | Ammonio Methacrylate Copolymer Type B (500 mg) | G0I049 | F2C082 (31-DEC-2010) | 33434-24-1 | N/A | |
1029929 | Ammonium Glycyrrhizate (100 mg) | F0L228 | 53956-04-0 | N/A | ||
1029942 | Ammonium Carbonate (2 g) (AS) | F0D102 | 8000-73-5 | N/A | ||
1029953 | Ammonium Chloride (200 mg) | F0C134 | 12125-02-9 | N/A | ||
1029986 | Ammonium Phosphate Dibasic (1 g) (AS) | F0D104 | 7783-28-0 | N/A | ||
1029997 | Ammonium Salts of Phosphatidic Acid (1.5 g) | F0M512 | N/A | N/A | ||
1030001 | Amobarbital CII (200 mg) | F3G273 | F-2 (30-APR-2009) | 57-43-2 | 0021601010 5 | Controlled |
1031004 | Amodiaquine Hydrochloride (500 mg) | J0I144 | I0G043 (31-DEC-2010) | 6398-98-7 | N/A | |
1031401 | Amoxapine (200 mg) | R000B0 | G1D375 (29-FEB-2016) | 14028-44-5 | N/A | |
1031445 | Amoxapine Related Compound D (50 mg) (2-Chlorodibenzo[b,f ]-[1,4]-oxazepin-11-o ne) | F032U0 | N/A | N/A | ||
1031478 | Amoxapine Related Compound G (50 mg) (3-Chloro-11-(pipera zin-1-yl)dibenzo[b,f][ 1,4]oxazepine) | F03310 | N/A | N/A | ||
1031503 | Amoxicillin (200 mg) | L0K359 | K0H332 (30-NOV-2013) | 61336-70-7 | N/A | |
1031514 | Amoxicillin Related Compound A (15 mg) ((2S,5R,6R)-6-Amin o-3,3-dimethyl-7-oxo -4-thia-1-azabicyclo[ 3.2.0]heptane-2-car boxylic acid) | R02470 | G0M004 (30-SEP-2016) | 551-16-6 | N/A | |
1031525 | Amoxicillin Related Compound B (15 mg) (L-amoxicillin) | F0J124 | 26889-93-0 | N/A | ||
1031536 | Amoxicillin Related Compound C (15 mg) ((4S)-2-[5-(4-hydrox yphenyl)-3,6-dioxopi perazin-2-yl]-5,5-dim ethylthiazolidine-4-c arboxylic acid) | F1K023 | F0J128 (31-MAR-2012) | 94659-47-9 | N/A | |
1031547 | Amoxicillin Related Compound D (50 mg) ((4S)-2--5,5-dimeth ylthiazolidine-4-carboxylic acid,monosodium salt) | R051S0 | H0M291 (31-DEC-2017) | 1642559-71-4 | N/A | |
1031558 | Amoxicillin Related Compounds D and E Mixture (15 mg) | F0J382 | N/A | N/A | ||
1031569 | Amoxicillin Related Compound F (15 mg) (3-(4-Hydroxyphenyl )pyrazin-2-ol; phenylpyrazinediol) | F0J349 | 126247-63-0 | N/A | ||
1031570 | Amoxicillin Related Compound G (15 mg) ((2S,5R,6R)-6-{(R)-2 -[(R)-2-Amino-2-(4-h ydroxyphenyl)aceta mido]-2-(4-hydroxyp henyl)acetamido}-3, 3-dimethyl-7-oxo-4-t hia-1-azabicyclo[3.2. 0]heptane-2-carboxy lic acid) | R019S0 | F0J278 (31-JAN-2016) | 188112-75-6 | N/A | |
1031591 | Amoxicillin Related Compound I (25 mg) ((R)-2-Amino-2-(4-hydroxyphenyl)aceticacid) | R02120 | F1L294 (31-MAY-2017) | 22818-40-2 | N/A | |
1031605 | Amoxicillin Related Compound J (15 mg) (Mixture of amoxicillin and amoxicillin related compound J (open ring dimer)) | R064U0 | F0J150 (31-MAY-2017) | N/A | N/A | |
1031616 | Amoxicillin Related Compound H (15 mg) ((R)-2-(4-hydroxyph enyl)-2-pivalamidoac etic acid) | F066E0 | 205826-86-4 | N/A | ||
1032007 | Amphotericin B (125 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | K1M387 | K0H185 (30-NOV-2014) | 1397-89-3 | N/A | International Cold Chain Shipment Required |
1033000 | Ampicillin (200 mg) | K1M493 | K0D139 (31-JAN-2015) | 69-53-4 | N/A | |
1033203 | Ampicillin Sodium (125 mg) | R019R0 | H0I248 (30-JUN-2016) | 69-52-3 | N/A | |
1033247 | Ampicillin System Suitability Mixture(10 mg) | F0L226 | N/A | N/A | ||
1033407 | Ampicillin Trihydrate (200 mg) | I0M457 | H1L041 (30-SEP-2015) | 7177-48-2 | N/A | |
1034002 | Amprolium (200 mg) | H0K314 | G0C317 (31-JAN-2013) | 121-25-5 | N/A | |
1034308 | Amrinone (500 mg) (Inamrinone) | G | 60719-84-8 | N/A | ||
1034320 | Amrinone Related Compound A (100 mg) (5-carboxamide[3,4'- bipyridin]-6(1H)-one) (Inamrinone Related Compound A) | F1B042 | F (30-NOV-2010) | 62749-46-6 | N/A | |
1034341 | Amrinone Related Compound B (100 mg) (N-(1,6-dihydro-6-ox o-(3,4'-bipyridine)-5- yl)-2-hydroxypropan amide) (Inamrinone Related Compound B) | F-1 | F (31-MAR-2000) | N/A | N/A | |
1034363 | Amrinone Related Compound C (50 mg)(1,6-dihydro-6-oxo-( 3,4'-bipyridine)-5-car bonitrile) (Inamrinone Related Compound C) | F-1 | F (31-MAY-2000) | N/A | N/A | |
1034498 | alpha-Amylcinnamal dehyde Dimethyl Acetal (500 mg) | F0L267 | 91-87-2 | N/A | ||
1034501 | alpha-Amylcinnamyl Acetate (500 mg) | F0L288 | 7493-78-9 | N/A | ||
1034512 | alpha-Amylcinnamyl Alcohol (500 mg) | F0L262 | 101-85-9 | N/A | ||
1034523 | alpha-Amylcinnamyl Formate (500 mg) | F0L317 | 7493-79-0 | N/A | ||
1034738 | Anagrelide Hydrochloride (100 mg) | F0K113 | 823178-43-4 | N/A | ||
1034749 | Anagrelide Related Compound A (25 mg) (ethyl 2-(6-amino-2,3-dichl orobenzylamino)ace tate) | F0K164 | 85325-12-8 | N/A | ||
1034750 | Anagrelide Related Compound B (25 mg) ((2-amino-5,6-dichloroquinazolin-3(4H)-y l)acetic acid) | F0K172 | N/A | N/A | ||
1034771 | Anagrelide Related Compound C (25 mg) (Ethyl 2-(5,6-dichloro-2-imi ,2-dihydroquina zolin-3(4H)-yl)acetat e) | F0K162 | 70381-75-8 | N/A | ||
1034807 | Anastrozole (200 mg) | G0L030 | F0H034 (31-MAY-2013) | 120511-73-1 | N/A | |
1034818 | Anastrozole Related Compound A (20 mg) (2,2'-(5-methyl-1,3-p henylene)bis(2-meth ylpropanenitrile)) | F0H036 | 120511-72-0 | N/A | ||
1034862 | Andrographolide (50 mg) | F0I344 | 5508-58-7 | N/A | ||
1034873 | Powdered Andrographis Extract (500 mg) | F0I342 | 90244-84-1 | N/A | ||
1035005 | Anethole (4 x 0.5 mL) | G0L346 | F0E023 (30-JUN-2015) | 4180-23-8 | N/A | |
1035300 | 1,6-anhydro-D-gluco se (50 mg) | F0G227 | 498-07-7 | N/A | ||
1035402 | Anhydro Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)- 3,7-Dimethyl-8-[2-[(2 R)-6-oxo-3,6-dihydro -2H-pyran-2-yl]ethyl] -1,2,3,7,8,8a-hexahy dronaphthalen-1-yl 2,2-dimethylbutanoa te) | F007S0 | 210980-68-0 | N/A | ||
1035708 | Anhydrotetracycline Hydrochloride (25 mg) ((4S ,4aS ,12aS )-4-(Dimethylamino)- 3,10,11,12a-tetrahyd roxy-6-methyl-1,12-d ioxo-1,4,4a,5,12,12a -hexahydrotetracene -2-carboxamide monohydrochloride) | F023A0 | 13803-65-1 | N/A | ||
1036008 | Anileridine Hydrochloride CII (250 mg) | F | 126-12-5 | 0021601050 6 | Controlled | |
1036110 | Aniline (250 mg) | F036F0 | 62-53-3 | N/A | ||
1036507 | 3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile (25 mg)(AS) | G2D383 | G-1 (30-APR-2006) | 30078-48-9 | N/A | |
1036937 | p-Anisaldehyde (3 x 500 mg) | F0M439 | 123-11-5 | N/A | ||
1036948 | o-Anisaldehyde (3 x 0.5 mL) | F0L524 | 135-02-4 | N/A | ||
1037011 | Anisole (1.2 mL/ampule; 3 ampules) | F0E216 | 100-66-3 | N/A | ||
1037022 | Anisyl Butyrate (5 x 0.5 mL) | F0L343 | 6963-56-0 | N/A | ||
1037033 | Anisyl Propionate (5 x 0.5 mL) | F0L289 | 7549-33-9 | N/A | ||
1037044 | Anisyl Phenylacetate (5 x 0.5 mL) | F0L482 | 102-17-0 | N/A | ||
1038003 | Antazoline Phosphate (200 mg) | R019L0 | H (30-APR-2016) | 154-68-7 | N/A | |
1038025 | Antazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2- [benzyl(phenyl)amin o]acetamide) | F01990 | 26953-37-7 | N/A | ||
1039006 | Anthralin (200 mg) | I0B221 | H (30-NOV-2002) | 1143-38-0 | N/A | |
1039152 | Allyl Anthranilate (0.5 mL/ampule; 5 ampules) | F0L016 | 7493-63-2 | N/A | ||
1040005 | Antipyrine (200 mg) | R02990 | G2J201 (31-AUG-2016) | 60-80-0 | N/A | |
1040016 | Antipyrine Related Compound A (25 mg) (3-methyl-1-phenyl-1 H-pyrazol-5(4H)-one ) | F0L242 | 89-25-8 | N/A | ||
1040504 | Antithrombin III Human (4.38 IU) | F033S0 | 9000-94-6 | N/A | ||
1040683 | Apigenin (30 mg) | F0H245 | 520-36-5 | N/A | ||
1040708 | Apigenin-7-glucosid e (30 mg) | R03170 | H0L150 (31-AUG-2016) | N/A | N/A | |
1040854 | Apocarotenal (3 x 50 mg) (Beta-Apo-8'-Carote nal) | F0K231 | 1107-26-2 | N/A | ||
1041008 | Apomorphine Hydrochloride (250 mg) | I0M162 | H (30-APR-2014) | 41372-20-7 | N/A | |
1041609 | Apraclonidine Hydrochloride (100 mg) | I0G001 | H0B112 (31-DEC-2007) | 73218-79-8 | N/A | |
1041904 | Aprepitant (150 mg) | R047A0 | F0K081 (31-JAN-2017) | 170729-80-3 | N/A | |
1041915 | Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1 -[3,5-Bis(trifluoromet hyl)phenyl]ethoxy]-3 -(4-fluorophenyl)mor pholino]methyl]-1H-1 ,2,4-triazol-5(4H)-on e) | F0K082 | 1148113-53-4 | N/A | ||
1041926 | Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1 -[3,5-Bis(trifluoromet hyl)phenyl]ethoxy]-3 -(4-fluorophenyl)mor pholino]methyl]-1H-1 ,2,4-triazol-5(4H)-on e) | F0K083 | 172822-29-6 | N/A | ||
1041992 | Desfluoro Aprepitant (15 mg) (5--3-phenylmorpholino] methyl}-2H-1,2,4-triazol-3(4H)-one) | F01950 | 170729-76-7 | N/A | ||
1042055 | Arabinose (50 mg) | F02410 | 87-72-9 | N/A | ||
1042102 | L-Arabinitol (250 mg) | R05730 | F0E311 (30-NOV-2017) | 7643-75-6 | N/A | |
1042270 | Arachidyl Alcohol (125 mg) | F001A0 | 629-96-9 | N/A | ||
1042408 | Argatroban (350 mg) | F0M506 | 141396-28-3 | N/A | ||
1042419 | Argatroban Related Compound A (15 mg) ((2R,4R)-1-[N8-nitro- N2-(3-methylquinolin e-8-sulfonyl)-L-argin yl]-4-methylpiperidin e-2-carboxylic acid) | F0M521 | N/A | N/A | ||
1042420 | Argatroban Related Compound B (20 mg) (Ethyl (4R)-1-[N^8-nitro-L- arginyl]-4-methylpip eridine-2-carboxylat e dihydrochloride) | F0M536 | N/A | N/A | ||
1042437 | Argatroban Related Compound C (20 mg) ((2R,4R)-1-[N^8-ami no- N^2-(3-methyl-1,2,3, 4-tetrahydroquinolin e-8-sulfonyl)-L-argin yl]-4-methylpiperidin e-2-carboxylic acid) | F0M483 | N/A | N/A | ||
1042500 | L-Arginine (200 mg) | I1J237 | I0J237 (31-JUL-2016) | 74-79-3 | N/A | |
1042554 | Arginine Ethyl Ester Dihydrochloride (250 mg) | F0K087 | 36589-29-4 | N/A | ||
1042601 | Arginine Hydrochloride (125 mg) | R00400 | G1G075 (28-FEB-2015) | 32042-43-6 | N/A | |
1042634 | Aripiprazole (200 mg) | R045S0 | R01490 (31-OCT-2017) | 129722-12-9 | N/A | |
1042645 | Aripiprazole Related Compound B (25 mg) (7-(4-hydroxy-butoxy )-3,4-dihydroquinolin -2(1H)-one) | F0L066 | 889443-20-3 | N/A | ||
1042656 | Aripiprazole Related Compound C (25mg) (1-(2,3-dichlorophen yl)piperazine hydrochloride) | F0L067 | 119532-26-2 | N/A | ||
1042689 | Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophen yl)-1-[4-(2-oxo-1,2,3, 4-tetrahydroquinolin- 7-yloxy)butyl]piperaz in 1-oxide) | R035L0 | F0L068 (31-DEC-2016) | 573691-09-5 | N/A | |
1042690 | Aripiprazole Related Compound G (25 mg) (7-quinolin-2(1 H)-one) | F0L069 (28-FEB-2018) | 129722-25-4 | N/A | ||
1042703 | Arsanilic Acid (25 mg) | F | 98-50-0 | N/A | ||
1042714 | Aripiprazole Related Compound H (25 mg) (7-(4-{4-[4-(2,3-dichl orophenyl)piperazin- 1-yl]butoxy}butoxy)-3,4-dihydroquinolin- 2(1H)-one) | F0L070 | N/A | N/A | ||
1042747 | Artemisinin (50 mg) ((3R,5aS,6R,8aS,9R ,12S,12aR)-Octahyd ro-3,6,9-trimethyl-3, 12-epoxy-12H-pyran o[4,3-j]-1,2-benzodio xepin-10(3H)-one) | R057Y0 | F003U0 (28-FEB-2018) | 63968-64-9 | N/A | |
1042780 | Artemether (100 mg) | H0M313 | G0L560 (31-JAN-2015) | 71963-77-4 | N/A | |
1042805 | Artemether Related Compound B (15 mg) ((3R,5aS,6R,8aS,9R ,10R,12R,12aR)-De cahydro-10-methoxy -3,6,9-trimethyl-3,12 -epoxy-12H-pyrano[ 4,3-j]-1,2-benzodiox epin) | F0I295 | 71939-51-0 | N/A | ||
1042850 | Artesunate (200 mg) | F1L256 | F0J018 (31-JUL-2014) | 88495-63-0 | N/A | |
1042907 | Articaine (40 mg) | F0I197 | 23964-58-1 | N/A | ||
1042918 | Articaine Hydrochloride (125mg) | F1K153 | F0I198 (30-NOV-2012) | 23964-57-0 | N/A | |
1042929 | Articaine Related Compound A (40 mg) (Methyl 4-methyl-3-[2-(propy lamino)acetamido]thi ophene-2-carboxylat e) | F0I199 | N/A | N/A | ||
1042930 | Articaine Related Compound B (25 mg) (4-methyl-3-thiophene-2-ca rboxylic acid) | F0K104 | 114176-52-2 | N/A | ||
1042962 | Articaine Related Compound E (40 mg) (Methyl 3-[2-(isopropylamino )propanamido]-4-me thylthiophene-2-carb oxylate) | F0I200 | N/A | N/A | ||
1043003 | Ascorbic Acid (1 g) (Vitamin C) | R1K253 | R0K142 (30-JUN-2015) | 50-81-7 | N/A | |
1043105 | Ascorbyl Palmitate (500 mg) | R010G0 | F1I336 (30-APR-2015) | 137-66-6 | N/A | |
1043149 | Ascorbyl Stearate (500 mg) | F053E0 | 10605-09-1 | N/A | ||
1043309 | Powdered Ashwagandha Root Extract (1 g) | F1I273 | F0I273 (30-APR-2017) | 90147-43-6 | N/A | |
1043331 | Asiaticoside (30 mg) | R04440 | F0J354 (31-JUL-2017) | 16830-15-2 | N/A | |
1043502 | Asparagine Anhydrous (200 mg) | R05130 | F0E013 (31-JUL-2017) | 70-47-3 | N/A | |
1043513 | Asparagine Monohydrate (200 mg) | F0E012 | 5794-13-8 | N/A | ||
1043706 | Aspartame (200 mg) | R054U0 | R008X1 (31-JUL-2017) | 22839-47-0 | N/A | |
1043728 | Aspartame Related Compound A (25 mg) (5-Benzyl-3,6-dioxo- 2-piperazineacetic Acid) | J0J061 | I0D208 (30-NOV-2011) | 5262-10-2 | N/A | |
1043750 | Aspartame Acesulfame (200 mg) | F0C137 | 106372-55-8 | N/A | ||
1043819 | Aspartic Acid (100 mg) | R05750 | F0B087 (31-OCT-2017) | 56-84-8 | N/A | |
1044006 | Aspirin (500 mg) | H | G-1 (30-NOV-2002) | 50-78-2 | N/A | |
1044108 | Astragaloside IV (100 mg) ((3beta,6alpha,9beta ,16beta,20R,24S)-1 6,25-Dihydroxy-3-(b eta-D-xylopyranosyl oxy)-20,24-epoxy-9, 19-cyclolanostan-6-y l beta-D-glucopyrano side) | F01460 | 84687-43-4 | N/A | ||
1044119 | Astragalus Root Dry Extract (1 g) | F01440 | N/A | N/A | ||
1044200 | Astaxanthin (Synthetic) (3 x 30 mg) | R036P0 | R006L0 (31-JUL-2017) | 7542-45-2 | N/A | |
1044210 | Astaxanthin Esters from Haematococcus pluvialis (5 x 100 mg) | R034E0 | F0J415 (31-OCT-2017) | N/A | N/A | |
1044301 | Astemizole (200 mg) | F | 68844-77-9 | N/A | ||
1044334 | Atazanavir Sulfate (200 mg) | F020D0 | 229975-97-7 | N/A | ||
1044345 | Atazanavir System Suitability Mixture (25 mg) (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer) | F015B1 | F015B0 (30-APR-2016) | N/A | N/A | |
1044356 | Atazanavir Related Compound A (25 mg) ((S)-2-[(Methoxycarb onyl)amino]-3,3-dim ethylbutanoic acid) | F020K0 | 162537-11-3 | N/A | ||
1044403 | Atenolol (200 mg) | I1F032 | I0F032 (31-AUG-2016) | 29122-68-7 | N/A | |
1044469 | Atomoxetine Hydrochloride (125 mg) | R008H0 | F0J366 (30-NOV-2015) | 82248-59-7 | N/A | |
1044470 | Atomoxetine Related Compound A (10 mg) (3-(Methylamino)-1- phenylpropan-1-ol) | F0J401 | 42142-52-9 | N/A | ||
1044488 | Atomoxetine Related Compound B (10 mg)(N-Methyl-3-phenyl- 3-(m-tolyloxy)propan-1-amine hydrochloride) | F0J334 | 873310-28-2 | N/A | ||
1044491 | Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl- 3-(p-tolyloxy)propan- 1-amine hydrochloride) | F0J335 | 873310-31-7 | N/A | ||
1044516 | Atorvastatin Calcium (100 mg) | H0M533 | G0J276 (31-JAN-2015) | 344423-98-9 | N/A | |
1044527 | Atorvastatin Related Compound A (20 mg) (Desfluoro impurity, or (3R,5R)-7-[3-(phenyl carbamoyl)-2-isopro pyl-4,5-diphenyl-1H- pyrrol-1-yl]-3,5-dihyd roxyheptanoic acid calcium salt) | H0L181 | G0J255 (30-NOV-2013) | 433289-83-9 | N/A | |
1044538 | Atorvastatin Related Compound B (20 mg) (3S,5R isomer, or (3S,5R)-7-[3-(phenyl carbamoyl)-5-(4-fluo rophenyl)-2-isopropy l-4-phenyl-1H-pyrrol- 1-yl]-3,5-dihydroxyh eptanoic acid calcium salt) | H0L297 | G0J256 (31-AUG-2013) | 887196-25-0 | N/A | |
1044549 | Atorvastatin Related Compound C (20 mg) (Difluoro impurity, or Calcium (3R,5R)-7-[2,3-Bis(4 -fluorophenyl)-5-isop ropyl-4-(phenylcarba moyl)-1H-pyrrol-1-yl] -3,5-dihydroxyhepta noate (1:2)) | H1M148 (28-FEB-2018) | 693793-53-2 | N/A | ||
1044550 | Atorvastatin Related Compound D (10 mg) (Epoxide impurity, or 3-(4-Fluorobenzoyl)- 2-isobutyryl-3-pheny l-oxirane-2-carboxyli c acid phenylamide) | R00280 | H0M138 (31-MAR-2016) | 148146-51-4 | N/A | |
1044571 | Atorvastatin Related Compound E (10 mg) (3S, 5S enantiomer of Atorvastatin Calcium) | R002U0 | G0J426(31-MAR-2016) | 1105067-88-6 | N/A | |
1044582 | Atorvastatin Related Compound H (20 mg) (Lactone Impurity, 5-(4-Fluorophenyl)-1 -{2-[(2R, 4R)-4-hydroxy-6-oxo tetrahydro-2H-pyran -2-yl]ethyl}-2-isoprop yl-N,4-diphenyl-1H-p yrrole-3-carboxamid e) | R04610 | G0M500 (31-DEC-2017) | N/A | N/A | |
1044593 | Atorvastatin Related Compound I (20 mg) (tert-Butyl 2-((4R,6R)-6-{2-[2-(4 -fluorophenyl)-5-isop ropyl-3-phenyl-4-(ph enylcarbamoyl)-1H- pyrrol-1-yl]ethyl}-2,2- dimethyl-1,3-dioxan- 4-yl)acetate) | R03460 | F0K121 (31-JAN-2017) | N/A | N/A | |
1044651 | Atovaquone (200 mg) | R003Y0 | G0H328 (31-OCT-2015) | 95233-18-4 | N/A | |
1044662 | Atovaquone Related Compound A (25 mg) (cis-2-[4-(4-chloroph enyl)cyclohexyl]-3-h ydroxy-1,4-naphthoq uinone) | F0B188 | N/A | N/A | ||
1044800 | Atracurium Besylate (100 mg) | G0L391 | F1H342 (31-AUG-2014) | 64228-81-5 | N/A | |
1044913 | Atomoxetine S-Isomer (10 mg) ((S)-N-Methyl-3-phe nyl-3-(o-tolyloxy)pro pan-1-amine hydrochloride) | F0J333 | 82857-39-4 | N/A | ||
1045009 | Atropine Sulfate (500 mg) | R01050 | N0H159 (31-MAR-2016) | 5908-99-6 | N/A | |
1045337 | Avobenzone (500 mg) | R038Y0 | I0L261 (31-JUL-2017) | 70356-09-1 | N/A | |
1045508 | Aurothioglucose (100 mg) | I0E208 | H0B224 (31-AUG-2007) | 12192-57-3 | N/A | |
1045520 | Azacitidine (150 mg) | R056T0 | R012Q0 (31-DEC-2017) | 320-67-2 | N/A | |
1045539 | Azacitidine Related Compound A (15 mg) (4-Ami,3,5-triazi n-2(1H)-one) | F0L163 | 931-86-2 | N/A | ||
1045541 | Azacitidine Related Compound B (15 mg) (1-O-Acetyl-2,3,5-tri- O-benzoyl-Beta-D-ri bofuranose) | F0L164 | 6974-32-9 | N/A | ||
1045574 | Azacitidine Related Compound C (15 mg) (1-beta-D-Ribofuran osyl-3-guanylurea picrate) | R02800 | F0L319 (31-DEC-2016) | 931-86-2 | N/A | |
1045600 | Azaerythromycin A (100 mg) (9-Deoxo-9a-aza-9a -homoerythromycin A) | R02440 | H1L361 (31-MAY-2017) | 76801-85-9 | N/A | |
1045756 | Azaperone (200 mg) | F1F183 | F (30-SEP-2007) | 1649-18-9 | N/A | |
1045803 | Azatadine Maleate (200 mg) | G0B300 | F-1 (30-APR-2004) | 3978-86-7 | N/A | |
1045938 | Azathioprine Related Compound G (15 mg) (6-[(1-methyl-4-nitro- 1H-imidazol-5-yl)thio ]-9H-purin-2-amine) | F009L0 | 5581-52-2 | N/A | ||
1045993 | Azathioprine Related Compound A (15 mg) (1-methyl-4-nitro-1H -imidazol-5-amine) | F009K0 | 4531-54-8 | N/A | ||
1046001 | Azathioprine (200 mg) | I0J145 | H1H303 (31-MAR-2013) | 446-86-6 | N/A | |
1046012 | Azithromycin Identification Mixture (75 mg) | F0J232 | N/A | N/A | ||
1046023 | Azithromycin Related Compound H (15 mg) (3'-N-[[4-(acetylamin o)phenyl]sulfonyl]-3'- N-demethylazithrom ycin) | R068K0 | F0J303 (31-JAN-2018) | 612069-30-4 | N/A | |
1046045 | Azithromycin Related Compound F (25 mg) (3'-N-demethyl-3'-N- formylazithromycin) | R063K0 | F0H313 (31-JUL-2017) | 612069-28-0 | N/A | |
1046056 | Azithromycin (200mg) | R043P0 | J0I240(30-SEP-2017) | 117772-70-0 | N/A | |
1046067 | Azithromycin Identity (75 mg) | F0G111 | N/A | N/A | ||
1046078 | Desosaminylazithro mycin (15 mg) | R001W0 | G0H171 (31-MAR-2016) | N/A | N/A | |
1046089 | N-Demethylazithrom ycin (15 mg) | I0M262 | H0K433 (30-SEP-2014) | N/A | N/A | |
1046090 | Azithromycin N-Oxide (15 mg) | G0M507 | F1K426 (31-MAY-2015) | 90503-06-3 | N/A | |
1046147 | Azo-Aminoglutethimi de (100 mg) | F | N/A | N/A | ||
1046158 | Azelastine Hydrochloride (300 mg) | F0L494 | 79307-93-0 | N/A | ||
1046170 | Azelastine Related Compound B (20 mg) (N'-(1-methylazepan -4-yl)benzohydrazid e hydrochloride) | F0L553 | 117078-69-0 | N/A | ||
1046191 | Azelastine Related Compound D (20 mg) (4-(4-chlorobenzyl)p hthalazin-1(2H)-one) | F0L457 | 53242-88-9 | N/A | ||
1046202 | Azelastine Related Compound E (20 mg) (3-(4-chlorobenzylid ene)isobenzofuran-1 (3H)-one) | F0L463 | N/A | N/A | ||
1046205 | Aztreonam (200 mg) | R041F0 | R01520 (30-NOV-2016) | 78110-38-0 | N/A | |
1046307 | Aztreonam E-Isomer (15 mg) | R05390 | G1L370 (30-SEP-2017) | N/A | N/A | |
1046351 | Azure B (50 mg) (3-(Dimethylamino)- 7-(methylamino)phe nothiazin-5-ium chloride) | F035H0 | 531-55-5 | N/A | ||
1046409 | Open Ring Aztreonam (10 mg) | R014U0 | H1K400 (29-FEB-2016) | 87500-74-1 | N/A | |
1047300 | Bacampicillin Hydrochloride (200 mg) | G0B053 | F (30-NOV-2002) | 37661-08-8 | N/A | |
1048007 | Bacitracin Zinc (200 mg) | R048C0 | P0J327 (30-SEP-2017) | 1405-89-6 | N/A | |
1048200 | Baclofen (350 mg) | J1H297 | J0H297 (30-NOV-2016) | 1134-47-0 | N/A | |
1048222 | Baclofen Related Compound A (50mg) (4-(4-Chlorophenyl)- 2-pyrrolidinone) | R03750 | J0I383 (30-NOV-2016) | N/A | N/A | |
1048233 | Bacoside A3 (15 mg) | F0J420 | N/A | N/A | ||
1048244 | Powdered Bacopa Extract (500 mg) | F0J416 | 93164-89-7 | N/A | ||
1048255 | Balsalazide Disodium (200 mg) | F0I275 | 150399-21-6 | N/A | ||
1048266 | Balsalazide Related Compound A (100 mg) ((E)-5-[(p-carboxyph enyl)azo]-2-salicylic acid, disodium salt) | F0I277 | N/A | N/A | ||
1048277 | Balsalazide Related Compound B (25 mg) ((E)-5-((m-[(2-carbox yethyl)carbamoyl]ph enyl)azo)-2-salicylic acid) | F0I278 | N/A | N/A | ||
1048288 | Beta Glucan (1 g) (Beta Glucan from Baker's Yeast (Saccharomyces cerevisiae) | F0K129 | 9012-72-0 | N/A | ||
1048415 | Lagerstroemia speciosa Leaf Dry Extract (1g) | F00360 | N/A | N/A | ||
1048506 | Beclomethasone Dipropionate (200 mg) | M0L276 | L0D312 (30-JUN-2014) | 5534-09-8 | N/A | |
1048550 | Behenoyl Polyoxylglycerides (500 mg) | F0I006 | N/A | N/A | ||
1048572 | Bemotrizinol (200 mg) | F0G275 | 187393-00-6 | N/A | ||
1048583 | Bemotrizinol Impurity Mixture (100 mg) | F0H296 | N/A | N/A | ||
1048619 | Benazepril Hydrochloride (125 mg) | R023E0 | G1G280 (31-OCT-2016) | 86541-74-4 | N/A | |
1048620 | Benazepril Related Compound A (25 mg) ((3R)-3-[[(1R)-1-(eth oxycarbonyl)-3-phen ylpropyl]amino]-2,3, 4,5-tetrahydro-2-oxo -1H-1-benzazepine- 1-acetic acid, monohydrochloride) | H1M034 | H0K411 (30-SEP-2014) | N/A | N/A | |
1048630 | Benazepril Related Compound B (15 mg) ((3S)-3-[[(1R)-1-(eth oxycarbonyl)-3-phen ylpropyl]amino]-2,3, 4,5-tetrahydro-2-oxo -1H-1-benzazepine- 1-acetic acid, monohydrochloride) | J0M140 | I0K261 (30-SEP-2014) | N/A | N/A | |
1048641 | Benazepril Related Compound C (50 mg) ((3S)-3-[[(1S)-1-carb oxy-3-phenylpropyl] amino-2,3,4,5-tetrah ydro-2-oxo-1H-1-be nzazepine]-1-acetic acid) | F0C425 | 86541-78-8 | N/A | ||
1048652 | Benazepril Related Compound D (15 mg) (3-(1-Ethoxycarbony l-3-cyclohexyl-(1S)-p ropyl)amino-2,3,4,5-tetrahydro-2-oxo-1H- 1-(3S)-benzazepine- 1-acetic acid monohydrochloride) | G0M337 | F0F149 (31-MAY-2014) | N/A | N/A | |
1048663 | Benazepril Related Compound E (25 mg) (3-amino-2,3,4,5-tetr ahydro-2-oxo-1H-1-( 3S)-benzazepine-1- acetic acid, monohydrochloride) | G0M421 | F0F280 (30-JUN-2016) | N/A | N/A | |
1048674 | Benazepril Related Compound F (15 mg) (tert-butyl (S)-2-(3-amino-2-ox o-2,3,4,5-tetrahydro- 1H-benzo[b]azepin- 1-yl)acetate) | R034C0 | F0F150 (30-NOV-2016) | 109010-60-8 | N/A | |
1048685 | Benazepril Related Compound G (15 mg) (COLD SHIPMENT REQUIRED) ((3-(1-Ethoxycarbonyl-3-phenyl-(1S)-pro pyl)amino-2,3,4,5-tet rahydro-2-oxo-1H-1- (3S)-benzazepine)-1 -acetic acid, ethyl ester) | G0M066 | F0F155 (31-MAY-2014) | 103129-58-4 | N/A | |
1049000 | Bendroflumethiazide (200 mg) | I0M111 | H0C402 (31-MAR-2014) | 73-48-3 | N/A | |
1050009 | Benoxinate Hydrochloride (200 mg) | G0J084 | F-2 (30-NOV-2011) | 5987-82-6 | N/A | |
1050905 | Benzaldehyde (3 X 1 mL) (List Chemical) | I0M304 | H0L174 (31-JUL-2016) | 100-52-7 | N/A | List Chemical |
1050949 | Benzaldehyde Propylene Glycol Acetal (5 x 0.5 mL) | F0L333 | 2568-25-4 | N/A | ||
1050982 | Benzalkonium Bromide (C12) (150 mg) | F023U0 | 7281-04-1 | N/A | ||
1051001 | Benzalkonium Chloride (5 mL of approx. 10% aqueous solution) | L1I130 | L0D209 (30-NOV-2011) | 8001-54-5 | N/A | |
1051500 | Benzethonium Chloride (500 mg) | R026T0 | G1M022 (31-OCT-2017) | 121-54-0 | N/A | |
1051602 | Benzhydrol (50 mg) | F1L360 | F0L360 (30-APR-2015) | 91-01-0 | N/A | |
1054000 | Benzocaine (500 mg) | J2M122 | J1G214 (31-DEC-2014) | 94-09-7 | N/A | |
1055002 | Benzoic Acid (300 mg) | R044Q0 | H0L534 (31-DEC-2017) | 65-85-0 | N/A | |
1056005 | Benzonatate (1 g) | R04360 | I0B003 (31-MAR-2017) | 32760-16-0 | N/A | |
1056130 | Benzophenone (25 mg) (Diphenylmethanone ) | F011V0 | 119-61-9 | N/A | ||
1056504 | 1,4-Benzoquinone (200 mg) | I0L535 | H1G332 (31-MAR-2014) | 106-51-4 | N/A | |
1057507 | Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1, 3-benzenedisulfona mide) | J0L279 | I0F027 (28-FEB-2014) | 121-30-2 | N/A | |
1059003 | Benzphetamine Hydrochloride CIII (200 mg) | G0I243 | F2C272 (31-MAY-2011) | 5411-22-3 | 0021602010 5 | Controlled |
1061005 | Benztropine Mesylate (200 mg) | J0M328 | I1H117 (31-OCT-2013) | 132-17-2 | N/A | |
1061901 | Benzyl Alcohol (500mg/ampule) | R01940 | I0J228(31-JUL-2016) | 100-51-6 | N/A | |
1062008 | Benzyl Benzoate (5 g) | K0K392 | J0C060 (30-JUN-2013) | 120-51-4 | N/A | |
1062020 | Benzyl Disulfide (200 mg) | F021W0 | 150-60-7 | N/A | ||
1062074 | Benzyl Mercaptan (5 x 0.5 mL) | F0L563 | 100-53-8 | N/A | ||
1062085 | Benzyl Methyl Sulfide (5 x 0.5 mL) | F0L566 | 766-92-7 | N/A | ||
1064003 | 1-Benzyl-3-methyl-5 -aminopyrazole Hydrochloride (25 mg) | F-1 | N/A | N/A | ||
1064058 | 3-Benzyl-4-Heptano ne (5 x 0.5 mL) | F0M428 | 7492-37-7 | N/A | ||
1064122 | N-Benzyl-N-methyl- ethanolamine (3 x 0.2 mL) (2-[benzyl(methyl)a mino]ethanol) | F0L517 | 101-98-4 | N/A | ||
1065006 | Bephenium Hydroxynaphthoate (500 mg) | F | 3818-50-6 | N/A | ||
1065210 | Berberine Chloride (50 mg) | R04130 | F0E185 (30-SEP-2017) | 633-65-8 | N/A | |
1065480 | Beta Carotene (7 x100 mg) (COLD SHIPMENT REQUIRED) | G0M537 | F0J240(30-JUN-2016) | 7235-40-7 | N/A | Cold Shipment Required |
1065491 | Beta Carotene System Suitability (200 mg) (COLD SHIPMENT REQUIRED) | F0K128 | N/A | N/A | Cold Shipment Required | |
1065550 | Betadex Sulfobutyl Ether Sodium (500 mg) | R057H0 | F1K026 (31-DEC-2017) | 182410-00-0 | N/A | |
1065618 | Betahistine Hydrochloride (200 mg) | R030R0 | H0L386 (31-MAY-2017) | 5579-84-0 | N/A | |
1065695 | Betaine (1 g) | F0I379 | 107-43-7 | N/A | ||
1065709 | Betaine Hydrochloride (200 mg) | G0F176 | F-1 (30-SEP-2007) | 590-46-5 | N/A | |
1066009 | Betamethasone (200 mg) | R01380 | L0G059 (31-AUG-2015) | 378-44-9 | N/A | |
1067001 | Betamethasone Acetate (500 mg) | L0L112 | K0G274 (30-APR-2013) | 987-24-6 | N/A | |
1067307 | Betamethasone Benzoate (200 mg) | G0J080 | F-1 (31-DEC-2011) | 22298-29-9 | N/A | |
1067704 | Betamethasone Dipropionate (125 | R02220 | L0G377 (31-OCT-2015) | 5593-20-4 | N/A | |
mg) | ||||||
1068004 | Betamethasone Sodium Phosphate (500 mg) | R004E0 | M0H437 (31-MAY-2015) | 151-73-5 | N/A | |
1069007 | Betamethasone Valerate (200 mg) | R02150 | L0K350 (28-FEB-2017) | 2152-44-5 | N/A | |
1069018 | Betamethasone Valerate Related Compound A (50 mg) (9-Fluoro-11beta,17- dihydroxy-16beta-m ethyl-3,20-dioxopreg na-1,4-diene-21-yl valerate) | F1F229 | F0F229 (30-APR-2017) | 2240-28-0 | N/A | |
1069903 | Betaxolol Hydrochloride (200 mg) | R011H0 | G (30-APR-2015) | 63659-19-8 | N/A | |
1070006 | Betazole Hydrochloride (200 mg) | H | 138-92-1 | N/A | ||
1071009 | Bethanechol Chloride (200 mg) | J0M369 | I0H206 (31-JUL-2014) | 590-63-6 | N/A | |
1071202 | Bicalutamide (200 mg) | G0I298 | F0E321 (31-DEC-2011) | 90357-06-5 | N/A | |
1071213 | Bicalutamide | F0E322 | N/A | N/A | ||
Related Compound A (25 mg) (N-[4-cyano-3-(trifluo romethyl)phenyl]-3-[( 4-fluoro-phenyl)sulfi nyl]-2-hydroxy-2-met hyl-prop*) | ||||||
1071224 | Bicalutamide Related Compound B (10 mg) ((RS)-N-[4-cyano-3-( trifluoromethyl)phen yl]-3-(3-fluorophenyl sulfonyl)-2-hydroxy- 2-methylpropanamid e) | R006N0 | G0J195 (31-AUG-2015) | N/A | N/A | |
1071268 | Powdered Bilberry Extract (500 mg) | F0H286 | 84082-34-8 | N/A | ||
1071304 | Bile Salts (10 g) | K0L559 | J0G309 (28-FEB-2014) | 145-42-6 | N/A | |
1071381 | Biochanin A (20 mg) | F0L141 | 491-80-5 | N/A | ||
1071508 | Biotin (200 mg) | R04670 | J0L310 (31-JAN-2018) | 58-85-5 | N/A | |
1072001 | Biperiden (200 mg) | F2B080 | F-1 (29-FEB-2004) | 514-65-8 | N/A | |
1073004 | Biperiden | R038J0 | G0E182 | 1235-82-1 | N/A | |
Hydrochloride (200 mg) | (31-MAR-2017) | |||||
1073423 | Biphenyl (500 mg) | F017V0 | 92-52-4 | N/A | ||
1074007 | Bisacodyl (125 mg) | J0G408 | I1B162 (30-APR-2009) | 603-50-9 | N/A | |
1074030 | Bisacodyl Related Compound A (20 mg) (4,4'-(Pyridin-2-ylme thylene)diphenol) | F0K095 | 603-41-8 | N/A | ||
1074042 | Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylme thylene)diphenol) | F0K096 | 16985-05-0 | N/A | ||
1074051 | Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxypheny l)(pyridin-2-yl)methyl ]phenyl acetate) | F0K097 | 72901-16-7 | N/A | ||
1074073 | Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl )(pyridin-2-yl)methyl] | F0K098 | 111664-35-8 | N/A | ||
phenyl acetate) | ||||||
1074700 | 2,5-Bis(D-arabi, 2,3,4-tetrahydroxybu tyl)pyrazine (25 mg) | F | N/A | N/A | ||
1075203 | Bis(2-ethylhexyl)mal eate (2 g) (Maleic acid, bis(2-ethylhexyl)este r) | R04300 | H1K384 (30-NOV-2017) | 142-16-5 | N/A | |
1075305 | Bisdesmethoxycurcu min (30 mg) | F0H152 | 24939-16-0 | N/A | ||
1075509 | p-Bis(di-n-propyl)car bamylbenzenesulfon amide (50 mg) | F | N/A | N/A | ||
1075531 | Bismuth Citrate (100 mg) | F | 813-93-4 | N/A | ||
1075553 | Bismuth Subsalicylate (100 mg) | F1C394 | F (31-AUG-2005) | 14882-18-9 | N/A | |
1075600 | Bismuth Subcarbonate (1 g) (AS) | F0D324 | 5892-10-4 | N/A | ||
1075622 | Bismuth Subgallate (2 g) (AS) | F0D323 | 22650-86-8 | N/A | ||
1075644 | Bismuth Subnitrate | F0D388 | 1304-85-4 | N/A | ||
(1.5 g) (AS) | ||||||
1075677 | Bisoctrizole (200 mg) | R010V0 | F0F222 (29-FEB-2016) | 103597-45-1 | N/A | |
1075688 | Bisoctrizole Related Compound A (25 mg) (2-(2H-Benzotriazol- 2-yl)-4-(1,1,3,3-tetra methylbutyl) phenol) | F0F225 | 3147-75-9 | N/A | ||
1075699 | Bisoctrizole Resolution Mixture (50 mg) | F0F239 | N/A | N/A | ||
1075757 | Bisoprolol Fumarate (200 mg) | R01980 | H0J057 (30-SEP-2016) | 104344-23-2 | N/A | |
1075892 | Bisphenol A (200 mg) | F059D0 | 80-05-7 | N/A | ||
1076057 | Borage Seed Oil (1 g) | F0M139 | 84012-16-8 | N/A | ||
1076115 | Bosentan (200 mg) | R012A0 | F0L283 (31-MAR-2016) | 157212-55-0 | N/A | |
1076126 | Bosentan Related Compound A (15 mg) (4-(tert-butyl)-N-[6-c hloro-5-(2-methoxyp | F0L411 | 150727-06-3 | N/A | ||
henoxy)-(2,2'-bipyri midin)-4-yl] benzenesulfonamide ) | ||||||
1076137 | Bosentan Related Compound B (15 mg) (4-(tert-butyl)-N-[6-h ydroxy-5-(2-methoxy phenoxy)-(2,2'-bipyri midin)-4-yl]benzene sulfonamide) | F0L345 | 174227-14-6 | N/A | ||
1076148 | Bosentan Related Compound C (15 mg) (1,2-bis(oxy)ethane) | F0L304 | 1097263-60-9 | N/A | ||
1076159 | Bosentan Related Compound D (15 mg) (4,6-dichloro-5-(2-m ethoxyphenoxy)-2,2' -bipyrimidine) | F0L300 | 150728-13-5 | N/A | ||
1076160 | Bosentan Related Compound E (15 mg) (4-(tert-butyl)benzen esulfonamide) | F0L301 | 6292-59-7 | N/A | ||
1076192 | BSA for Protein Quantitation (5 x 1 mL) | F026Q0 | 9048-46-8 | N/A | ||
1076206 | Powdered Black Cohosh Extract (1.5 g) | F0D086 | 84776-26-1 | N/A | ||
1076250 | Boswellia Serrata Extract (1 g) | F0J024 | N/A | N/A | ||
1076261 | 3-Acetyl-11-Keto-Be ta-Boswellic Acid (20 mg) | F0J011 | 67416-61-9 | N/A | ||
1076308 | Bleomycin Sulfate (15 mg) | L0L527 | K0K126 (30-JUN-2015) | 9041-93-4 | N/A | |
1076341 | Boric Acid (1 g) | F1D036 | F0D036 (30-APR-2016) | 10043-35-3 | N/A | |
1076352 | Bretylium Tosylate (200 mg) | G0I231 | F-1 (31-JUL-2010) | 61-75-6 | N/A | |
1076363 | Brinzolamide (200 mg) | G0K216 | F0C034 (30-SEP-2012) | 138890-62-7 | N/A | |
1076374 | Brinzolamide Related Compound | F0C033 | 154127-19-2 | N/A | ||
A (50 mg) ((S)-(-)-4-ethylamino -2,3-dihydro-2-(3-me thoxypropyl)-4H-thie no-[3,2,e]-thiazine-6- sulfonamide-1,1-dio xide) | ||||||
1076385 | Brinzolamide Related Compound B (50 mg) ((R)-4-Amino-2-(3-m ethoxypropyl)-3,4-di hydro-2H-thieno[3,2- e][1,2]thiazine-6-sulf onamide 1,1-dioxide oxalate) | R068J0 | F0C035 (31-OCT-2017) | N/A | N/A | |
1076400 | Brimonidine Tartrate (250 mg) | F034H0 | 70359-46-5 | N/A | ||
1076419 | Brimonidine Related Compound A (50 mg) (5-Bromoquinoxalin- 6-amine) | F034J0 | 50358-63-9 | N/A | ||
1076421 | Brimonidine Related Compound B (50 mg) (1-(5-Bromoquinoxal | F034K0 | 842138-74-3 | N/A | ||
in-6-yl)thiourea) | ||||||
1076454 | Brimonidine Related Compound E (15 mg) (2-(5-Bromoquinoxal in-6-yl)guanidine) | F06310 | 168329-48-4 | N/A | ||
1076465 | Bromazepam CIV (100 mg) (AS) | F0F064 | 1812-30-2 | 0021627480 1 | Controlled | |
1076501 | Bromocriptine Mesylate (150 mg) | J0E206 | I1C197 (31-AUG-2007) | 22260-51-1 | N/A | |
1077005 | Bromodiphenhydra mine Hydrochloride (200 mg) | F010R2 | F-1 (30-SEP-2015) | 1808-12-4 | N/A | |
1077708 | 8-Bromotheophylline (400 mg) | G | F (31-JUL-2002) | 10381-75-6 | N/A | |
1077887 | Bromperidol Decanoate (15 mg) | F0G395 | 75067-66-2 | N/A | ||
1078008 | Brompheniramine Maleate (125 mg) | J0H148 | I1A036 (30-SEP-2009) | 980-71-2 | N/A | |
1078201 | Budesonide (200 mg) | R036W0 | G0M194 (31-MAY-2017) | 51333-22-3 | N/A | |
1078245 | Budesonide Related Compound E (25 mg) (16alpha,17-[butylid enebis(oxy)]-11Beta, | F005X0 | 131918-64-4 | N/A | ||
21-dihydroxypregna- 1,4,14-triene-3,20-di one) | ||||||
1078267 | Budesonide Related Compound G (25 mg) (16alpha,17-[butylid enebis(oxy)]-11beta, 21-dihydroxypregna- 4-ene-3,20-dione) | F005Y0 | 137174-25-5 | N/A | ||
1078289 | Budesonide Related Compound L (25 mg) (16alpha,17-[butylid enebis(oxy)]-21-hydr oxypregna-1,4-diene -3,11,20-trione) | F00600 | 216453-74-6 | N/A | ||
1078303 | Bumetanide (125 mg) | R039M0 | J0L145 (31-MAY-2017) | 28395-03-1 | N/A | |
1078325 | Bumetanide Related Compound A (10 mg) (3-Amino-4-phenoxy -5-sulfamoylbenzoic Acid) | H0G264 | G0F031 (30-APR-2009) | N/A | N/A | |
1078336 | Bumetanide Related Compound B (25 | F-2 | 28328-53-2 | N/A | ||
mg) (3-Nitro-4-phenoxy-5 -sulfamoylbenzoic Acid) | ||||||
1078507 | Bupivacaine Hydrochloride (300 mg) | I0L104 | H2H088 (31-DEC-2014) | 14252-80-3 (an); 73360-54-0 (M | N/A | |
1078518 | Bupivacaine Related Compound A (50 mg) (6-(butylamino)-N-(2 ,6-dimethylphenyl)h ex*) (AS) | F0F154 | N/A | N/A | ||
1078529 | Bupivacaine Related Compound B (50 mg) (N-(2,6-dimethylphe nyl)piperidine-2-carb oxamide) | F2F156 | F1F156 (31-OCT-2016) | 15883-20-2 | N/A | |
1078573 | Buspirone Related Compound A (75 mg x 2) (2-(Piperazin-1-yl)py rimidine) | F015R0 | 20980-22-7 | N/A | ||
1078642 | Buspirone Related Compound K (50 | F015S0 | 1075-89-4 | N/A | ||
mg) (8-azaspiro[4.5]deca ne-7,9-dione) | ||||||
1078700 | Buprenorphine Hydrochloride CIII (50 mg) | R00770 | I0K247 (30-JUN-2015) | 53152-21-9 | 0021690640 2 | Controlled |
1078711 | Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en- 1-yl)-4,5alpha-epoxy -3-hydroxy-6-methox y-6alpha,14-ethano morphinan-7alpha-yl ]- 3,3-dimethylbutan-2- ol) | R018K0 | H0L456 (31-OCT-2015) | 457071-73-7 | 0021693330 1 | Controlled |
1078722 | Buprenorphine System Suitability Mixture CII (50 mg) (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphin e) | F05320 | N/A | 0021698172 5 | Controlled | |
1078733 | Bupropion Hydrochloride (200 | R010E0 | I0L057 (31-AUG-2016) | 31677-93-7 | N/A | |
mg) | ||||||
1078744 | Bupropion Hydrochloride Related Compound A (15 mg) (2-(tert-butylamino)- 4'-chloropropiophen one hydrochloride) | G0L359 | F0E082 (31-JAN-2015) | N/A | N/A | |
1078755 | Bupropion Hydrochloride Related Compound B (10 mg) (2-(tert-butylamino)- 3'-bromopropiophen one hydrochloride) | R01090 | G0L045 (30-SEP-2016) | N/A | N/A | |
1078766 | Bupropion Hydrochloride Related Compound C (40 mg) (1-(3-chlorophenyl)- 2-hydroxypropan-1- one) (COLD SHIPMENT REQUIRED) | R012J0 | I0M146 (31-AUG-2016) | N/A | N/A | Cold Shipment Required |
1078799 | Bupropion Hydrochloride Related Compound | R015C0 | J0M184 (30-SEP-2016) | N/A | N/A | Cold Shipment Required |
F (40 mg) (1-(3-chlorophenyl)- 1-hydroxy-2-propan one) (COLD SHIPMENT REQUIRED) | ||||||
1078802 | Buspirone Hydrochloride (200 mg) | I0G171 | H0B301 (31-DEC-2008) | 33386-08-2 | N/A | |
1078813 | Buspirone Related Compound G (50 mg) (1,4-Di(pyrimidin-2-y l)piperazine) | F015T0 | 84746-24-7 | N/A | ||
1078824 | Buspirone Related Compound L (75 mg x 2) (8-(4-Chlorobutyl)-8- azaspiro[4.5]decane -7,9-dione) | F015U0 (31-DEC-2017) | 21098-11-3 | N/A | ||
1078835 | Buspirone Related Compound N (50 mg) (8,8'-(Butane-1,4-diy l)bis(8-azaspiro[4.5] decane-7,9-dione) | F015V0 | 257877-44-4 | N/A | ||
1078846 | Bupropion | F00610 | 905818-69-1 | N/A | ||
Hydrobromide (200 mg) | ||||||
1079000 | Butabarbital CIII (200 mg) | R032G0 | H0C007 (31-JUL-2017) | 125-40-6 | 0021602020 5 | Controlled |
1080000 | Butacaine Sulfate (600 mg) | F | 149-15-5 | N/A | ||
1081002 | Butalbital CIII (200 mg) | R028K0 | I0F204 (31-AUG-2016) | 77-26-9 | 0021602030 5 | Controlled |
1081501 | Butamben (200 mg) | H0K373 | G0F059 (30-SEP-2013) | 94-25-7 | N/A | |
1081807 | 1-Butanol (1.2 mL/ampule; 3 ampules) | G0M154 | F0E244 (30-JUN-2015) | 71-36-3 | N/A | |
1081829 | 2-Butanol (1.2 mL/ampule; 3 ampules) | R006S0 | F0E213 (30-SEP-2016) | 78-92-2 | N/A | |
1081842 | 2,3-Butanedithiol (3 x 1 g) | F0M159 | 4532-64-3 | N/A | ||
1082300 | Butoconazole Nitrate (200 mg) | G0J131 | F1B097 (31-AUG-2011) | 64872-77-1 | N/A | |
1082504 | Butorphanol Tartrate CIV (350 mg) | K1L363 | K0I267 (28-FEB-2015) | 58786-99-5 | 0021697200 6 | Controlled |
1082592 | Butyl Anthranilate (1 mL) (List Chemical) | F023W0 | 7756-96-9 | N/A | List Chemical | |
1082606 | Butyl Acetate (1.2 mL/ampule; 3 | F0E171 | 123-86-4 | N/A | ||
ampules) | ||||||
1082617 | Butyl Cinnamate (500 mg) | F0M389 | 538-65-8 | N/A | ||
1082628 | Butyl Heptanoate (5 x 0.5 mL) | F0L520 | 5454-28-4 | N/A | ||
1082639 | Butyl Stearate (500 mg) | F0L302 | 123-95-5 | N/A | ||
1082640 | Butyl Isothiocyanate (1 mL) | F023Y0 | 592-82-5 | N/A | ||
1082672 | Butyl Valerate (1 ml) | F023X0 | 591-68-4 | N/A | ||
1082708 | Butylated Hydroxytoluene (500 mg) | R052T0 | H1L344 (30-SEP-2017) | 128-37-0 | N/A | |
1082901 | Butyl 3-(butylamino)-4-ph enoxy-5-sulfamoylbe nzoate (25 mg) | F2L281 | F-1 (31-MAY-2013) | N/A | N/A | |
1082956 | Butane-1,3-diol (1 mL) | F0M073 | 107-88-0 | N/A | ||
1082967 | Butyl Hexanoate (3 x 500 mg) | F0M366 | 626-82-4 | N/A | ||
1083008 | 2-tert-Butyl-4-hydrox yanisole (200 mg) | L2E348 | L1E348 (30-NOV-2015) | 88-32-4 | N/A | |
1083100 | 3-tert-Butyl-4-hydrox yanisole (200 mg) | R043W0 | N0L032 (31-DEC-2017) | 121-00-6 | N/A | |
1083303 | tert-Butylmethyl ether (1.2 mL/ampule; 3 ampules) | F0E192 | 1634-04-4 | N/A | ||
1083529 | Butyl Palmitate (500 mg) | F0L291 | 111-06-8 | N/A | ||
1084000 | Butylparaben (200 mg) | J0L173 | I0C139 (30-APR-2014) | 94-26-8 | N/A | |
1084215 | Allyl Butyrate (5 x 0.5 mL) | F0L017 | 2051-78-7 | N/A | ||
1084259 | Butyraldehyde (3 x 1.2 mL) | R013G0 | F0L063 (31-DEC-2016) | 123-72-8 | N/A | |
1084292 | CD34+ Cell Enumeration System Suitability (1.24 x 10^4 CD34+ Cells) | F045V0 | N/A | N/A | ||
1084306 | Cabergoline (125 mg) | F0H240 | 81409-90-7 | N/A | ||
1084995 | Caffeic Acid (15 mg) | F0M198 | 331-39-5 | N/A | ||
1085003 | Caffeine (200 mg) | R04330 | K0K210 (30-SEP-2017) | 58-08-2 | N/A | |
1086006 | Caffeine Melting Point Standard (1 g) (Approximay 236 | K2M218 | K1L100 (31-JUL-2014) | 58-08-2 | N/A | |
degrees) | ||||||
1086039 | Caftaric Acid (20 mg) | F0L120 | 67879-58-7 | N/A | ||
1086108 | Calcifediol (75 mg) | R03160 | G2K349 (30-NOV-2016) | 63283-36-3 | N/A | |
1086141 | Calcipotriene (200 mg) | F029A0 | 112965-21-6 | N/A | ||
1086152 | Calcipotriene Related Compound C (15 mg) ((5E,7E,22E,24S)-2 4-Cyclopropyl-9,10-s ecochola-5,7,10(19), 22-tetraene-1alpha, 3beta,24-triol) | F03900 | 113082-99-8 | N/A | ||
1086200 | Calcitonin Salmon (20 mg) (COLD SHIPMENT REQUIRED) | F0K101 | 47931-85-1 | N/A | Cold Shipment Required | |
1086210 | Calcitonin Salmon Related Compound A (20 mg) (N-acetyl-Cys(1)-cal citonin salmon) (COLD SHIPMENT REQUIRED) | F0K102 | N/A | N/A | Cold Shipment Required | |
1086221 | Calcitonin Salmon Related Compound B (0.34 mg) (calcitonin salmon-glycine) (COLD SHIPMENT REQUIRED) | F0K103 | N/A | N/A | Cold Shipment Required | |
1086301 | Calcitriol (10 mg) (COLD SHIPMENT REQUIRED) | J0M085 | I0H427 (31-MAY-2014) | 32222-06-3 | N/A | |
1086312 | Calcitriol Solution (5 mL) (COLD SHIPMENT REQUIRED) | F2L073 | F1J229 (31-AUG-2013) | N/A | N/A | |
1086334 | Calcium Acetate (1 g) (AS) | F0D156 | 62-54-4 | N/A | ||
1086356 | Calcium Ascorbate (200 mg) | R053M0 | F-1 (28-FEB-2018) | 5743-28-2 | N/A | |
1086378 | Calcium Benzoate (200 mg) | F0J356 | 5743-30-6 | N/A | ||
1086403 | Calcium Carbonate (1 g) | R030A0 | F0D099 (28-FEB-2017) | 471-34-1 | N/A | |
1086436 | Calcium Chloride (1 g) (AS) | F0D153 | 10035-04-8 | N/A | ||
1086447 | Calcium Cyclamate (200 mg) | F0J378 | 5897-16-5 (dihydrate); | N/A | ||
139-06- | ||||||
1086800 | Calcium Gluceptate (200 mg) | R032C0 | F-1 (31-MAR-2017) | 29039-00-7 | N/A | |
1086822 | Calcium Gluconate Anhydrous (200 mg) | F0M412 | 299-28-5 | N/A | ||
1086833 | Calcium Gluconate Monohydrate (200 mg) | F0M413 | 69905-23-5 | N/A | ||
1086855 | Calcium Hydroxide (1 g) (AS) | F0D168 | 1305-62-0 | N/A | ||
1086866 | Calcium (-)-Hydroxycitrate (150 mg) | F0K014 | 921226-01-9 (anhydrous) | N/A | ||
1086888 | Calcium Lactate (1 g) | F0D227 | 63690-56-2 | N/A | ||
1086902 | Calcium Lactobionate (200 mg) | G0B138 | F-1 (31-JAN-2004) | 110638-68-1 | N/A | |
1086935 | Calcium Levulinate (1 g) (AS) | F0E142 | 5743-49-7 | N/A | ||
1086957 | Calcium Lignosulfonate (40-65) (2 g) | F0M267 | 8061-52-7 | N/A | ||
1087009 | Calcium Pantothenate (200 | P0L523 | O1H081 (31-MAR-2014) | 137-08-6 | N/A | |
mg) (Vitamin B5) | ||||||
1087031 | Tribasic Calcium Phosphate (1 g) (AS) | F0D394 | 12167-74-7 | N/A | ||
1087202 | Calcium Saccharate (200 mg) | G1I221 | G0I221 (30-APR-2015) | 5793-89-5 | N/A | |
1087359 | Calcium Stearate (2 g) (AS) | F0D255 | 1592-23-0 | N/A | ||
1087360 | Calcium Succinate (200 mg) | F037E0 | 159389-75-0 | N/A | ||
1087406 | Calcium Sulfate (1 g) (AS) | F0D236 | 10101-41-4 | N/A | ||
1087472 | Calycosin (50 mg) (7-Hydroxy-3-(3-hyd roxy-4-methoxyphen yl)-4H-chromen-4-on e) | F01430 | 20575-57-9 | N/A | ||
1087483 | Calycosin 7-O-beta-D-Glucopy ranoside (50 mg) (3-(3-Hydroxy-4-met hoxyphenyl)-4-oxo-4 H-chromen7-yl beta-D-glucopyrano side) | F01470 | 20633-67-4 | N/A | ||
1087508 | Camphor (1 g) | R02450 | G0J151 | 464-49-3 | N/A | |
(31-JUL-2016) | ||||||
1087520 | D-camphor sulfonic acid (100 mg) | F009A0 | 3144-16-9 | N/A | ||
1087701 | Candelilla Wax (250 mg) | F1D123 | F0D123 (31-MAY-2017) | 8006-44-8 | N/A | |
1087803 | Candesartan Cilexetil (100 mg) | F0K123 | 145040-37-5 | N/A | ||
1087814 | Candesartan Cilexetil Related Compound A (10 mg) (Ethyl 1--2-ethoxybenzimid azole-7-carboxylate) | F03410 | N/A | N/A | ||
1087825 | Candesartan Cilexetil Related Compound B (10 mg) (1-(Cyclohexyloxyca rbonyloxy)ethyl 1-{[2'-(1H- tetrazol-5-yl)bipheny l-4-yl]methyl}-2-oxo- 2,3-dihydrobenzimid azole-7-carboxylate) | F03420 | 869631-11-8 | N/A | ||
1087847 | Candesartan Cilexetil Related Compound D (10 mg) (1-ethyl 3-({2'-(2-ethyl-2H-tet razol-5-yl)-[1,1'-biph enyl]-4-yl}methyl)-2- oxo-2,3-dihydro-1H- benzimidazole-4-car boxylate) | F03430 | N/A | N/A | ||
1087869 | Candesartan Cilexetil Related Compound F (10 mg) (1-(Cyclohexyloxyca rbonyloxy)ethyl 2-ethoxy-1- -1H-benzimidazole-7 -carboxylate) | F03440 | N/A | N/A | ||
1087870 | Candesartan Cilexetil Related Compound G (10 | F03450 | 139481-59-7 | N/A | ||
mg) (1-{[2'-(1H-tetrazol-5 -yl)biphenyl-4-yl]met hyl}-2-ethoxybenzimi dazole-7-carboxylic acid) | ||||||
1090014 | Exo-tetrahydrocann abinol (1 mL) | F0G078 | N/A | N/A | ||
1090150 | Canola Oil (1 g) | F0L366 | 120962-03-0 | N/A | ||
1090706 | Capecitabine (200 mg) | R014M0 | G0J205 (30-APR-2016) | 154361-50-9 | N/A | |
1090717 | Capecitabine Related Compound A (15 mg) (5'-deoxy-5-fluorocyt idine) | R01540 | H0L146 (30-NOV-2017) | 66335-38-4 | N/A | |
1090728 | Capecitabine Related Compound B (20 mg) (5'-deoxy-5-fluorouri dine) | G0L481 | F2K212 (31-JUL-2014) | 3094-09-5 | N/A | |
1090739 | Capecitabine Related Compound C (10 mg) (2',3'-O-carbonyl-5'- deoxy-5-fluoro-N4-(p | R01550 | I0L372 (31-OCT-2016) | N/A | N/A | |
entyloxycarbonyl)cyt idine) (COLD SHIPMENT REQUIRED) | ||||||
1091006 | Capreomycin Sulfate (250 mg) | H0H181 | G1F191 (31-MAY-2009) | 1405-37-4 | N/A | |
1091028 | Capric Alcohol (5 x 30 mg) | F0M530 | 112-30-1 | N/A | ||
1091040 | Caprylic Acid (300 mg) | F1L115 | F0D378 (31-JAN-2014) | 124-07-2 | N/A | |
1091108 | Capsaicin (100 mg) | I0L046 | H0G235 (31-JAN-2014) | 404-86-4 | N/A | |
1091200 | Captopril (200 mg) | H | 62571-86-2 | N/A | ||
1091221 | Captopril Disulfide (100 mg) | I0M130 | H0F251 (31-MAY-2014) | 64806-05-9 | N/A | |
1091505 | Caprylocaproyl Polyoxylglycerides (200 mg) | F0C312 | N/A | N/A | ||
1092009 | Carbachol (200 mg) | G2M012 | G1E010 (31-MAR-2015) | 51-83-2 | N/A | |
1093001 | Carbamazepine (100 mg) | K1K246 | K0E209 (30-SEP-2014) | 298-46-4 | N/A | |
1093012 | Carbamazepine Related Compound A (30 mg) (10,11-dihydrocarba | R045K0 | H0K408 (30-NOV-2017) | 3564-73-6 | N/A | |
mazepine) | ||||||
1093023 | Carbamazepine Related Compound B (50 mg) (Iminostilbene) | F0G132 | 256-96-2 | N/A | ||
1093205 | Carbarsone (200 mg) | F | 121-59-5 | N/A | ||
1093500 | Carbenicillin Indanyl Sodium (300 mg) | G | 26605-69-6 | N/A | ||
1094004 | Carbenicillin Monosodium Monohydrate (200 mg) | G3G012 | G-2 (30-SEP-2007) | N/A | N/A | |
1095506 | Carbidopa (400 mg) | J0F258 | I (30-SEP-2007) | 38821-49-7 | N/A | |
1095517 | Carbidopa Related Compound A (25 mg) (3-O-Methylcarbidop a) | R065X0 | I1L005 (30-SEP-2016) | N/A | N/A | |
1096000 | Carbinoxamine Maleate (200 mg) | I1K403 | I0K403 (30-APR-2016) | 3505-38-2 | N/A | |
1096019 | Carbinoxamine Related Compound A (25 mg) ((4-Chlorophenyl)(py | F044R0 | 6318-51-0 | N/A | ||
ridin-2-yl)methanone ) | ||||||
1096021 | Carbinoxamine Related Compound B (25 mg) ((4-Chlorophenyl)(py ridin-2-yl)methanol) | F044S0 | 27652-89-7 | N/A | ||
1096032 | Carbinoxamine Related Compound C (25 mg) (N,N-Dimethyl-2-[ph enyl(pyridin-2-yl)met hoxy]ethan-1-amine oxalate) | F044T0 | N/A | N/A | ||
1096407 | Carboplatin (100 mg) | R01080 | I0J009 (30-APR-2015) | 41575-94-4 | N/A | |
1096509 | Carboprost Tromethamine (30 mg) | R058P0 | R009Q0 (30-APR-2017) | 58551-69-2 | N/A | |
1096510 | Carglumic Acid Related Compound A (30 mg) ((S)-3-(2,5-dioxoimid azolidin-4-yl)propan oic acid) | F048H0 | 17027-50-8 | N/A | ||
1096529 | Carglumic Acid Related Compound | F048J0 | N/A | N/A | ||
B (30 mg) ((S)-2,7-dioxo-1,3-di azepane-4-carboxyli c acid) | ||||||
1096531 | Carboxymethylcellul ose Calcium (1.5 g) (AS) | F0D336 | 9050-04-8 | N/A | ||
1096553 | Carboxymethylcellul ose Sodium (1.5 g) | F0D357 | 9004-32-4 | N/A | ||
1096564 | D-Carglumic Acid (30 mg) (N-Carbamoyl-D-glut amic acid) | F048G0 | 26117-15-7 | N/A | ||
1096586 | Carglumic Acid (200 mg) | F048F0 | 1188-38-1 | N/A | ||
1096597 | Carisoprodol Related Compound A (10 mg) (2-hydroxymethyl-2- methylpentyl carbamate) | F1K347 | F0K347 (31-OCT-2016) | 1471-56-3 | N/A | |
1096600 | Carisoprodol CIV (1 g) | H2L295 | H1L295 (30-NOV-2017) | 78-44-4 | 0021603100 1 | Controlled |
1096611 | Carmellose (500 mg) | F0I355 | 9000-11-7 | N/A | ||
1096622 | Carvedilol (200 mg) | H0M299 | G0K336 | 72956-09-3 | N/A | |
(30-NOV-2014) | ||||||
1096633 | Carvedilol Related Compound A (15 mg) (1-(4-(2-hydroxy-3-( 2-(2-methoxyphenox y)ethylamino)propox y)-9H-carbazol-9-yl)- 3-(2-(2-methoxyphe noxy)ethylamino)pro pan-2-ol) | R037U0 | F0H146 (30-JUN-2016) | 1198090-73-1 | N/A | |
1096644 | Carvedilol Related Compound B (15 mg) (3,3'-(2-(2-methoxyp henoxy)ethylazanedi yl)bis(1-(9H-carbazo l-4-yloxy)propan-2-ol )) | F0H192 | 918903-20-5 | N/A | ||
1096655 | Carvedilol Related Compound C (20 mg) (1-(9H-Carbazol-4-yl oxy)-3-(benzyl(2-(2- methoxyphenoxy)et hyl)amino)propan-2- ol) | R038F0 | F0H151 (31-DEC-2016) | 72955-94-3 | N/A | |
1096666 | Carvedilol Related Compound D (15 mg) (4-(Oxiran-2-ylmetho xy)-9H-carbazole) | F0H149 | 51997-51-4 | N/A | ||
1096677 | Carvedilol Related Compound E (15 mg) (2-(2-Methoxypheno xy)ethyl amine hydrochloride monohydrate) | F1H201 | F0H201 | 1836-62-0 | N/A | |
1096688 | Carvedilol System Suitability Mixture (25 mg) (carvedilol spiked with carvedilol related compound F) | F0I001 | N/A | N/A | ||
1096699 | Carprofen (200 mg) | R025W0 | G0H183 (31-OCT-2016) | 53716-49-7 | N/A | |
1096702 | Carprofen Related Compound A (50 mg) (carbazole) | F0F276 | 86-74-8 | N/A | ||
1096724 | Carmustine (75 mg) (COLD SHIPMENT REQUIRED) | R071D0 | F0I274 (31-JUL-2017) | 154-93-8 | N/A | |
1096735 | Carmustine Related | R035G0 | F0I284 | 2214-72-4 | N/A | |
Compound A (25 mg) (1,3-bis(2-chloroethy l)urea) | (30-SEP-2016) | |||||
1096746 | Carnosic acid (20 mg) | F011E0 | 3650-09-7 | N/A | ||
1096757 | Carteolol Hydrochloride (200 mg) | G0F326 | F-1 (31-DEC-2007) | 51781-21-6 | N/A | |
1096779 | Casticin (25 mg) | F0D358 | 479-91-4 | N/A | ||
1096790 | (+)-Catechin (25 mg) | R067H0 | F0H389 (28-FEB-2018) | 154-23-4 | N/A | |
1096804 | Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropio phenone Hydrochloride) | R006T0 | I (31-JAN-2014) | 16735-19-6 | 0021612350 2 | Controlled |
1096826 | Castor Oil (3 x 100 mg) (Mixture containing about 92% of Triricinolein) | F04450 | 8001-79-4 | N/A | ||
1096837 | Hydrogenated Castor Oil (250 mg) (Mixture containing | F04490 | 8001-78-3 | N/A | ||
about 83% triglyceride of 12-hydroxystearic acid) | ||||||
1096848 | Powdered Cat's Claw Extract (1 g) | F0H321 | 289626-41-1 | N/A | ||
1096860 | Carnauba Wax (200 mg) | F04510 | 8015-86-9 | N/A | ||
1096906 | Cefaclor (400 mg) | R027T0 | I0E145 (31-JUL-2016) | 70356-03-5 | N/A | |
1096917 | Cefaclor Delta-3 Isomer (15 mg) | R044L0 | I0L239 (31-JUL-2017) | N/A | N/A | |
1096994 | Cefadroxil System Suitability Mixture (25 mg) | F0M150 | N/A | N/A | ||
1097104 | Cefadroxil (200 mg) | K0L280 | J0H018 (30-NOV-2013) | 66592-87-8 | N/A | |
1097126 | Cefadroxil Related Compound B (25 mg) ((6R,7R)-7-amino-3- methyl-8-oxo-5-thia- 1-azabicyclo[4.2.0]o ct-2-ene-2-carboxyli c acid) | F0M141 | 22252-43-3 | N/A | ||
1097148 | Cefadroxil Related | F0M168 | 144790-28-3 | N/A | ||
Compound D (25 mg) ((6R,7R)-7-[(S)-2-A mino-2-(4-hydroxyph enyl)acetamido]-3-m ethyl-8-oxo-5-thia-1- azabicyclo[4.2.0]oct- 2-ene-2-carboxylic acid) | ||||||
1097192 | Cefadroxil Related Compound I (25 mg) ((6R,7R)-7-[(R)-2-a mino-2-(4-hydroxyph enyl)acetamido]-3-m ethyl-8-oxo-5-thia-1- azabicyclo[4.2.0]oct- 3-ene-2-carboxylic acid) | F0M169 | 147103-94-4 | N/A | ||
1097308 | Cefamandole Lithium (200 mg) | H | N/A | N/A | ||
1097400 | Cefamandole Nafate (250 mg) | I0J092 | H (31-MAR-2011) | 42540-40-9 | N/A | |
1097589 | Cefdinir Related Compound B (10 mg) ((6R,7R)-7-[2-(2-ami no-4-thiazolyl)aceta | R047H0 | R011W0 (31-OCT-2016) | 79350-10-0 | N/A | |
mido]-8-oxo-3-vinyl- 5-thia-1-azabicyclo[4 ,2,0]oct-2-ene-2-car boxylic acid) | ||||||
1097590 | Cefditoren Pivoxil (350 mg) | F0I164 | 117467-28-4 | N/A | ||
1097603 | Cefazolin (200 mg) | L1K284 | L0C345 (31-AUG-2013) | 25953-19-9 | N/A | |
1097614 | Cefdinir (300 mg) | R061W0 | G0K367 (30-NOV-2017) | 91832-40-5 | N/A | |
1097625 | Cefdinir Related Compound A (10 mg) (2(R)-2-[(Z)-2-(2-ami nothiazol-4-yl)-2-(hy droxyimino)acetamid o]-2-[(2RS,5RS)-5-m ethyl-7-oxo-2,4,5,7-t etrahydro-1H-furo[3, 4-d][1,3]thiazin-2-yl] acetic acid) | F0G373 | 178422-42-9 | N/A | ||
1097636 | Cefepime Hydrochloride (500 mg) | I0L200 | H0G278 (31-JAN-2014) | 123171-59-5 | N/A | |
1097658 | Cefixime (500 mg) | R03930 | G1M078 (31-MAY-2015) | 125110-14-7 | N/A | |
1097680 | Cefepime Related | F0L019 | 65872-41-5 | N/A | ||
Compound D (20 mg) ((Z)-2-(2-aminothiaz ol-4-yl)-2-(methoxyi mino)acetic acid) | ||||||
1097691 | Cefepime Related Compound E (20 mg) (1-{[(6R,7R)-7-Amin o-2-carboxy-8-oxo-5 -thia-1-azabicyclo[4. 2.0]oct-2-en-3-yl]met hyl}-1-methylpyrrolid in-1-ium chloride) | F0L020 | 103121-85-3 | N/A | ||
1097705 | Cefoperazone Dihydrate (200 mg) | R05230 | I0K056 (30-NOV-2017) | 113826-44-1 | N/A | |
1097727 | Cefetamet (15 mg) | F014W0 | 65052-63-3 | N/A | ||
1097750 | Cefonicid Sodium (1 g) (COLD SHIPMENT REQUIRED) | I0K020 | H0D105 (31-OCT-2014) | 61270-78-8 | N/A | |
1097771 | Cefmenoxime Hydrochloride (350 mg) | G0K110 | F (30-NOV-2011) | 75738-58-8 | N/A | |
1097782 | Cefmetazole (200 mg) | H0K343 | G0E260 (31-JAN-2013) | 56796-20-4 | N/A | |
1097807 | Ceforanide (200 mg) | G0M081 | F-1 (31-MAY-2014) | 60925-61-3 | N/A | |
1097909 | Cefotaxime Sodium (500 mg) | R021H0 | K0I356 (31-AUG-2016) | 64485-93-4 | N/A | |
1097953 | Cefotaxime Related Compound E (15 mg) ((Z)-2-(2-aminothiaz ol-4-yl)-N-{(5aR,6R)- 1,7-dioxo-1,3,4,5a,6, 7-hexahydroazeto[2, 1-b]furo[3,4-d][1,3]th iazin-6-yl}-2-(methox yimino)acetamide) | F01110 | 66340-33-8 | N/A | ||
1097975 | Cefotetan (500 mg) | R017L0 | I0E277 (30-SEP-2016) | 69712-56-7 | N/A | |
1097986 | Cefprozil Related Compound D (30 mg) ((6R,7R)-7-amino-8- oxo-3-[(Z)-prop-1-en yl]-5-thia-1-azabicycl o[4.2.0]oct-2-ene-2- carboxylic acid) | F0L132 | 106447-44-3 | N/A | ||
1097997 | Cefprozil L-Epimer (30 mg) ((6R,7R)-7-[(S)-2-a | F0L134 | 110764-35-7 | N/A | ||
mino-2-(4-hydroxyph enyl)acetamido]-8-o xo-3-[(Z)-prop-1-enyl ]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-c arboxylic acid) | ||||||
1098005 | Cefotiam Hydrochloride (350 mg) | H0J328 | G0B050 (30-JUN-2012) | 66309-69-1 | N/A | |
1098016 | Cefprozil Related Compound H (30 mg) ((6R,7R)-7-{(R)-2-[( R)-2-amino-2-(4-hyd roxyphenyl)acetamid o]-2-(4-hydroxyphen yl)acetamido}-8-oxo- 3-[(Z)-prop-1-enyl]-5 -thia-1-azabicyclo[4. 2.0]oct-2-ene-2-carb oxylic acid) | F0L133 | N/A | N/A | ||
1098027 | Cefpodoxime Proxetil (350 mg) | R044K0 | H0K009 (31-MAR-2017) | 87239-81-4 | N/A | |
1098038 | Cefprozil Related Compound K (30 mg) (3-(5-ethyl-7-oxo-2,4 | F0L162 | N/A | N/A | ||
,5,7-tetrahydro-1H-f uro[3,4-d][1,3]thiazin -2-yl)-6-(4-hydroxyp henyl)piperazine-2,5 -dione) | ||||||
1098049 | Cefprozil (E)-Isomer (50 mg) | R011C0 | H0H115 (30-SEP-2016) | 92676-86-3 | N/A | |
1098050 | Cefprozil (Z)-Isomer (200 mg) | J0L491 | I0H203 (31-MAR-2015) | 121412-77-9 | N/A | |
1098062 | Cefprozil (200 mg) | F0L131 | 121123-17-9 | N/A | ||
1098071 | Ceftiofur Hydrochloride (100 mg) | F02500 | 103980-44-5 | N/A | ||
1098082 | Ceftiofur Sodium (100 mg) | F0H388 | 104010-37-9 | N/A | ||
1098093 | Ceftiofur System Suitability Mixture (50 mg) (Mixture of about 93% of ceftiofur and total of about 2% of ceftiofur delta-3 isomer and ceftiofur E-isomer) | F024V0 | N/A | N/A | ||
1098107 | Cefoxitin (500 mg) | J1E038 | J0E038 (31-MAY-2017) | 35607-66-0 | N/A | |
1098118 | Cefpiramide (300 | G0J266 | F0C203 | 70797-11-4 | N/A | |
mg) | (31-AUG-2011) | |||||
1098129 | Ceftazidime, Delta-3-Isomer (15 mg) | R035X0 | R005C0 (31-OCT-2016) | N/A | N/A | |
1098130 | Ceftazidime Pentahydrate (300 mg) | I1K237 | I0I233 (31-OCT-2013) | 78439-06-2 | N/A | |
1098165 | Ceftiofur Sodium Trihydrate (100 mg) | F024W0 | N/A | N/A | ||
1098173 | Ceftizoxime (350 mg) | J0F181 | I0E262 (30-NOV-2007) | 68401-81-0 | N/A | |
1098184 | Ceftriaxone Sodium (350 mg) | H0J296 | G1D265 (31-JUL-2012) | 104376-79-6 | N/A | |
1098195 | Ceftriaxone Sodium E-Isomer (25 mg) | R011D0 | I2K393 (31-MAY-2016) | N/A | N/A | |
1098209 | Cefuroxime Sodium (200 mg) | I0I338 | H (30-NOV-2010) | 56238-63-2 | N/A | |
1098220 | Cefuroxime Axetil (350 mg) | R011M0 | H0K039 (30-SEP-2015) | 64544-07-6 | N/A | |
1098231 | Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1RS,6R,7R)-1-Ace toxyethyl 3-[(carbamoyloxy)m | R04630 | J0K016 (30-SEP-2017) | N/A | N/A | |
ethyl]-7-[(Z)-2-(furan -2-yl)-2-(methoxyimi no)acetamido]-8-oxo -5-thia-1-azabicyclo[ 4.2.0]oct-3-ene-2-ca rboxylate) | ||||||
1098253 | Cefuroxime Axetil E-isomers (15 mg) (1RS,6R,7R)-1-Acet oxyethyl 3-[(carbamoyloxy)m ethyl]-7-[(E)-2-(furan -2-yl)-2-(methoxyimi no)acetamido]-8-oxo -5-thia-1-azabicyclo[ 4.2.0]oct-2-ene-2-ca rboxylate) | F034U0 | 97232-96-7 | N/A | ||
1098300 | Cellulose Acetate (125 mg) | R01040 | G0E015 (31-MAR-2015) | 9004-35-7 | N/A | |
1098322 | Cellaburate (350 mg) (Cellulose Acetate Butyrate) | F0D220 | 9004-36-8 | N/A | ||
1098355 | Cellacefate (125 mg) (Cellulose Acetate Phthalate) | G0F177 | F-1 (31-MAY-2007) | 9004-38-0 | N/A | |
1098388 | Microcrystalline Cellulose (1 g) (AS) | F0D362 | 9004-34-6 | N/A | ||
1098399 | Silicified Microcrystalline Cellulose (1 g) | F0H401 | N/A | N/A | ||
1098402 | Powdered Cellulose (1 g) (AS) | F0D364 | 9004-34-6 | N/A | ||
1098504 | Celecoxib (200 mg) | G0M441 | F0L037 (28-FEB-2015) | 169590-42-5 | N/A | |
1098515 | Celecoxib Related Compound A (10 mg) (4-[5-(3-methylphen yl)-3-(trifluoromethyl) -1H-pyrazol-1-yl]ben zenesulfonamide) | R008U0 | F0L038 (31-JUL-2016) | 170570-01-1 | N/A | |
1098526 | Celecoxib Related Compound B (10 mg) (4-[3-(4-methylphen yl)-5-(trifluoromethyl) -1H-pyrazol-1-yl]ben zenesulfonamide) | R018P0 | F0L039 (30-JUN-2016) | 331943-04-5 | N/A | |
1098708 | Cephaeline Hydrobromide (200 mg) | G-1 | N/A | N/A | ||
1099008 | Cephalexin (400 mg) | K0J198 | J0D296 (29-FEB-2012) | 23325-78-2 | N/A | |
1099041 | Cephalexin Related | F018B0 | 34876-35-2 | N/A | ||
Compound D (25 mg) (3-Hydroxy-4-methyl thiophen-2(5H)-one) | ||||||
1099063 | Cephalexin Related Compound F (25 mg) ((6R,7R)-7-[(R)-2-A mino-2-phenylaceta mido]-3-methyl-8-ox o-5-thia-1-azabicycl o[4.2.0]oct-3-ene-2- carboxylic acid, dihydrate) | F018C0 | N/A | N/A | ||
1102000 | Cephalothin Sodium (200 mg) | R023F0 | I (31-JUL-2016) | 58-71-9 | N/A | |
1102408 | Cephapirin Benzathine (100 mg) | F03081 | F (31-DEC-2016) | 97468-37-6 | N/A | |
1102500 | Cephapirin Sodium (500 mg) | J0F171 | I-1 (30-JUN-2007) | 24356-60-3 | N/A | |
1102805 | Cephradine (200 mg) | J | I (30-APR-2000) | 58456-86-3 | N/A | |
1102929 | Cetirizine Hydrochloride (250 mg) | G0L451 | F0G124 (30-APR-2014) | 83881-52-1 | N/A | |
1102930 | Cetirizine Related Compound A (20 mg) ((RS)-2-[2-[4-[(4-Chl orophenyl)phenylme thyl]piperazin-1-yl]et hoxy]acetic acid ethyl ester oxalate) | R06380 | F0G122 (30-JUN-2016) | 246870-46-2 | N/A | |
1102941 | Cetirizine Related Compound B (25 mg) (2-(4-Benzhydrylpip erazin-1-yl)ethan-1- ol dihydrochloride) | F03380 | 108983-83-1 | N/A | ||
1102952 | Cetirizine Related Compound C (25 mg) (2-(2-ethoxy) acetamide) | F03390 | 83881-37-2 | N/A | ||
1102963 | Cetirizine Related Compound G (50 mg) (2-ethanol | F033A0 | N/A | N/A | ||
dihydrochloride) | ||||||
1102974 | Cetrimonium Bromide (1 g) | F0F316 | 57-09-0 | N/A | ||
1103003 | Cetyl Alcohol (100 mg) | R022B0 | I3I289 (31-JUL-2016) | 36653-82-4 | N/A | |
1103105 | Cetyl Palmitate (50 mg) | G0H314 | F0B241 (31-AUG-2010) | 540-10-3 | N/A | |
1104006 | Cetylpyridinium Chloride (500 mg) | J2K032 | J1K032 (31-AUG-2017) | 6004-24-6 | N/A | |
1105009 | Powdered Chaste Tree Extract (1.5 g) | F0C406 | 91722-47-3 | N/A | ||
1105280 | Chia Seed Oil (3 x 1 g) | F051A0 | 93384-40-8 | N/A | ||
1105315 | Chicoric Acid (20 mg) | F0L119 | 70831-56-0 | N/A | ||
1105417 | Powdered Chinese Salvia Extract (1 g) | F0L508 | 115939-25-8 | N/A | ||
1105508 | Chitosan (500 mg) | F0J417 | 9012-76-4 | N/A | ||
1106001 | Chlorambucil (125 mg) | G | F-1 (28-FEB-1999) | 305-03-3 | N/A | |
1106078 | Chlorambucil System Suitability Mixture (25 mg) (A mixture containing 4-[p-[Bis(2-chloroeth yl)amino]phenyl]buty | F049Y0 | N/A | N/A | ||
ric acid and a small amount of 4-[m-[Bis(2-chloroet hyl)amino]phenyl]but yric acid) | ||||||
1107004 | Chloramphenicol (200 mg) | R041V0 | O0H011 (31-JUL-2017) | 56-75-7 | N/A | |
1107300 | Chloramphenicol Palmitate (200 mg) | H0G266 | G-1 (31-DEC-2007) | 530-43-8 | N/A | |
1107401 | Chloramphenicol Palmitate Nonpolymorph A (200 mg) | G0H179 | F-1 (28-FEB-2009) | 530-43-8 | N/A | |
1107503 | Chloramphenicol Palmitate Polymorph A (100 mg) | G1D219 | G (31-OCT-2005) | 530-43-8 | N/A | |
1109000 | Chlordiazepoxide CIV (200 mg) | I2M083 | I1M083 (31-DEC-2017) | 58-25-3 | 0021603050 5 | Controlled |
1110009 | Chlordiazepoxide Hydrochloride CIV (200 mg) | G5I352 | G-4 (31-OCT-2010) | 438-41-5 | 0021603060 5 | Controlled |
1110020 | Chlordiazepoxide Related Compound A (25 mg) (7-Chloro-1,3-dihydr o-5-phenyl-2H-1,4-b enzodiazepin-2-one | H0L525 | G1H228 (31-OCT-2014) | 963-39-3 | N/A | |
4-Oxide) | ||||||
1111001 | Chlorhexidine (200 mg) | R02190 | G0L171 (31-DEC-2016) | 55-56-1 | N/A | |
1111012 | Chlorhexidine System Suitability Mixture (50 mg) | F016F0 | N/A | N/A | ||
1111103 | Chlorhexidine Acetate (200 mg) | I1L484 | I0J311 (30-NOV-2013) | 56-95-1 | N/A | |
1111908 | P-Chloroaniline (200 mg) | H0M240 | G0K206 (31-OCT-2014) | 106-47-8 | N/A | |
1112299 | 3-Chlorobenzoic Acid (25 mg) | F0M377 | 535-80-8 | N/A | ||
1112311 | Chlorobenzhydryl Piperazine (75 mg) | F02160 | 300543-56-0 | N/A | ||
1112423 | Indomethacin Related Compound B (25 mg) (4-chlorobenzoic acid) | F012F0 | 74-11-3 | N/A | ||
1112467 | 4-Chlorobenzophen one (30 mg) | F003D0 | 134-85-0 | N/A | ||
1112503 | Chlorobutanol (200 mg) | R043T0 | I0K276 (31-MAR-2017) | 6001-64-5 | N/A | |
1115545 | Chlorogenic Acid (50 mg) | R001C0 | F0C420 (31-JUL-2016) | 327-97-9 | N/A | |
1115556 | beta-Chlorogenin | F | N/A | N/A | ||
(20 mg) | ||||||
1115705 | Chloromethyl Isopropyl Carbonate (100 mg) | R043B0 | R021D0 (30-APR-2017) | 35180-01-9 | N/A | |
1116774 | Chlorophyll A (15 mg) | F0M405 | 479-61-8 | N/A | ||
1117008 | Chloroprocaine Hydrochloride (200 mg) | G1B285 | G0B285 (30-APR-2016) | 3858-89-7 | N/A | |
1117110 | Chloropropyl Vanillin (25 mg) (4-(3-Chloropropoxy )-3-methoxybenzald ehyde) | F051M0 | 151719-92-5 | N/A | ||
1118000 | Chloroquine Phosphate (500 mg) | J1L043 | J0J212 (30-APR-2014) | 50-63-5 | N/A | |
1118317 | Chloroquine Sulfate (500 mg) | F1L501 | F0J202 (31-DEC-2013) | 6823-83-2 | N/A | |
1118328 | Chloroquine Related Compound A (25 mg) (4,7-dichloroquinolin e) | F0J200 | 86-98-6 | N/A | ||
1118350 | Chloroquine Related Compound D (15 | F0L546 | 1476-52-4 | N/A | ||
mg) (7-Chloro-4- quinoline) | ||||||
1118361 | Chloroquine Related Compound E (15 mg) (N4-(5-chloroquinoli n-4-yl)-N1,N1-diethyl pentane-1,4-diamine oxalate) | F0L547 | N/A | N/A | ||
1118394 | Chloroquine Related Compound G (15 mg) (4-((7-chloroquinolin -4-yl)amino)-N,N-die thylpentan-1-amine oxide sulfate) | F0L548 | N/A | N/A | ||
1119309 | Chlorthalidone Related Compound A (10 mg) (4'-Chloro-3'-sulfam oyl-2-benzophenone Carboxylic Acid) | R002M0 | K0J098 (31-MAR-2016) | 5270-74-6 | N/A | |
1121005 | Chlorothiazide (200 mg) | I0L188 | H2J042 (30-SEP-2013) | 58-94-6 | N/A | |
1122700 | Chloroxylenol (125 mg) | R002L0 | G0I218 (31-AUG-2015) | 88-04-0 | N/A | |
1122722 | Chloroxylenol Related Compound A (25 mg) (2-chloro-3,5-dimeth ylphenol) | H0H221 | G0C275 (30-JUN-2009) | 5538-41-0 | N/A | |
1123000 | Chlorpheniramine Maleate (125 mg) | N0G316 | M0B020 (31-MAR-2009) | 113-92-8 | N/A | |
1123135 | Chlorpheniramine Related Compound B (25 mg) (di(pyridin-2-yl)amin e) | R040B0 | F0M273 (28-FEB-2017) | 1202-34-2 | N/A | |
1123146 | Chlorpheniramine Related Compound C (10 mg) (3-(4-chlorophenyl)- N-methyl-3-(pyridin- 2-yl)propan-1-amine maleate) | F0M275 | 22630-25-7 | N/A | ||
1124003 | Chlorphenoxamine Hydrochloride (200 mg) | F-1 | 562-09-4 | N/A | ||
1125006 | Chlorpromazine Hydrochloride (200 mg) | J1K257 | J (31-JUL-2013) | 69-09-0 | N/A | |
1126009 | Chlorpropamide (200 mg) | I0H184 | H (30-SEP-2009) | 94-20-2 | N/A | |
1129007 | Chlortetracycline Hydrochloride (200 mg) | L0F198 | K0C185 (31-JUL-2008) | 64-72-2 | N/A | |
1130006 | Chlorthalidone (200 mg) | R05140 | I1L127 (31-OCT-2017) | 77-36-1 | N/A | |
1130505 | Chlorzoxazone (350 mg) | J0H074 | I (31-DEC-2009) | 95-25-0 | N/A | |
1130527 | Chlorzoxazone Related Compound A (50 mg) (2-Amino-4-chloroph enol) | H0G336 | G-1 (30-NOV-2008) | 95-85-2 | N/A | |
1131009 | Cholecalciferol (30 mg/ampule; 5 ampules) (Vitamin D3) | Q0M510 | P0J194 (31-DEC-2014) | 67-97-0 | N/A | |
1131803 | Delta-4,6-cholestadi enol (30 mg) | F | 14214-69-8 | N/A | ||
1131858 | Cholestanol (200 mg) | F051B0 | 80-97-7 | N/A | ||
1131960 | Cholesterol (125 mg) | R062D0 | F0M491 (31-DEC-2017) | 57-88-5 | N/A | |
1132001 | Cholesteryl Caprylate (200 mg) | F1L277 | F (31-JUL-2013) | 1182-42-9 | N/A | |
1133004 | Cholestyramine Resin (500 mg) | J0J386 | I (31-JUL-2012) | 11041-12-6 | N/A | |
1133503 | Cholic Acid (2 g) | R016D0 | G0J404 (30-APR-2016) | 81-25-4 | N/A | |
1133536 | Choline Bitartrate (200 mg) | R028F0 | F0C057 (31-MAY-2016) | 87-67-2 | N/A | |
1133547 | Choline Chloride (500 mg) | H1J308 (31-JAN-2018) | 67-48-1 | N/A | ||
1133569 | Chondroitin Sulfate Sodium, Shark (300 mg) | F037Q0 | 9082-07-9 | N/A | ||
1133570 | Chondroitin Sulfate Sodium (300 mg) | R039A0 | H1K241 (31-JUL-2016) | 9082-07-9 | N/A | |
1133580 | Oversulfated Chondroitin Sulfate (10 mg) | R037X0 | H0M191 (30-APR-2017) | N/A | N/A | |
1133638 | Chromium Picolinate (100 mg) | F | 14639-25-9 | N/A | ||
1133842 | L-Citrulline (200 mg) | F046D0 | 372-75-8 | N/A | ||
1133853 | Cidofovir (100 mg) | F042K0 | 149394-66-1 | N/A | ||
1133864 | Cidofovir Enantiomer (15 mg) (1-[(R)-3-Hydroxy-2- (phosphonomethoxy )propyl]cytosine | F042P0 | N/A | N/A | ||
dihydrate) | ||||||
1133875 | Cidofovir Related Compound A (15 mg) (1-[(S)-3-Hydroxy-2- (O-ethylphosphono methoxy)propyl]cyto sine) | F042X0 | 1312776-50-3 | N/A | ||
1133886 | Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2- (O,O-diethylphospho nomethoxy)propyl]cy tosine hydrochloride) | F042Y0 | N/A | N/A | ||
1133897 | Cinnamaldehyde (3 x 100 mg) | F057Q0 | 14371-10-9 | N/A | ||
1133900 | Cinnamomum Cassia Twig Powder (5 g) | F057L0 | 84961-46-6 | N/A | ||
1133933 | Cinnamic Acid (100 mg) | R041T0 | F0L161 (30-APR-2017) | 140-10-3 | N/A | |
1133999 | Allyl Cinnamate (0.5 mL/ampule; 5 ampules) | F0L025 | 1866-31-5 | N/A | ||
1134007 | Chymotrypsin (300 mg) (COLD SHIPMENT REQUIRED) | J0F105 (31-JAN-2018) | 9004-07-3 | N/A | ||
1134018 | Ciclopirox (50 mg) | G1K115 | G0G398 (31-JUL-2012) | 29342-05-0 | N/A | |
1134029 | Ciclopirox Related Compound A (25 mg) (3-Cyclohexyl-4,5-di hydro-5-methyl-5-iso xazolyl acetic acid) | H0L577 | G0G212 (28-FEB-2014) | N/A | N/A | |
1134030 | Ciclopirox Olamine (125 mg) | J0L408 | I0F067 (30-JUN-2014) | 41621-49-2 | N/A | |
1134040 | Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-met hyl-2-pyrone) | H1M545 | H0M545 (01-MAR-2016) | 14818-35-0 | N/A | |
1134051 | Cilastatin Ammonium Salt (100 mg) | R012Y0 | I0J337 (30-SEP-2015) | N/A | N/A | |
1134062 | Cimetidine (200 mg) | J0H291 | I1C081 (28-FEB-2010) | 51481-61-9 | N/A | |
1134073 | Cimetidine Hydrochloride (200 mg) | G0G176 | F (31-AUG-2008) | 70059-30-2 | N/A | |
1134084 | Ciclopirox Related Compound C (10 mg) (6-Cyclohexyl-4-met hylpyridin-2(1H)-one ) | F0K084 | 67587-24-0 | N/A | ||
1134118 | Cisatracurium Besylate (350 mg) | F0M554 | 96946-42-8 | N/A | ||
1134120 | Cisapride (200 mg) | F0H112 | 260779-88-2 | N/A | ||
1134131 | Cisatracurium Besylate System Suitability Mixture (20 mg) | F0M559 | N/A | N/A | ||
1134142 | R-Citalopram Oxalate (10 mg), (R-1-[3-(dimethylami no)propyl]-1-(p-fluor ophenyl)-5-phthalan carbonitrile oxalate) | H0M319 | G0L158 (31-OCT-2014) | 219861-53-7 | N/A | |
1134153 | Cilostazol (200 mg) | G0M316 | F0G071 (31-AUG-2014) | 73963-72-1 | N/A | |
1134164 | Cilostazol Related Compound A (50 mg) (6-hydroxy-3,4-dihyd ro-1H-quinolin-2-one | F0G160 | 54197-66-9 | N/A | ||
) | ||||||
1134175 | Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl- 1H-tetrazol-5-yl)-but oxy]-1H-quinolin-2-o ne) | F0G073 | 73963-62-9 | N/A | ||
1134186 | Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl- 1H-tetrazol-1-yl)buty l)-6-(4-(1-cyclohexyl- 1H-tetrazol-5-yl)buto xy)-3,4-dihydroquino lin-2(1H)-one) | F0G074 | 865792-18-3 | N/A | ||
1134197 | Citalopram Related Compound G (25 mg) (1-(4'-fluorophenyl)- 1-(3-dimethylaminop ropyl)-5-chlorophthal ane hydrobromide) | F0G221 | N/A | N/A | ||
1134200 | Cladribine (200 mg) | R038Q0 | F0F243 (30-SEP-2016) | 4291-63-8 | N/A | |
1134211 | Cladribine Related | R009R0 | F0F244 | 24757-70-8 | N/A | |
Compound A (20 mg) (2-methoxy-2'-deoxy adenosine) | (31-MAY-2016) | |||||
1134222 | Citalopram Related Compound H (25 mg) (1-(4'-fluorophenyl)- 1-(3-dimethylaminop ropyl)-5-bromophtha lane hydrobromide) | F0G224 | 479065-02-6 | N/A | ||
1134233 | Citalopram Hydrobromide (200 mg) | G0J045 | F1G292 (30-NOV-2011) | 59729-32-7 | N/A | |
1134244 | Citalopram Related Compound A (25 mg) (1-(3-dimethylamino propyl)-1-(4-fluoroph enyl)-1,3-dihydroiso benzofuran-5-carbox amide) | R015E0 | G0L327 (30-JUN-2016) | 64372-56-1 | N/A | |
1134255 | Citalopram Related Compound B (25 mg) (1-[3-(dimethylamino )propyl]-1-(4-fluorop | G0L552 | F0F212 (31-JUL-2014) | N/A | N/A | |
henyl)-3-hydroxy-1,3 -dihydroisobenzofur an-5-carbonitrile oxalate) | ||||||
1134266 | Citalopram Related Compound C (25 mg) (3-(3-Dimethylamino propyl)-3-(4-fluoroph enyl)-6-cya(3H)- isobenzofuranone oxalate) | R030U0 | G0L177 (30-APR-2016) | N/A | N/A | |
1134277 | Citalopram Related Compound D (15 mg) 1-(4-Fluorophenyl)-1 -(3-methylaminoprop yl)-1,3-dihydroisobe nzofuran-5-carbonitri le hydrobromide | R01270 | H0L320 (31-MAR-2016) | N/A | N/A | |
1134288 | Citalopram Related Compound E (25 mg) (1-(3-dimethylamino propyl)-1-(4-fluoroph enyl)-1,3-dihydroiso benzofuran-5-carbo | G0M155 | F0F208 (31-OCT-2014) | N/A | N/A | |
nitrile-N-oxide hydrochloride) | ||||||
1134299 | Citalopram Related Compound F (200 mg) (dimethyl-(1-methyl- 3,3-diphenyl-allyl)-a mine hydrochloride) | F1K331 | F0F169 (31-JAN-2013) | 55011-89-7 | N/A | |
1134313 | Ciprofloxacin (200 mg) | I0L049 | H0E306 (30-SEP-2013) | 85721-33-1 | N/A | |
1134324 | Ciprofloxacin Ethylenediamine Analog (25 mg) (1-Cyclopropyl-6-flu oro-1, 4-dihydro-4-oxo-7-[( 2-aminoethyl)-amino ]-3-quinolinecarboxyl ic acid hydrochloride) | R013T0 | K0H239 (31-JUL-2015) | N/A | N/A | |
1134335 | Ciprofloxacin Hydrochloride (400 mg) | J1L040 | J0H307 (31-AUG-2014) | 86393-32-0 | N/A | |
1134346 | Ciprofloxacin Related Compound A (25 mg) | F0E333 | N/A | N/A | ||
(7-Chloro-1-cyclopro pyl-4-oxo-6-(piperazi n-1-yl)-1,4-dihydroq uinoline-3-carboxylic acid hydrochloride salt) (AS) | ||||||
1134357 | Cisplatin (100 mg) | R00510 | J0L420 (30-APR-2016) | 15663-27-1 | N/A | |
1134368 | Citric Acid (200 mg) | H0K310 | G0F161 (28-FEB-2013) | 77-92-9 | N/A | |
1134379 | Clarithromycin (100 mg) | H0H380 | G2I235 (31-JAN-2014) | 81103-11-9 | N/A | |
1134380 | Clarithromycin Related Compound A (50 mg) (6,11-di-O-methylery thromycin A) | R070X0 | H1H381 (31-DEC-2017) | N/A | N/A | |
1134390 | Clarithromycin Identity (10 mg) | R003C0 | F3L128 (30-NOV-2015) | 81103-11-9 | N/A | |
1134404 | Clavam-2-carboxylat e Potassium (4.0 micrograms) | L1L187 | L0L186 (30-NOV-2017) | N/A | N/A | |
1134426 | Clavulanate Lithium (200 mg) | R071W0 | K0J130 (31-MAY-2017) | N/A | N/A | |
1134459 | Ciprofloxacin Formamide (125 | F0G009 | 93594-39-9 | N/A | ||
mg) | ||||||
1134506 | Clemastine Fumarate (250 mg) | J0C090 | I (30-SEP-2006) | 14976-57-9 | N/A | |
1134619 | Clarithromycin Impurity D (10 mg) (N-desmethyl clarithromycin) | F0J140 | 101666-68-6 | N/A | ||
1134620 | Clarithromycin Impurity H (10 mg) (N-formyl clarithromycin) | F0J141 | 127140-69-6 | N/A | ||
1134631 | Clarithromycin Impurity Q (10 mg) (N-oxide clarithromycin) | F0J142 | 118074-07-0 | N/A | ||
1134642 | Clarithromycin Impurity R (10 mg) (N-desmethyl erythromycin A) | F0J143 | 992-62-1 | N/A | ||
1134674 | Clenbuterol Hydrochloride (100 mg) | F0I214 | 21898-19-1 | N/A | ||
1134696 | Clenbuterol Related Compound B (10 mg) (1-(4-amino-3,5-dich | F0I215 | 37148-49-5 | N/A | ||
lorophenyl)-2-tert-bu tylaminoethanone hydrochloride) | ||||||
1135000 | Clidinium Bromide (500 mg) | R02650 | H1I271 (31-JUL-2016) | 3485-62-9 | N/A | |
1135021 | Clidinium Bromide Related Compound A (250 mg) (3-Hydroxy-1-methyl quinuclindinium Bromide) | J0J154 | I (31-AUG-2011) | 76201-95-1 | N/A | |
1135600 | Climbazole (400 mg) | F0G338 | 38083-17-9 | N/A | ||
1136002 | Clindamycin Hydrochloride (200 mg) | R011T0 | H1K043 (30-JUN-2016) | 58207-19-5 | N/A | |
1137005 | Clindamycin Palmitate Hydrochloride (500 mg) | I0M437 | H0I037 (30-NOV-2014) | 25507-04-4 | N/A | |
1138008 | Clindamycin Phosphate (300 mg) | K0M017 | J0I236 (28-FEB-2015) | 24729-96-2 | N/A | |
1138201 | Clioquinol (500 mg) | O0M378 | N0E020 (31-JAN-2015) | 130-26-7 | N/A | |
1138405 | Clobetasol | H1K292 | H0K292 | 25122-46-7 | N/A | |
Propionate (200 mg) | (30-APR-2017) | |||||
1138427 | Clobetasol Propionate Related Compound A (50 mg) (9-alpha-fluoro-11-b eta-hydroxy-16-beta -methyl-3-oxoandros ta-1,4-diene-17(R)-s piro-2'-[4'-chloro-5'-e thylfuran-3'(2'H)-one ]) | R01360 | G0G268 (30-SEP-2015) | N/A | N/A | |
1138507 | Clocortolone Pivalate (200 mg) | R00480 | I0K296 (31-MAY-2015) | 34097-16-0 | N/A | |
1138904 | Clofazimine (200 mg) | R017W0 | F2C392 (30-NOV-2015) | 2030-63-9 | N/A | |
1138926 | Clofazimine Related Compound B (25 mg) (5-(4-chlorophenyl)- 3-(isopropylimino)-N -phenyl-3,5-dihydrop henazin-2-amine) | R064W0 | F00320 (28-FEB-2018) | N/A | N/A | |
1139000 | Clofibrate (1 g) | I | H (30-APR-2001) | 637-07-0 | N/A | |
1140000 | Clomiphene Citrate | R052A0 | I1J350 | 50-41-9 | N/A | |
(500 mg) | (31-OCT-2017) | |||||
1140101 | Clomiphene Related Compound A (100 mg) ((E,Z)-2-[4-(1,2-diph enylethyl)phenoxy]- N,N-diethylethanami ne hydrochloride (1:1)) | R06400 | F2K006 (31-AUG-2017) | N/A | N/A | |
1140247 | Clomipramine Hydrochloride (200 mg) | R026G0 | G0H405 (30-JUN-2016) | 17321-77-6 | N/A | |
1140258 | Clomipramine Related Compound A (25 mg) (N^1-[3-(3-Chloro-10 ,11-dihydro-5H-dibe nzo[b,f]azepin-5-yl)p ropyl]-N^1,N^3,N^3-t rimethylpropane-1,3- diamine dihydrochloride) | F052V0 | N/A | N/A | ||
1140269 | Clomipramine Related Compound C (15 mg) (3-(3-Chloro-5H-dibe nzo[b,f]azepin-5-yl)- | F0M541 | N/A | N/A | ||
N,N-dimethylpropan- 1-amine hydrochloride, monohydrate) | ||||||
1140270 | Clomipramine Related Compound D (15 mg) (3-(3,7-Dichloro-10,1 1-dihydro-5H-dibenz o[b,f]azepin-5-yl)-N, N-dimethylpropan-1- amine hydrochloride) | F0M542 | 115189-28-1 | N/A | ||
1140292 | Clomipramine Related Compound F (15 mg) (3-Chloro-10,11-dihy dro-5H-dibenzo[b,f]a zepine) | F0M543 | 32943-25-2 | N/A | ||
1140305 | Clonazepam CIV (200 mg) | R008P0 | H0E003 (31-OCT-2015) | 1622-61-3 | 0021603080 5 | Controlled |
1140327 | Clonazepam Related Compound A (25 mg) (3-Amino-4-(2-chloro phenyl)-6-nitrocarbo styril) | R012X0 | G3F034 (31-AUG-2015) | N/A | N/A | |
1140338 | Clonazepam Related Compound B (25 mg) (2-Amino-2'-chloro-5 -nitrobenzophenone) | I0G326 | H (28-FEB-2009) | 2011-66-7 | N/A | |
1140349 | Clonazepam Related Compound C (25 mg) (2-bromo-2'-(2-chlor obenzoyl)-4'-nitroac etanilide) | G0F152 | F0C340 (31-JUL-2007) | N/A | N/A | |
1140393 | Clonidine (200 mg) | G0G086 | F0C401 (31-MAR-2008) | 4205-90-7 | N/A | |
1140407 | Clonidine Hydrochloride (200 mg) | I0M189 | H1I279 (31-JUL-2014) | 4205-91-8 | N/A | |
1140418 | Clonidine Related Compound A (25 mg) (1-acetyl-2-(2,6-dichl orophenylimino)imid azolidine) | R025P0 | G1M172 (30-SEP-2016) | 54707-71-0 | N/A | |
1140429 | Clonidine Related Compound B (25 mg) (2-[(E)-2,6-dichlorop | G0G323 | F0C403 (31-DEC-2008) | N/A | N/A | |
henylimino]-1-(1-{2-[ (E)-2,6-dichlorophen ylimino]-imidazolidin -1-yl}-ethyl)-imidazol idine) | ||||||
1140430 | Clopidogrel Bisulfate (125 mg) | R018J0 | G1K326 (31-MAY-2016) | 120202-66-6 | N/A | |
1140509 | Clorazepate Dipotassium CIV (125 mg) | G1F159 | G0B027 (31-DEC-2007) | 57109-90-7 | 0021603070 4 | Controlled |
1140586 | Clopidogrel Related Compound A (20 mg) ((+)-(S)-(o-chlorophe nyl)-6,7-dihydrothien o[3,2-c]pyridine-5(4 H)-acetic acid, hydrochloride) | H0M124 | G1K001 (31-MAR-2015) | 144750-42-5 | N/A | |
1140597 | Clopidogrel Related Compound B (20 mg) (Methyl(+/-)-(o-chlor ophenyl)-4,5-dihydro thieno[2,3-c]pyridine -6(7H)-acetate, hydrochloride) | R014S0 | G2J411 (31-MAY-2016) | 144750-52-7 | N/A | |
1140600 | Clopidogrel Related | G0L573 | F3K088 | 120202-71-3 | N/A | |
Compound C (20 mg) (methyl (-)-(R)-(o-chlorophen yl)-6,7-dihydrothieno [3,2-c]pyridine-5(4H) -acetate, hydrogen sulfate) | (31-JAN-2015) | |||||
1140666 | Cloprostenol Sodium (400 mg) | F0H392 | 55028-72-3 | N/A | ||
1140702 | Clorsulon (200 mg) | G0F275 | F1B084 (30-JUN-2008) | 60200-06-8 | N/A | |
1141002 | Clotrimazole (200 mg) | K1C282 | K0C282 (31-AUG-2015) | 23593-75-1 | N/A | |
1141024 | Clotrimazole Related Compound A (25 mg) ((o-chlorophenyl)dip henylmethanol) | R02240 | J2M033 (28-FEB-2017) | 66774-02-5 | N/A | |
1141909 | Cloxacillin Benzathine (200 mg) | G0M102 | F-1 (31-MAY-2014) | 23736-58-5 | N/A | |
1142005 | Cloxacillin Sodium (200 mg) | L1K266 | L0B086 (30-APR-2013) | 7081-44-9 | N/A | |
1142107 | Clozapine (100 mg) | R018R0 | H0J166 (31-MAY-2017) | 5786-21-0 | N/A | |
1142108 | Clozapine | F0G277 | 5786-21-0 | N/A | ||
Resolution Mixture (30 mg) | ||||||
1143008 | Cocaine Hydrochloride CII (250 mg) | I1I294 | I0B074 (31-MAY-2011) | 53-21-4 | 0021603030 6 | Controlled |
1143802 | Codeine N-Oxide CI (30 mg) | R023N0 | G0A034 (28-FEB-2017) | 3688-65-1 | 0021698102 4 | Controlled |
1144000 | Codeine Phosphate CII (100 mg) | L0K249 | K0G040 (28-FEB-2013) | 41444-62-6 | 0021603010 3 | Controlled |
1144951 | Cloxacillin Related Compound D (15 mg) (3-(2-Chlorophenyl)- 5-methylisoxazole-4- carboxylic acid) | F01770 | 23598-72-3 | N/A | ||
1145003 | Codeine Sulfate CII (250 mg) | I1J167 | I0G213 (31-MAR-2012) | 6854-40-6 | 0021603040 6 | Controlled |
1145025 | Codeine System Suitability Mixture CI (25 mg) | F0M067 | N/A | 0021603112 3 | Controlled | |
1145207 | Cod Liver Oil (1 g) | F0D400 | 8001-69-2 | N/A | ||
1146006 | Colchicine (350 mg) | L1H214 | L0H214 (31-OCT-2016) | 64-86-8 | N/A | |
1146505 | Colestipol Hydrochloride (200 mg) | F-1 | 37296-80-3 | N/A | ||
1147009 | Colistimethate Sodium (200 mg) | H3J047 | H2J047 (31-MAY-2016) | 8068-28-8 | N/A | |
1148001 | Colistin Sulfate (200 mg) | R02022 | G-1 (30-APR-2016) | 1264-72-8 | N/A | |
1148089 | Collagenase I (2 x 0.5 mL) (COLD SHIPMENT REQUIRED) | F029B0 | 9001-12-1 | N/A | Cold Shipment Required | |
1148090 | Collagenase II (2 x 0.5 mL) (COLD SHIPMENT REQUIRED) | F029C0 | 9001-12-1 | N/A | Cold Shipment Required | |
1148238 | Color Related Compound 005 (20 mg) (3-hydroxy-2-naphth alenecarboxylic acid) | F015K0 | 92-70-6 | N/A | ||
1148249 | Color Related Compound 006 (20 mg) (3-hydroxy-4-[(4-met hylphenyl)azo]-2-na phthalenecarboxylic acid) | F015L0 | 82896-77-3 | N/A | ||
1148250 | Color Related Compound 007 (20 | F015M0 | 6756-41-8 | N/A | ||
mg) (1-[(4-methylphenyl) azo]-2-naphthalenol) | ||||||
1148500 | Copovidone (100 mg) | F0C194 | 2586-89-9 | N/A | ||
1148737 | Corosolic Acid (50 mg) | F00370 | 4547-24-4 | N/A | ||
1148806 | Corn Oil (1 g) | G0L404 | F0D181 (31-JUL-2014) | 8001-30-7 | N/A | |
1149004 | Corticotropin (5.3 Units/vial; 2 vials) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | R054N0 | M2I180 (30-JUN-2017) | 9002-60-2 | N/A | International Cold Chain Shipment Required |
1149999 | Cortisone (20 mg) (17, 21-Dihydroxypregna -4-ene-3,11,20-trion e) | F048M0 | 53-06-5 | N/A | ||
1150003 | Cortisone Acetate (150 mg) | J0M362 | I (30-APR-2015) | 50-04-4 | N/A | |
1150115 | Cosyntropin Acetate (1.69 mg) (alpha1-24-Corticotr opin) | F0M134 | 16960-16-0 | N/A | ||
1150207 | Cottonseed Oil (1 g) | G0L406 | F0D173 (30-JUN-2016) | 8001-29-4 | N/A | |
1150320 | Creatine (200 mg) | F05410 | 6020-87-7 | N/A | ||
1150353 | Creatinine (100 mg) | F1F318 | F (31-JAN-2008) | 60-27-5 | N/A | |
1150502 | Cromolyn Sodium (500 mg) | K0L232 | J1E187 (30-APR-2013) | 15826-37-6 | N/A | |
1150513 | Cromolyn Related Compound A (25 mg) (1,3-bis(2-acetyl-3-h ydroxyphenoxy) propan-2-ol) | F1E045 | F0E045 (31-AUG-2015) | 16150-44-0 | N/A | |
1150524 | Cromolyn Related Compound B (25 mg) (diethyl 5,5'-[(2-hydroxyprop ane-1,3-diyl)bis(oxy) ]bis(4-oxo-4H-chrom ene-2-carboxylate)) | F014N0 | N/A | N/A | ||
1150706 | Crospovidone (100 mg) | H1I211 | H0I211 (31-MAY-2017) | 9003-39-8 | N/A | |
1151006 | Crotamiton (200 mg) | R021N0 | I1L567 (31-AUG-2016) | 483-63-6 | N/A | |
1151709 | Cumene (1.2 mL/ampule; 3 | F0E215 | 98-82-8 | N/A | ||
ampules) | ||||||
1151855 | Curcumin (30 mg) | F0H127 | 458-37-7 | N/A | ||
1151866 | Curcuminoids (300 mg) | F0H161 | N/A | N/A | ||
1151924 | Cyanidin Chloride (25 mg) | F0I010 | 528-58-5 | N/A | ||
1151935 | Cyanidin-3-O-glucos ide Chloride (15 mg) | F0H218 | 7084-24-4 | N/A | ||
1152009 | Cyanocobalamin (5 x 300 mg) (Vitamin B12) | P0M220 (02-NOV-2016) | 68-19-9 | N/A | ||
1152600 | Cyclamic Acid (100 mg) | F0K344 | 100-88-9 | N/A | ||
1152701 | Cyclandelate (200 mg) | F0C384 | 456-59-7 | N/A | ||
1152814 | Cyclic Olefin Polymer (1 g) | F022T0 | N/A | N/A | ||
1152825 | Cyclic Olefin Copolymer (3 strips, 2' x 2' x 1 mm each) | F0M398 | 26007-43-2 | N/A | ||
1154004 | Cyclizine Hydrochloride (200 mg) | H0D321 | G (31-OCT-2005) | 303-25-3 | N/A | |
1154015 | Cyclizine Related | F0L023 | 109-01-3 | N/A | ||
Compound A (50 mg) (1-methylpiperazine) | ||||||
1154503 | Cyclobenzaprine Hydrochloride (200 mg) | I0L264 | H0G399 (30-APR-2014) | 6202-23-9 | N/A | |
1154514 | Cyclobenzaprine Related Compound A (10 mg) (5-[3-(dimethylamino )propyl]-5H-dibenzo[ a,d]-cyclohepten-5-o l) | F0L193 | 18029-54-4 | N/A | ||
1154525 | Cyclobenzaprine Related Compound B (10 mg) (3-(5H-dibenzo[a,d]c yclohepten-5-ylidene )-N-methyl-1-propan amine, hydrochloride) | F1L194 | F0L194 (30-SEP-2017) | 438-59-5 | N/A | |
1154558 | Alpha Cyclodextrin (500 mg) | G0H079 | F-1 (31-DEC-2009) | 10016-20-3 | N/A | |
1154569 | Beta Cyclodextrin (500 mg) | H1K030 | H0K030 (31-MAR-2017) | 7585-39-9 | N/A | |
1154591 | Gamma | F0D396 | 17465-86-0 | N/A | ||
Cyclodextrin (200 mg) | ||||||
1154605 | Cyclohexylmethanol (1 mL/ampule; 2 ampules) | F0F072 | 100-49-2 | N/A | ||
1154649 | Cyclohexanecarbox ylic Acid (500 mg) | F0L384 | 98-89-5 | N/A | ||
1154650 | Allyl Cyclohexane Valerate (3 x 0.5 mL) | F0M321 | 7493-68-7 | N/A | ||
1154707 | Cyclomethicone 4 (200 mg) | R040C0 | G0J394 (31-DEC-2016) | 556-67-2 | N/A | |
1154809 | Cyclomethicone 5 (200 mg) | H1J269 | H0J269 (30-SEP-2015) | 69430-24-6 | N/A | |
1154900 | Cyclomethicone 6 (200 mg) | F2B024 | F-1 (31-MAR-2003) | 540-97-6 | N/A | |
1156000 | Cyclopentolate Hydrochloride (300 mg) | R045B0 | J0J112 (31-MAY-2017) | 5870-29-1 | N/A | |
1157002 | Cyclophosphamide (500 mg) | R01530 | J1B200 (31-OCT-2016) | 6055-19-2 | N/A | |
1157013 | Cyclophosphamide Related Compound A (25 mg) (bis(2-chloroethyl)a mine hydrochloride) | F1I380 | F0I380 (31-MAR-2017) | 821-48-7 | N/A | |
1157024 | Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2- oxo-2-hydroxy-1,3,6, 2-oxadiazaphospho nane) | F1I381 | F0I381 (31-DEC-2015) | 158401-52-6 | N/A | |
1157035 | Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate) | R052B0 | F1I382 (31-AUG-2017) | 1071-28-9 | N/A | |
1157046 | Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethyla mino)ethylamino]pro pyl dihydrogen phosphate dihydrochloride) | F1I375 | F0I375 (31-DEC-2015) | 158401-51-5 | N/A | |
1157501 | 2-Cyclopropylmethyl amino-5-chlorobenz ophenone (50 mg) | F | N/A | N/A | ||
1158005 | Cycloserine (250 mg) | R010F0 | H1J318 (30-JUN-2015) | 68-41-7 | N/A | |
1158504 | Cyclosporine (50 mg) | J0M382 | I0F343 (28-FEB-2015) | 59865-13-3 | N/A | |
1158650 | Cyclosporine Resolution Mixture (25 mg) | G0J352 | F1F134 (30-APR-2012) | N/A | N/A | |
1159008 | Cyclothiazide (200 mg) (AS) | F2F329 | F-1 (31-MAY-2008) | 2259-96-3 | N/A | |
1161000 | Cyproheptadine Hydrochloride (500 mg) | H1L349 | H0I002 (31-OCT-2013) | 41354-29-4 | N/A | |
1161010 | Cyproheptadine Related Compound A (40 mg) (5H-dibenzo[a,d]cycl oheptene) | F1L356 | F0F350 (30-SEP-2013) | 256-81-5 | N/A | |
1161032 | Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidi n-4-yl)-5H-dibenzo[a ,d]cyclohepten-5-ol) | F0L388 | 3967-32-6 | N/A | ||
1161203 | Cyromazine (200 mg) | F0H086 | 66215-27-8 | N/A | ||
1161509 | L-Cysteine Hydrochloride (600 mg) | R043K0 | I0I177 (31-MAY-2017) | 7048-04-6 | N/A | |
1161586 | Cystine (200 mg) | F1M308 | F0I088 (30-JUN-2014) | 56-89-3 | N/A | |
1162002 | Cytarabine (250 mg) | R046F0 | H1M420 (28-FEB-2018) | 147-94-4 | N/A | |
1162126 | 5'-Cytidylic Acid (500 mg) | F0J209 | 63-37-6 | N/A | ||
1162148 | Cytosine (100 mg) | G0M164 | F1J197 (30-JUN-2014) | 71-30-7 | N/A | |
1162308 | Dacarbazine (125 mg) | R028N0 | I0J135 (31-JUL-2016) | 4342-03-4 | N/A | |
1162320 | Dacarbazine Related Compound A (50 mg) (5-aminoimidazole-4 -carboxamide hydrochloride) | R037K0 | I0M531 (30-SEP-2016) | 72-40-2 | N/A | |
1162330 | Dacarbazine Related Compound B (50 mg) (2-azahypoxanthine monohydrate) | R01740 | H0H274 (29-FEB-2016) | 7151-03-3 | N/A | |
1162400 | Dactinomycin (50 mg) | R00870 | J0H376 (31-MAY-2015) | 50-76-0 | N/A | |
1162421 | Daidzein (25 mg) | F0H362 | 486-66-8 | N/A | ||
1162432 | Daidzin (30 mg) | F0H251 | 552-66-9 | N/A | ||
1162443 | Dalfampridine | F00440 | N/A | N/A | ||
Resolution Mixture (15 mg) | ||||||
1162454 | Dalfampridine (200 mg) | F0M557 | 504-24-5 | N/A | ||
1162487 | Dalteparin Sodium (300 mg) | F0M431 | 9041-08-1 | N/A | ||
1162501 | Danazol (200 mg) | I1M174 | I0F168 (31-OCT-2014) | 17230-88-5 | N/A | |
1162545 | Dalfampridine Related Compound A (25 mg) (4-Aminopyridine 1-oxide) | F053K0 | 3535-75-9 | N/A | ||
1162556 | Dalfampridine Related Compound B (50 mg) (3,5-Dibromopyridin- 4-amine) | F053J0 | 84539-34-4 | N/A | ||
1162567 | Dalfampridine Related Compound C (25 mg) (1,3-Di(pyridin-4-yl)u rea) | F053H0 | 39642-87-0 | N/A | ||
1162626 | Alpha-Damascone (3 x 0.5 mL) | F0M367 | 43052-87-5 | N/A | ||
1162637 | Delta-Damascone (3 | F0M320 | 57378-68-4 | N/A | ||
x 0.5 mL) | ||||||
1162648 | Beta-Damascone (3 x 0.5 mL) | F0M128 | N/A | N/A | ||
1163140 | Dantrolene (200 mg) | F0G120 | 7261-97-4 | N/A | ||
1163151 | Dantrolene Sodium (100 mg) | R051P0 | F0G156 (31-DEC-2017) | 24868-20-0 | N/A | |
1163162 | Dantrolene Related Compound A (50 mg) (5-(4-nitrophenyl)-2-f uraldehyde azine) | F0G170 | 301359-05-7 | N/A | ||
1163173 | Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-f uraldehyde-(2-carbo xymethyl) semicarbazone) | F0G098 | 57268-33-4 | N/A | ||
1163184 | Dantrolene Related Compound C (50 mg) ((5-(4-nitrophenyl)-2- furancarboxyaldehy de) | F0G099 | 7147-77-5 | N/A | ||
1164008 | Dapsone (200 mg) | R020A0 | I0L013 | 80-08-0 | N/A | |
(31-AUG-2015) | ||||||
1164200 | Darifenacin Hydrobromide (150 mg) | F04960 | 133099-07-7 | N/A | ||
1164211 | Darifenacin Chiral Peak ID Mixture (25 mg) (See USP Certificate for full Chemical Name) | F04970 | N/A | N/A | ||
1164222 | Darifenacin Peak ID Mixture (25 mg) (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%)) | F04980 | N/A | N/A | ||
1164697 | Daunorubicinone (25 mg) ((8S,10S)-8-Acetyl-6 ,8,10,11-tetrahydrox y-1-methoxy-7,8,9,1 0-tetrahydrotetracen e-5,12-dione) | F016G0 | 21794-55-8 | N/A | ||
1164700 | Daunorubicin Hydrochloride (200 mg) | M1M099 | M0I190 (31-JAN-2016) | 23541-50-6 | N/A | |
1165408 | Decoquinate (200 mg) | F0G036 | 18507-89-6 | N/A | ||
1166003 | Deferoxamine Mesylate (300 mg) | K0K196 | J0G233 (31-JUL-2011) | 138-14-7 | N/A | |
1166116 | Deflazacort (100 mg) | F0L473 | 14484-47-0 | N/A | ||
1166309 | Dehydroacetic Acid (200 mg) | R035K0 | F (28-FEB-2017) | 520-45-6 | N/A | |
1166400 | Dehydrocarteolol Hydrochloride (100 mg) | F | N/A | N/A | ||
1166502 | Dehydrocholic Acid (200 mg) | F-1 | F (31-MAR-2004) | 81-23-2 | N/A | |
1169001 | Demecarium Bromide (250 mg) | G0G185 | F (31-MAR-2008) | 56-94-0 | N/A | |
1170000 | Demeclocycline Hydrochloride (200 mg) (COLD SHIPMENT REQUIRED) | R024Q1 | R024Q0 (28-JUL-2016) | 64-73-3 | N/A | |
1171003 | Denatonium Benzoate (200 mg) | R020M0 | I1F025 (30-APR-2016) | 3734-33-6 | N/A | |
1171207 | 23-EPI-26-Deoxyact | R03180 | F0H262 | 264624-38-6 | N/A | |
ein (20 mg) | (31-OCT-2017) | |||||
1171251 | 2-Deoxy-D-Glucose (100 mg) | G0M207 | F0E006 (31-AUG-2015) | 154-17-6 | N/A | |
1171273 | Deoxycholic Acid (Desoxycholic Acid) (100 mg) | F05420 | 83-44-3 | N/A | ||
1171397 | Depramine (20 mg) (3-(5H-dibenzo[b,f]a zepin-5-yl)-N,N-dime thylpropan-1-amine hydrochloride) | F000A0 | N/A | N/A | ||
1171455 | Dermatan Sulfate (25 mg) (COLD SHIPMENT REQUIRED) | G0M092 | F1J362 (31-MAR-2014) | 54328-33-5 | N/A | Cold Shipment Required |
1171706 | Desacetyl Diltiazem Hydrochloride (50 mg) | J1C143 | J0C143 (30-SEP-2015) | 23515-45-9 | N/A | |
1171819 | Desbenzyl Donepezil Hydrochloride (20 mg) (5,6-dimethoxy-2-(pi peridin-4-ylmethyl)in dan-1-one hydrochloride) | F0L339 | 120013-39-0 | N/A | ||
1171900 | Desflurane (0.5 mL) | H1L485 | H0L485 (30-SEP-2017) | 57041-67-5 | N/A | |
1171910 | Desflurane Related Compound A (0.1 mL) (bis-(1,2,2,2-tetraflu oroethyl) ether) | F0C031 | N/A | N/A | ||
1172006 | Desipramine Hydrochloride (125 mg) | J0L554 | I0E283 (30-SEP-2015) | 58-28-6 | N/A | |
1173009 | Deslanoside (200 mg) | R00170 | H-1 (31-MAR-2015) | 17598-65-1 | N/A | |
1173042 | Desloratadine (200 mg) | F006W0 | 100643-71-8 | N/A | ||
1173053 | Desloratadine Related Compound A (20 mg) (8-Bromo-6,11-dihyd ro-11-(piperidin-4-yli dene)-5H-benzo[5,6] cyclohepta[1,2-b]pyri dine) | F000P0 | 117796-50-6 | N/A | ||
1173064 | Desloratadine Related Compound F (50 mg) (8-Chloro-6,11-dihyd ro-11-(N-formyl-4-pi | F04050 | 117810-61-4 | N/A | ||
peridinylidene) -5H-benzo[5,6]cyclo hepta[1,2-b]pyridine) | ||||||
1173086 | Desloratadine Related Compound B (20 mg) (8-chloro-11-(1,2,3,6 -tetrahydropyridin-4- yl)-6,11-dihydro-5H- benzo[5,6]cyclohept a[1,2-b]pyridine hydrochloride) | F04040 | N/A | N/A | ||
1173100 | Desmethoxycurcumi n (30 mg) | F0H153 | 24939-17-1 | N/A | ||
1173202 | Desmopressin Acetate (2.01 mg) (COLD SHIPMENT REQUIRED) | H0M344 | G0K019 (31-OCT-2013) | 62357-86-2 | N/A | |
1173235 | Desogestrel (50 mg) | I0L398 | H0H041 (31-MAR-2015) | 54024-22-5 | N/A | |
1173246 | Desogestrel Related Compound A (15 mg) (13-Ethyl-11-methyl ene-18, 19-dinor-5alpha, | G0G004 | F0B279 (28-FEB-2009) | N/A | N/A | |
17alpha-preg-3-en-2 0-yn-17-ol, desogestrel Delta-3 Isomer) | ||||||
1173257 | Desogestrel Related Compound B (25 mg) (3-Hydroxy-desoges trel) | R024C0 | H0K327 (31-MAY-2016) | N/A | N/A | |
1173268 | Desogestrel Related Compound C (25 mg) (3-Ketodesogestrel) | H0L400 | G0J223 (31-OCT-2014) | 54048-10-1 | N/A | |
1173279 | Desogestrel Related Compound D (25 mg) (13-Ethyl-11-methyl enegon-4-en-17-one ) | F042B0 | 54024-21-4 | N/A | ||
1173304 | Desonide (250 mg) | F0M374 | 638-94-8 | N/A | ||
1173315 | Desonide Impurities Mixture (25 mg) | F00340 | N/A | N/A | ||
1173508 | Desoximetasone (200 mg) | R012H0 | H1H451 (31-MAR-2016) | 382-67-2 | N/A | |
1174001 | Desoxycorticosteron | R037A0 | J1I297 | 56-47-3 | N/A | |
e Acetate (200 mg) | (31-JUL-2017) | |||||
1175004 | Desoxycorticosteron e Pivalate (125 mg) | H1J119 | H0C276 (31-AUG-2011) | 808-48-0 | N/A | |
1176007 | Dexamethasone (125 mg) | R00520 | K0H243 (30-SEP-2016) | 50-02-2 | N/A | |
1176506 | Dexamethasone Acetate (200 mg) | I0L425 | H1J301 (30-SEP-2014) | 1177-87-3 | N/A | |
1177000 | Dexamethasone Phosphate (200 mg) | L1M534 | L0M534 (31-OCT-2015) | 312-93-6 | N/A | |
1177032 | Dexamethasone Sodium Phosphate (350 mg) | F0M447 (31-JAN-2018) | 2392-39-4 | N/A | ||
1178002 | Dexbrompheniramin e Maleate (200 mg) | K1M358 | K0M358 (31-MAY-2017) | 2391-03-9 | N/A | |
1179005 | Dexchlorpheniramin e Maleate (300 mg) | R005Q0 | H0D199 (30-NOV-2015) | 2438-32-6 | N/A | |
1179118 | Dexketoprofen Tromethamine (200 mg) | F0M372 | 156604-79-4 | N/A | ||
1179333 | Dexmedetomidine Hydrochloride (200 mg) | R04840 | R01590 (30-NOV-2017) | 145108-58-3 | N/A | |
1179344 | Levomedetomidine (25 mg) | R03120 | F0M051 (30-SEP-2016) | 190000-46-5 | N/A | |
1179504 | Dexpanthenol (500 | K0I270 | J1F296 | 81-13-0 | N/A | |
mg) | (29-FEB-2012) | |||||
1179628 | Dextran 1 (50 mg) | F0D297 | 9004-54-0 | N/A | ||
1179650 | Dextran T-10 (200 mg) | F0D238 | 9004-54-0 | N/A | ||
1179708 | Dextran 40 (50 mg) | R067Q0 | F0C247 (30-NOV-2017) | 9004-54-0 | N/A | |
1179720 | Dextran 40 System Suitability (200 mg) | F0B181 | 9004-54-0 | N/A | ||
1179741 | Dextran 70 (50 mg) | F2M324 | F1J372 (31-DEC-2014) | 9004-54-0 | N/A | |
1179763 | Dextran 70 System Suitability (100 mg) | R053S0 | G1J169 (31-JAN-2018) | 9004-54-0 | N/A | |
1179800 | Dextran Vo Marker (100 mg) | R07020 | F0B242 (31-DEC-2017) | 9004-54-0 | N/A | |
1179854 | Dextran 4 Calibration (100 mg) | R053U0 | G0M350 (31-JAN-2018) | 9004-54-0 | N/A | |
1179865 | Dextran 10 Calibration (100 mg) | R053X0 | G0M351 (31-JUL-2017) | 9004-54-0 | N/A | |
1179876 | Dextran 40 Calibration (100 mg) | G0L325 | F0C011 (30-SEP-2013) | 9004-54-0 | N/A | |
1179887 | Dextran 70 Calibration (100 mg) | G1J373 | G0J373 (30-JUN-2016) | 9004-54-0 | N/A | |
1179898 | Dextran 250 Calibration (100 mg) | G0M352 | F0C039 (31-OCT-2013) | 9004-54-0 | N/A | |
1180004 | Dextroamphetamine Sulfate CII (500 mg) | R004C0 | J0L459 (31-MAR-2016) | 51-63-8 | 0021604010 8 | Controlled |
1180015 | Dextroamphetamine Related Compound A (25 mg) (1-Phenyl-2-propano l) | F0H131 | 698-87-3 | N/A | ||
1180026 | Dextroamphetamine Related Compound B CII (25 mg) (Phenyl acetone) | F0H132 | 103-79-7 | 0021685020 1 | Controlled | |
1180503 | Dextromethorphan (2 g) | I3F274 | I2F274 (28-FEB-2017) | 125-71-3 | N/A | |
1181007 | Dextromethorphan Hydrobromide (500 mg) | K0F118 | J0B167 (31-MAR-2008) | 6700-34-1 | N/A | |
1181302 | Dextrose (500 mg) | R035J0 | K0K311 (30-APR-2017) | 50-99-7 | N/A | |
1181506 | Diacetylated Monoglycerides (200 mg) | R024D1 | G (31-DEC-2015) | 68990-54-5 | N/A | |
1182000 | Diacetylfluorescein | I0L140 | H (30-SEP-2013) | 596-09-8 | N/A | |
(200 mg) | ||||||
1183002 | Diacetylmorphine Hydrochloride CI (25 mg) (AS) (Heroin Hydrochloride) | J1G200 | J (31-AUG-2008) | 1502-95-0 | 0021692000 1 | Controlled |
1184005 | Diatrizoic Acid (100 mg) | H0E084 | G (30-APR-2006) | 50978-11-5 | N/A | |
1184027 | Diatrizoic Acid Related Compound A (50 mg) (5-Acetamido-3-ami no-2,4,6-triiodobenz oic Acid) | J0J206 | I (31-DEC-2011) | 1713-07-1 | N/A | |
1184118 | Diaveridine (25 mg) (5-(3,4-Dimethoxybe nzyl)pyrimidine-2,4- diamine) | F03830 | 5355-16-8 | N/A | ||
1185008 | Diazepam CIV (100 mg) | R005P0 | J0J208 (31-AUG-2016) | 439-14-5 | 0021604040 3 | Controlled |
1185020 | Diazepam Related Compound A (25 mg) (2-methylamino-5-ch lorobenzophenone) | J0H438 | I1F077 (31-AUG-2010) | 1022-13-5 | N/A | |
1186000 | Diazoxide (200 mg) | H0F314 | G1C017 (30-NOV-2007) | 364-98-7 | N/A | |
1187003 | Dibucaine Hydrochloride (500 mg) | J0I022 | I (31-JAN-2010) | 61-12-1 | N/A | |
1187080 | Dibutyl Phthalate (200 mg) | F0D125 | 84-74-2 | N/A | ||
1187091 | Dibutyl Sebacate (1 mL) | R03810 | F1K138 (28-FEB-2017) | 109-43-3 | N/A | |
1187207 | Dichloralphenazone CIV (200 mg) | G0K269 | F0B010 (30-JUN-2012) | 480-30-8 | 0021624670 1 | Controlled |
1187954 | 2,4-Dichlorophenol (100 mg) | F0E113 | 120-83-2 | N/A | ||
1188006 | Dichlorphenamide (200 mg) | G2C046 | G-1 (31-MAY-2007) | 120-97-8 | N/A | |
1188301 | Dichlorvos (150 mg) (2,2-dichlorovinyl dimethyl phosphate) (AS) | F0D141 | 62-73-7 | N/A | ||
1188560 | Diclazuril (200 mg) | F0H416 | 101831-37-2 | N/A | ||
1188571 | Diclazuril System Suitability Mixture (50 mg) | F0H404 | N/A | N/A | ||
1188709 | Diclofenac Potassium (200 mg) | R034L0 | F0F269 (30-SEP-2017) | 15307-81-0 | N/A | |
1188800 | Diclofenac Sodium (200 mg) | R038G0 | H2K051 (31-JAN-2018) | 15307-79-6 | N/A | |
1188811 | Diclofenac Related Compound A (25 mg) (N-(2,6-dichlorophen yl)indolin-2-one) | L0M175 | K0I100 (31-OCT-2014) | 15362-40-0 | N/A | |
1189009 | Dicloxacillin Sodium (300 mg) | J1L192 | J0C182 (28-FEB-2014) | 13412-64-1 | N/A | |
1189053 | Dicloxacillin Related Compound D (15 mg) (3-(2,6-Dichlorophen yl)-5-methylisoxazol e-4-carboxylic acid) | F01780 | 3919-76-4 | N/A | ||
1190008 | Dicumarol (200 mg) | G | 66-76-2 | N/A | ||
1191000 | Dicyclomine Hydrochloride (125 mg) | I1M524 | I0M524 (30-APR-2016) | 67-92-5 | N/A | |
1191204 | Didanosine (200 mg) | F0G088 | 69655-05-6 | N/A | ||
1191215 | Didanosine System Suitability Mixture (10 mg) | F0G034 | 69655-05-6 | N/A | ||
1191226 | Didanosine Related Compound A (25 mg) (Hypoxanthine) | F0G113 | 68-94-0 | N/A | ||
1191237 | Didanosine Related Compound B (25 mg) (2',3'-dideoxyadenos ine) | F0G209 | 4097-22-7 | N/A | ||
1191554 | Didymin (30 mg) ((RS)-5-Hydroxy-2-( 4-methoxyphenyl)-4- oxo-3,4-dihydro-2H- chromen-7-yl 6-O-(alpha-L-rhamn opyranosyl)-beta-D- glucopyranoside) | F041S0 | N/A | N/A | ||
1192003 | Dienestrol (125 mg) | I | 84-17-3 | N/A | ||
1192808 | Diethanolamine (3 mL) | R043V0 | G0M390 (31-MAY-2017) | 111-42-2 | N/A | |
1193006 | Diethylcarbamazine Citrate (200 mg) | G-1 | 1642-54-2 | N/A | ||
1193265 | Diethylene Glycol (5 x 0.2 mL) | R05070 | G0J412 (31-JAN-2018) | 111-46-6 | N/A | |
1193301 | Diethylene Glycol Monoethyl Ether (0.5 mL/ampule) | G1I320 | G0C159 (31-MAY-2012) | 111-90-0 | N/A | |
1193356 | Iscotrizinol (200 mg) | F024R0 | 154702-15-5 | N/A | ||
1193378 | Iscotrizinol Related Compound B (25 mg) (4-[(4--6-[(4-ph enyl)amino]-1,3,5-tri azin-2-yl)amino]ben zoic acid) | F02550 | N/A | N/A | ||
1193389 | Iscotrizinol Related Compound C (25 mg) (2-Ethylhexyl 4-[(4--6-chloro-1,3,5-tri azin-2-yl)amino]ben zoate) | F02560 | N/A | N/A | ||
1193390 | Iscotrizinol Related Compound D (25 mg) (2-Ethylhexyl 4-[(4,6-bis-1,3,5-triazin- 2-yl)amino]benzoate ) | F02570 | N/A | N/A | ||
1193414 | Iscotrizinol Related | F02580 | N/A | N/A | ||
Compound F (25 mg) (Bis(2-ethylhexyl) 4,4'-(bi s(azanediyl))dibenzo ate) | ||||||
1193425 | Iscotrizinol Related Compound G (25 mg) (2-Ethylhexyl 4--6-[(4-p henyl)amino]-1,3,5-tr iazin-2-yl)amino]ben zamido}benzoate) | F02590 | N/A | N/A | ||
1193447 | Iscotrizinol Related Compound I (25 mg) (Bis(2-ethylhexyl) 4,4'-{[6-({4-[(4-{[(2-et hylhexyl)oxy]carbon yl}phenyl)carbamoyl] phenyl}amino)-1,3,5- triazine-2,4-diyl]bis(a zanediyl)}dibenzoate | F025A0 | N/A | N/A | ||
) | ||||||
1193505 | Diethyl Phthalate (200 mg) | G1J427 | G (31-JUL-2012) | 84-66-2 | N/A | |
1194009 | Diethylpropion Hydrochloride CIV (200 mg) | J0L029 | I0G127 (31-MAY-2013) | 134-80-5 | 0021604030 5 | Controlled |
1194803 | Diethyl Sebacate (1 mL) | F1K329 | F0I171 (30-JUN-2015) | 110-40-7 | N/A | |
1195001 | Diethylstilbestrol (200 mg) | K5B291 | K-4 (31-MAY-2004) | 56-53-1 | N/A | |
1197007 | Diethyltoluamide (3 g) | R021J0 | I0H013 (31-JAN-2016) | 134-62-3 | N/A | |
1197018 | Diethyltoluamide Related Compound A (25 mg) (N,N-Diethyl-4-tolua mide) | F004N0 | 2728-05-4 | N/A | ||
1197302 | Diflorasone Diacetate (200 mg) | R042F0 | H0G388 (30-JUN-2017) | 33564-31-7 | N/A | |
1197506 | Diflunisal (200 mg) | R02890 | G1F320 (31-MAY-2017) | 22494-42-4 | N/A | |
1198000 | Digitalis (3 g) | F | 8031-42-3 | N/A | ||
1199002 | Digitoxin (200 mg) | N0I195 | M (28-FEB-2011) | 71-63-6 | N/A | |
1200000 | Digoxin (250 mg) | P0I054 | O0B096 (30-APR-2012) | 20830-75-5 | N/A | |
1200520 | Dihydroartemisinin | F0M339 | 81496-81-3 | N/A | ||
(200 mg) | ||||||
1200600 | Dihydrocapsaicin (25 mg) | H1M408 | H0F210 (28-FEB-2015) | 19408-84-5 | N/A | |
1200804 | Dihydrocodeine Bitartrate CII (200 mg) | J0K044 | I0D205 (31-AUG-2012) | 5965-13-9 | 0021691200 5 | Controlled |
1200881 | Dihydrodaunorubicin Hydrochloride (20 mg) ((8S,10S)-10-[(3-Am ino-2,3,6-trideoxy-al pha-L-lyxo-hexopyra nosyl)oxy]-6,8,11-tri hydroxy-8-(1-hydrox yethyl)-1-methoxy-7, 8,9,10-tetrahydrotetr acene-5,12-dione hydrochloride) | F022N0 | N/A | N/A | ||
1201002 | 17alpha-Dihydroequi lin (50 mg) (Estra-1,3,5(10),7-te traene-3,17alpha-dio l) | J1L148 | J0L148 (30-JUN-2017) | 651-55-8 | N/A | |
1202005 | Dihydroergotamine Mesylate (250 mg) | L0M289 | K0H019 (31-AUG-2014) | 6190-39-2 | N/A | |
1203008 | Dihydrostreptomycin | R031Q0 | K0I335 | 5490-27-7 | N/A | |
Sulfate (200 mg) | (30-NOV-2016) | |||||
1204000 | Dihydrotachysterol (30 mg/ampule; 4 ampules) | L0L505 | K0K428 (28-FEB-2015) | 67-96-9 | N/A | |
1204102 | Dihydroxyacetone (250 mg) | F | 96-26-4 | N/A | ||
1204805 | Diloxanide Furoate (200 mg) | F0C026 | 3736-81-0 | N/A | ||
1205003 | Diltiazem Hydrochloride (200 mg) | J1M121 | J0F005 (31-JUL-2014) | 33286-22-5 | N/A | |
1205014 | Diltiazem Related Compound A (AS) (25 mg) (trans-diltiazem hydrochloride) | F0E296 | N/A | N/A | ||
1206006 | Dimenhydrinate (200 mg) | R041E0 | J1H302 (30-JUN-2017) | 523-87-5 | N/A | |
1206017 | Dimenhydrinate Related Compound E (15 mg) (8-chloro-3,7-dihydr o-1,3,7-trimethyl-1H- purine-2,6-dione) | F0M219 | 4921-49-7 | N/A | ||
1211006 | Dimethyl Sulfoxide (3 g) | R056E0 | H0D273 (31-DEC-2017) | 67-68-5 | N/A | |
1211254 | 2,3-Dimethylaniline (50 mg) | F0M286 | 87-59-2 | N/A | ||
1211287 | 6,6'-Dinicotinic Acid (50 mg) | F00200 | 1802-30-8 | N/A | ||
1213001 | Dinoprost Tromethamine (50 mg) | G0G082 | F (30-SEP-2008) | 38562-01-5 | N/A | |
1213103 | Dinoprostone (125 mg) (COLD SHIPMENT REQUIRED) | R037Y0 | F0C030 (31-JUL-2016) | 363-24-6 | N/A | |
1213136 | Dinoprostone Related Compound C (20 mg) ((E)-7-{(1R,2R,3R)-3 -Hydroxy-2-[(S,E)-3- hydroxyoct-1-en-1-yl ]-5-oxocyclopentyl}h ept-5-enoic acid) | F01210 | 36150-00-2 | N/A | ||
1213318 | Diosmin (300 mg) | R05500 | R02090 (31-OCT-2017) | 520-27-4 | N/A | |
1213329 | Diosmin for System Suitability (15 mg) | F0K325 | N/A | N/A | ||
1214004 | Dioxybenzone (150 mg) | G1M334 | G0K415 (31-JUL-2014) | 131-53-3 | N/A | |
1217909 | Diphenhydramine | H2I247 | H1C350 | 88637-37-0 | N/A | |
Citrate (200 mg) | (30-NOV-2011) | |||||
1218005 | Diphenhydramine Hydrochloride (200 mg) | R04070 | K0K041 (31-OCT-2017) | 147-24-0 | N/A | |
1218016 | Diphenhydramine Related Compound A (25 mg) (2-(Diphenylmethoxy )-N-methylethanami ne hydrochloride) | R057W0 | G1M528 (28-FEB-2018) | 53499-40-4 | N/A | |
1218027 | Diphenhydramine Related Compound B (20 mg) (3-(benzhydryloxy)pr opane-1,2-diol) | F016V0 | 19574-66-4 | N/A | ||
1218050 | Diphenhydramine N-Oxide (25 mg) (2-(benzhydryloxy)- N,N-dimethylethan-1 -amine oxide hydrochloride) | F016W0 | 13168-00-8 | N/A | ||
1219008 | Diphenoxylate Hydrochloride CII (200 mg) | R06680 | I1D339 (31-JAN-2018) | 3810-80-8 | 0021604020 5 | Controlled |
1219019 | Diphenoxylate Related Compound | F017G0 | 28782-42-5 | 0021698012 3 | Controlled | |
A CI (25 mg) (1-(3-Cyano-3,3-dip henylpropyl)-4-phen ylpiperidine-4-carbo xylic acid) | ||||||
1220302 | Dipivefrin Hydrochloride (200 mg) | I | H (30-JUN-1999) | 64019-93-8 | N/A | |
1220357 | Dipivefrin Related Compound E (25 mg) (4-[(Methylamino)ac etyl]-1,2-phenylene dipivalate hydrochloride) | F011L0 | N/A | N/A | ||
1220506 | Dipyridamole (200 mg) | I0K205 | H1F120 (31-AUG-2012) | 58-32-2 | N/A | |
1220517 | Dipyridamole Related Compound A (25 mg) (2,2'-diethanol) | F031B0 | 16982-40-4 | N/A | ||
1220528 | Dipyridamole Related Compound B (25 mg) | F031C0 | 16908-47-7 | N/A | ||
(2,2',2'',2''',2'''',2'''''-{[ 8-(Piperidin-1-yl)pyri mido[5,4-d]pyrimidin e-2,4,6-triyl]tris(azan etriyl)}hexaethanol) | ||||||
1220539 | Dipyridamole Related Compound C (25 mg) (2,2'-{[6-chloro-4,8-d i(piperidin-1-yl)pyrim ido[5,4-d]pyrimidin-2 -yl]azanediyl}diethan ol) | F031D0 | 54093-92-4 | N/A | ||
1220540 | Dipyridamole Related Compound D (25 mg) (2,2'-({6-[(2-Hydroxy ethyl)amino]-4,8-di(p iperidin-1-yl)pyrimid o[5,4-d]pyrimidin-2-y l}azanediyl)diethanol ) | F031G0 | 1176886-12-6 | N/A | ||
1220559 | Dipyridamole Related Compound E (25 mg) (2,2',2'',2'''-{[6,8-Di(p iperidin-1-yl)pyrimid | F031E0 | N/A | N/A | ||
o[5,4-d]pyrimidine-2, 4-diyl]bis(azanetriyl)} tetraethanol) | ||||||
1220561 | Dipyridamole Related Compound F (25 mg) (2,2',2'',2'''-({4-[(2-Hy droxyethyl)amino]-8- (piperidin-1-yl)pyrimi do[5,4-d]pyrimidine- 2,6-diyl}bis(azanetriy l))tetraethanol) | F031F0 | 60286-30-8 | N/A | ||
1220700 | Dirithromycin (200 mg) | F | 62013-04-1 | N/A | ||
1221000 | Disodium Guanylate (350 mg) | H0L488 | G0H049 (28-FEB-2014) | 5550-12-9 | N/A | |
1222002 | Disodium Inosinate (500 mg) | G0J162 | F (31-MAR-2011) | 4691-65-0 | N/A | |
1222400 | Disodium 5'-Uridylate (500 mg) | F0J213 | 3387-36-8 | N/A | ||
1222501 | Disopyramide Phosphate (200 mg) | I0E337 | H-1 (31-AUG-2007) | 22059-60-5 | N/A | |
1223005 | 2,4-Disulfamyl-5-Trifl uoromethylaniline (50 mg) | I0M436 | H0H040 (31-OCT-2014) | 654-62-6 | N/A | |
1223209 | Allyl Disulfide (5 x 0.5 mL) | F0L062 | 2179-57-9 | N/A | ||
1224008 | Disulfiram (200 mg) | G0H277 | F-3 (31-AUG-2009) | 97-77-8 | N/A | |
1224201 | Divalproex Sodium (200 mg) | R01500 | F0G392 (31-AUG-2016) | 76584-70-8 | N/A | |
1224507 | Dobutamine Hydrochloride (400 mg) | I0L492 | H-1 (31-MAR-2014) | 49745-95-1 | N/A | |
1224551 | Docetaxel (200 mg) | R021Y0 | R002E0 (31-AUG-2017) | 148408-66-6 | N/A | |
1224562 | Docetaxel Identification (50 mg) | R008Q0 | F1L350 (30-SEP-2015) | N/A | N/A | |
1224573 | Docetaxel System Suitability Mixture (15 mg) | R023J0 | F0K229 (31-OCT-2016) | N/A | N/A | |
1224620 | Docosahexaenoic Acid Ethyl Ester (500 mg) | H0M544 | G0K228 (31-AUG-2015) | 84494-72-4 | N/A | |
1224664 | Docosyl Ferulate (50 mg) | F0E143 | 101927-24-6 | N/A | ||
1224700 | Docusate Calcium (500 mg) | R06870 | I0M469 | 128-49-4 | N/A | |
1224802 | Docusate Sodium (1 g) | R030M0 | L0H276 (31-DEC-2016) | 577-11-7 | N/A | |
1224824 | Docusate Sodium Related Compound B (40 mg) (disodium mono (2-ethylhexyl) sulfosuccinate) | F0I194 | N/A | N/A | ||
1224904 | Docusate Potassium (100 mg) | F-1 | F (30-NOV-1999) | 7491-09-0 | N/A | |
1224937 | Dofetilide (200 mg) | F0I317 | 115256-11-6 | N/A | ||
1224948 | Dofetilide Related Compound A (25 mg) (N-[4-(2-(2-[4-(meth anesulfonamido)phe noxy]ethyl)amino)ph enyl]methanesulfona mide) | F0I373 | 176447-94-2 | N/A | ||
1224959 | Dolasetron Mesylate (125 mg) | R032Y0 | F0C319 (30-JUN-2016) | 878143-33-0 | N/A | |
1224960 | Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydro xy-2,6-methano-2H- quinolizin-3(4H)-one hydrochloride) | F0C321 | N/A | N/A | ||
1224970 | Donepezil-N-Oxide | F0M027 | 120013-84-5 | N/A | ||
(20 mg) | ||||||
1224981 | Donepezil Hydrochloride (200 mg) | R020S0 | G0K230 (30-APR-2016) | 884740-09-4 | N/A | |
1224992 | Donepezil Related Compound A (25 mg) ((E)-2-[(1-benzylpipe ridin-4-yl)methylene] -5,6-dimethoxyindan -1-one) | G0K187 | F0J070 (31-MAY-2012) | 145546-80-1 | N/A | |
1225000 | Doxapram Hydrochloride (200 mg) | G0G110 | F4C053 (31-MAR-2009) | 7081-53-0 | N/A | |
1225022 | Doxapram Related Compound B (25 mg) (1-Ethyl-4--3,3-diphenylpyrroli din-2-one, hydrochloride) | F03760 | 100106-91-0 | N/A | ||
1225204 | Dopamine Hydrochloride (200 mg) | R038X0 | H0H456 (31-DEC-2017) | 62-31-7 | N/A | |
1225281 | Dorzolamide | R036L0 | H0L259 | 130693-82-2 | N/A | |
Hydrochloride (200 mg) | (31-JUL-2017) | |||||
1225292 | Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylami no)-5,6-dihydro-6-m ethyl-4H-thieno[2,3- b]thiopyran-2-sulfon amide-7,7-dioxide, monohydrochloride) | R054K0 | I0J226 (30-NOV-2017) | N/A | N/A | |
1225306 | Dorzolamide Related Compound D (30 mg) ((4S,6S)-4-Amino-6- methyl-5,6-dihydro-4 H-thieno[2,3-b]thiop yran-2-sulfonamide 7,7-dioxide hydrochloride) | R037V0 | F0L206 (31-AUG-2016) | 164455-27-0 | N/A | |
1225317 | Dorzolamide Related Compound B (15 mg) ((4R,6S)-4-(Ethylami no)-6-methyl-5,6-dih | F0L205 | 1417607-96-5 | N/A | ||
ydro-4H-thieno[2,3-b ]thiopyran-2-sulfona mide 7,7-dioxide hydrochloride) | ||||||
1225419 | Doxazosin Mesylate (200 mg) | H0L151 | G0E173 (30-SEP-2013) | 77883-43-3 | N/A | |
1225420 | Doxazosin Related Compound A (20 mg) (N-(1,4-benzodioxan e-2-carbonyl)piperaz ine hydrochloride) | R041Y0 | F0H023 (31-JUL-2017) | 70918-74-0 | N/A | |
1225441 | Doxazosin Related Compound B (20 mg) (6,7-dimethoxyquina zoline-2,4-dione) | F0H024 | 28888-44-0 | N/A | ||
1225452 | Doxazosin Related Compound C (20 mg) (2-chloro-4-amino-6, 7-dimethoxyquinazol ine) | F0H025 | 23680-84-4 | N/A | ||
1225463 | Doxazosin Related Compound D (20 mg) (1,4-benzodioxane-2 | F0H026 | 3663-80-7 | N/A | ||
-carboxylic acid) | ||||||
1225474 | Doxazosin Related Compound E (20 mg) (2,4-dichloro-6,7-dim ethoxyquinazoline) | F1M466 | F0H027 (31-DEC-2014) | 27631-29-4 | N/A | |
1225485 | Doxazosin Related Compound F (15 mg) (N,N'-bis(1,4-benzod ioxane-2-carbonyl)pi perazine) | R022Q0 | F0H028 (30-APR-2016) | 617677-53-9 | N/A | |
1225500 | Doxepin Hydrochloride (500 mg) | J0M472 | I (31-JUL-2015) | 1229-29-4 | N/A | |
1225511 | Doxepin Related Compound A (50 mg) (dibenzo[b,e]oxepin- 11(6H)-one) | F0G020 | 4504-87-4 | N/A | ||
1225522 | Doxepin Related Compound B (50 mg) ((11RS)-11-[3-(dimet hylamino)propyl]-6,1 1-dihydrodibenzo[b, e]oxepin-11-ol) | F0F328 | 4504-88-5 | N/A | ||
1225533 | Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]o xepin-11(6H)-yliden e)-N-methylpropan-1 -amine hydrochloride) | G0J309 | F0G062 (31-OCT-2011) | 4504-96-5 | N/A | |
1225601 | Doxercalciferol (2 x 20 mg) | R060R0 | F0M300 (31-JUL-2017) | 54573-75-0 | N/A | |
1225703 | Doxorubicin Hydrochloride (50 mg) | L0K258 | K1G106 (31-MAR-2013) | 25316-40-9 | N/A | |
1225758 | Doxorubicinone (25 mg) ((8S,10S)-6,8,10,11- Tetrahydroxy-8-(hyd roxyacetyl)-1-metho xy-7,8,9,10-tetrahydr otetracene-5,12-dion e) | F01670 | 24385-10-2 | N/A | ||
1226003 | Doxycycline Hyclate (200 mg) | J1E174 | J0E174 (31-MAY-2015) | 24390-14-5 | N/A | |
1226014 | Doxycycline Related Compound A (10 mg) ((4S,4aR,5S,5aR,6S | R04660 | G1M394 (30-NOV-2016) | 41411-66-9 | N/A | |
,12aS)-4-(Dimethyla mino)-1,4,4a,5,5a,6, 11,12a-octahydro-3, 5,10,12,12a-pentahy droxy-6-methyl-1,11- dioxo-2-naphthacen ecarboxamide, monohydrochloride) | ||||||
1227006 | Doxylamine Succinate (300 mg) | I2M407 | I1F141 (31-DEC-2014) | 562-10-7 | N/A | |
1228009 | Drometrizole (25 mg) (2-(2H-Benzotriazol- 2-yl)-p-cresol) | F0J261 | 2440-22-4 | N/A | ||
1228010 | Drometrizole Trisiloxane (200 mg) | F0J247 | 155633-54-8 | N/A | ||
1228029 | Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol- 2-yl)-6-(isobuten-1-yl )-p-cresol) | F0J262 | 2170-37-8 | N/A | ||
1228031 | Drometrizole Trisiloxane Related | F0J263 | 98809-58-6 | N/A | ||
Compound B (25 mg) (2-(2H-Benzotriazol- 2-yl)-6-(isobuten-3-yl )-p-cresol) | ||||||
1228042 | Drometrizole Trisiloxane Related Compound C (150 mg) (2-(2H-Benzotriazol- 2-yl)-6-(isobuten-1-yl )-O1-[bis(trimethylsil oxy)methylsilyl]-p-cr esol) | F0J103 | N/A | N/A | ||
1228053 | Drometrizole Trisiloxane Related Compound D (25 mg) (2-(2H-Benzotriazol- 2-yl)-6-isobutyl-p-cre sol) | F0J264 | N/A | N/A | ||
1228064 | Drometrizole Trisiloxane Related Compound E (150 mg) (2-(2H-Benzotriazol- 2-yl)-6-{3-[bis(trimet | F0J104 | N/A | N/A | ||
hylsiloxy)methylsilyl]i sobutyl}-O1-[bis(trim ethylsiloxy)methylsil yl]-p-cresol) | ||||||
1228075 | Heptamethyl Trisiloxane (150 mg) (1,1,1,3,5,5,5-Hepta methyltrisiloxane) | F0J105 | 1873-88-7 | N/A | ||
1228530 | Dronedarone Hydrochloride (125 mg) | F029Q0 | 141625-93-6 | N/A | ||
1228541 | Dronedarone Related Compound A (25 mg) (N-{2-Butyl-3-[4-(3-b utylaminopropoxy)b enzoyl]benzofuran-5 -yl}methanesulfona mide, hydrochloride) | F029R0 | 197431-02-0 | N/A | ||
1228552 | Dronedarone Related Compound B (20 mg) ((5-Amino-2-butylbe nzofuran-3-yl)methanone | F029S0 | 1309476-91-2 | N/A | ||
, dihydrochloride) | ||||||
1228563 | Dronedarone Related Compound C (20 mg) ((5-Amino-2-butylbe nzofuran-3-yl)(4-hyd roxyphenyl)methano ne) | F029T0 | 1278585-68-4 | N/A | ||
1228574 | Dronedarone Related Compound D (20 mg) ((2-Butyl-5-nitrobenz ofuran-3-yl)(4-hydro xyphenyl)methanon e) | F029U0 | 141645-16-1 | N/A | ||
1229001 | Droperidol (250 mg) | J0K154 | I1G375 (31-JUL-2012) | 548-73-2 | N/A | |
1229409 | Drospirenone (200 mg) | R042S0 | G0K259 (30-JUN-2017) | 67392-87-4 | N/A | |
1229410 | Drospirenone Related Compound A (15 mg) (17-Hydroxy-6beta,7 beta:15beta,16beta- dimethylene-3-oxo-1 7beta-pregn-4-ene-2 1-carboxylic acid, | R02840 | G0L263 (29-FEB-2016) | 90457-65-1 | N/A | |
gamma-lactone) | ||||||
1229817 | Duloxetine Hydrochloride (100 mg) | R043X0 | F0J323 (31-JUL-2017) | 136434-34-9 | N/A | |
1229828 | Duloxetine Related Compound A (10 mg) ((R)-N-Methyl-3-(na phthalen-1-yloxy)-3-( thiophen-2-yl)propan -1-amine Hydrochloride) | G1M093 | G0M093 (31-DEC-2016) | 910138-96-4 | N/A | |
1229872 | Duloxetine Related Compound F (10 mg) ((S)-N-Methyl-3-(nap hthalen-1-yloxy)-3-(t hiophen-3-yl)propan -1-amine hydrochloride) | R032W0 | H0M463 (31-MAR-2017) | 1104890-90-5 | N/A | |
1229883 | Duloxetine Related Compound H (30 mg) ((S)-4-(Methyl[3-(na phthalen-1-yloxy)-3-( thiophen-2-yl)propyl] amino)-4-oxobutanoi | R066U0 | R032X0 (30-NOV-2017) | 199191-66-7 | N/A | |
c acid) | ||||||
1229922 | Dutasteride (200 mg) | F00710 | 164656-23-9 | N/A | ||
1229931 | Dutasteride Resolution Mixture (20 mg) | F00840 | N/A | N/A | ||
1230000 | Dyclonine Hydrochloride (200 mg) | H0F196 | G (30-APR-2008) | 536-43-6 | N/A | |
1231003 | Dydrogesterone (200 mg) | R013U0 | I1G011 (31-MAR-2016) | 152-62-5 | N/A | |
1231502 | Dyphylline (200 mg) | G-2 | G-1 (30-NOV-2002) | 479-18-5 | N/A | |
1231580 | Ecamsule Solution (0.5 mL) | F0H257 | N/A | N/A | ||
1231604 | Ecamsule Triethanolamine (200 mg) | F0H444 | 92841-53-7 | N/A | ||
1231615 | Ecamsule Related Compound A (50 mg) (1,4-Phenylenedimet hanol) | F0H400 | 589-29-7 | N/A | ||
1231626 | Ecamsule Related Compound B (50 mg) | F0H409 | 3006-96-0 | N/A | ||
(4-(hydroxymethyl)b enzoic acid) | ||||||
1231637 | Ecamsule Related Compound C (50 mg) (terephthalic acid) | F0H408 | 100-21-0 | N/A | ||
1231648 | Ecamsule Related Compound D (50 mg) (((1SR,4RS)-7,7-dim ethyl-2-oxobicyclo[2. 2.1]heptan-1-yl)meth anesulfonic acid) | F0H421 | 5872-08-2 | N/A | ||
1231659 | Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-( hydroxymethyl)benz ylidene)-7,7-dimethy l-2-oxobicyclo[2.2.1] heptan-1-yl)methane sulfonate) | F0H429 | N/A | N/A | ||
1231660 | Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)- 7,7-dimethyl-3-oxo-4 | F0H428 | N/A | N/A | ||
-(sulfomethyl)bicyclo [2.2.1]heptan-2-ylide ne)methyl)benzoic acid) | ||||||
1231681 | Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)- 7,7-dimethyl-3-oxo-4 -(sulfomethyl)bicyclo [2.2.1]heptan-2-ylide ne)methyl)benzalde hyde, sodium salt) | F0H432 | N/A | N/A | ||
1231706 | Powdered Echinacea Angustifolia Extract (1 g) | G0I377 | F0D019 (30-JUN-2011) | 84696-11-7 | N/A | |
1231717 | Powdered Echinacea Pallida Extract (1 g) | F0I285 | 97281-15-7 | N/A | ||
1231728 | Powdered Echinacea Purpurea Extract (1 g) | F0D018 | 90028-20-9 | N/A | ||
1231750 | Echinacoside (15 mg) | F0M214 | 82854-37-3 | N/A | ||
1231808 | Econazole Nitrate (250 mg) | R056L0 | H1K380 (31-DEC-2017) | 68797-31-9 | N/A | |
1231830 | Econazole Related Compound A (15 mg) (1-(2,4-Dichlorophen yl)-2-(1H-imidazole- 1-yl)ethanol) | F00060 | 24155-42-8 | N/A | ||
1231841 | Econazole Related Compound B (15 mg) (2-[(4-Chlorobenzyl) oxy]-2-(2,4-dichlorop henyl)ethanamine nitrate) | F00070 | N/A | N/A | ||
1231852 | Econazole Related Compound C (15 mg) (1-(4-Chlorobenzyl)- 3-[(2RS)-2-[(4-chloro benzyl)oxy]-2-(2,4-di chlorophenyl)ethyl]i midazolium chloride) | F00080 | N/A | N/A | ||
1232006 | Edetate Calcium Disodium (200 mg) | H1L565 | H0B272 (30-JUN-2014) | 23411-34-9 | N/A | |
1233009 | Edetate Disodium (200 mg) | R028C0 | J0J421 (30-NOV-2016) | 6381-92-6 | N/A | |
1233508 | Edetic Acid (200 | F2H030 | F-1 | 60-00-4 | N/A | |
mg) | (31-DEC-2009) | |||||
1234001 | Edrophonium Chloride (200 mg) | R03280 | H (31-DEC-2016) | 116-38-1 | N/A | |
1234103 | Efavirenz (200 mg) | R038U0 | G0L369 (31-MAY-2017) | 154598-52-4 | N/A | |
1234114 | Efavirenz Racemic (20 mg) ((+/-)-6-Chloro-4-(cy clopropylethynyl)-1,4 -dihydro-4-(trifluoro methyl)-2H-3,1-benz oxazin-2-one) | G0M381 | F0G381 (30-SEP-2014) | 177530-93-7 | N/A | |
1234125 | Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-ch lorophenyl)-4-cyclop ropyl-1,1,1-trifluorob ut-3-yn-2-ol) | R027V0 | F1L237 (30-APR-2016) | 209414-27-7 | N/A | |
1234136 | Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopro pyl-4-(trifluoromethyl )quinoline) | F1L211 | F0I394 (30-JUN-2013) | 391860-73-4 | N/A | |
1234147 | Efavirenz Related | R01700 | G0L438 | 440124-96-9 | N/A | |
Compound B (10 mg) ((S,E)-6-Chloro-4-(2- Cyclopropylvinyl)-4-( trifluoromethyl)-2H-3 ,1-benzoxazin-2-one ) | (31-JUL-2016) | |||||
1234249 | Eflornithine Hydrochloride (150 mg) | F0K432 | 96020-91-6 | N/A | ||
1234307 | Eicosapentaenoic Acid Ethyl Ester (500 mg) (All-cis-5,8,11,14,17- Eicosapentaenoic acid ethyl ester) | R023R0 | H0L521 (31-DEC-2016) | 86227-47-6 | N/A | |
1234668 | Eleutheroside B (15 mg) (Syringin) | F0E056 | 118-34-3 | N/A | ||
1234680 | Eleutheroside E (15 mg) (syringaresinol diglucoside) | F0E057 | 96038-87-8 | N/A | ||
1234704 | Powdered Eleuthero Extract (1.5 g) | F0C291 | 84696-12-5 | N/A | ||
1234806 | Emedastine Difumarate (100 mg) | F0C059 | 87233-62-3 | N/A | ||
1235004 | Emetine | H0B201 | G (31-MAY-2003) | 316-42-7 | N/A | |
Hydrochloride (300 mg) | ||||||
1235059 | Emodin (30 mg) (1,3,8-trihydroxy-6- methylanthracene-9, 10-dione) | F049E0 | 518-82-1 | N/A | ||
1235106 | Emtricitabine (200 mg) | R060K0 | F0J163 (31-AUG-2017) | 143491-57-0 | N/A | |
1235128 | Emtricitabine System Suitability Mixture A (15 mg) | R039Y0 | F0J164 (30-SEP-2016) | N/A | N/A | |
1235139 | Emtricitabine System Suitability Mixture B (15 mg) | R05270 | F0J165 (31-JAN-2017) | N/A | N/A | |
1235274 | Enalaprilat (300 mg) | R024A0 | K0M476 (29-FEB-2016) | 84680-54-6 | N/A | |
1235300 | Enalapril Maleate (200 mg) | K0L429 | J1C267 (31-JAN-2014) | 76095-16-4 | N/A | |
1235503 | Endotoxin (10,000 USP Endotoxin Units) (COLD SHIPMENT REQUIRED) | H0K354 | G3E069 (28-FEB-2013) | N/A | N/A | Cold Shipment Required |
1235809 | Enflurane (1 mL) | H0J179 | G-1 (31-JUL-2014) | 13838-16-9 | N/A | |
1235820 | Enoxaparin Sodium | R01010 | G0L137 | 679809-58-6 | N/A | |
(300 mg) | (30-SEP-2016) | |||||
1235831 | Enoxaparin Sodium for Bioassays (COLD SHIPMENT REQUIRED) | F0K265 | 9041-08-1 | N/A | ||
1235853 | Enoxaparin Sodium Molecular Weight Calibrant A (8.0 mg) | G0L138 | F0H193 (31-MAY-2013) | 9041-08-1 | N/A | |
1235864 | Enoxaparin Sodium Molecular Weight Calibrant B (6.0 mg) | G0L139 | F0H241 (31-MAY-2013) | 9041-08-1 | N/A | |
1235900 | Enrofloxacin (200 mg) | R04690 | G1H417 (31-OCT-2017) | 93106-60-6 | N/A | |
1235911 | Enrofloxacin Related Compound Mixture (50 mg) | F0H395 | N/A | N/A | ||
1235933 | Entacapone (150 mg) | F1L210 | F0I395 (31-JUL-2014) | 130929-57-6 | N/A | |
1235944 | Entacapone Related Compound A (25 mg) ((Z)-2-cyano-3-(3,4- dihydroxy-5-nitrophe nyl)-N,N-diethylacryl | F1I396 | F0I396 (28-FEB-2018) | 145195-63-7 | N/A | |
amide) | ||||||
1235966 | Entecavir Monohydrate (200 mg) | R05700 | F006H0 (31-DEC-2017) | 209216-23-9 | N/A | |
1235977 | Entecavir Related Compound A (15 mg) (9-[(1S,3R,4S)-4-Di methylphenylsilyl-3-( benzyloxymethyl)-2- methylenecyclopent yl]guanine) | F006J0 | 649761-24-0 | N/A | ||
1235988 | Entecavir System Suitability Mixture (15 mg) (A mixture containing entecavir 1-epimer (0.1%), entecavir (99.6%), 8-hydroxy entecavir (0.1%), and 8-methoxy entecavir (0.1%)) | F006K0 | N/A | N/A | ||
1235999 | Ephedrine Hydrochloride (200 mg) (List Chemical) | F03110 | 50-98-6 | N/A | List Chemical | |
1236007 | Ephedrine Sulfate (200 mg) (List | I1G194 | I0G194 (31-JAN-2017) | 134-72-5 | N/A | List Chemical |
Chemical) | ||||||
1236506 | 4-Epianhydrotetracy cline Hydrochloride (50 mg) | L1J359 | L0J359 (30-JUN-2015) | 4465-65-0 | N/A | |
1236663 | Epicoprostanol (200 mg) | F052S0 | 516-92-7 | N/A | ||
1236700 | (-)-Epigallocatechin- 3-O-gallate (20 mg) | G0L208 | F0H099 (31-JUL-2014) | 989-51-5 | N/A | |
1236801 | Epilactose (200 mg) | R018L0 | J0J219 (30-SEP-2016) | 50468-56-9 | N/A | |
1236833 | Lovastatin Epimer Mixture (25 mg) (Epilovastatin and Lovastatin 1:1 Mixture) | F006A0 | N/A | N/A | ||
1236889 | Epinastine Hydrochloride (250 mg) | F06760 | 108929-04-0 | N/A | ||
1237000 | Epinephrine Bitartrate (200 mg) | P2L152 | P1L152 (30-APR-2017) | 51-42-3 | N/A | |
1237382 | Epirubicin Hydrochloride (200 mg) | F0I341 | 56390-09-1 | N/A | ||
1237509 | Epitetracycline Hydrochloride (250 mg) | R064D0 | G1E261 (31-MAR-2017) | 23313-80-6 | N/A | |
1237553 | Eplerenone (250 mg) | F0M279 | 107724-20-9 | N/A | ||
1237600 | Epoprostenol Sodium (100 mg) (COLD SHIPMENT REQUIRED) | F0L201 | 61849-14-7 | N/A | Cold Shipment Required | |
1237611 | Epoprostenol Related Compound A (15 mg) (7-{(1R,2R,3R,5S)-3 ,5-Dihydroxy-2-[(S,E )-3-hydroxyoct-1-eny l]cyclopentyl}-6-oxoh eptanoic acid) (COLD SHIPMENT REQUIRED) | F1M152 | F0L042 (31-MAY-2014) | 58962-34-8 | N/A | Cold Shipment Required |
1237622 | Epoprostenol Related Compound B (15 mg) (Sodium 5-(diphenylphosphin oyl)pentanoate) | F0L234 | N/A | N/A | ||
1237752 | Eprinomectin (300 mg) (COLD SHIPMENT REQUIRED) | R009C0 | F0H199 (31-DEC-2015) | 123997-26-2 | N/A | Cold Shipment Required |
1238002 | Equilin (25 mg) | R030G0 | J0F228 (31-JAN-2017) | 474-86-2 | N/A | |
1238217 | Eprosartan Mesylate (50 mg) ((E)-2-Butyl-1-(p-car boxybenzyl)-alpha-2 -thenylimidazole-5-a crylic acid, monomethanesulfon ate) | F0L238 | 144143-96-4 | N/A | ||
1238228 | Eprosartan Related Compound A (20 mg) ((E)-3-(2-butyl-1H-im idazol-5-yl)-2-(thioph en-2-ylmethyl)acrylic acid hydrochloride) | F0L248 | N/A | N/A | ||
1238239 | Eprosartan Related Compound B (15 mg) (3-(thiophen-2-yl)pro panoic acid) | F0L243 | 5928-51-8 | N/A | ||
1238240 | Eprosartan Related Compound C (25 mg) (2-(thiophen-2-ylmet hyl)malonic acid) | F0L244 | 4475-24-5 | N/A | ||
1238251 | Eprosartan Related Compound D (15 | F0L240 | 6232-88-8 | N/A | ||
mg) (4-(bromomethyl)be nzoic acid) | ||||||
1238262 | Eprosartan Related Compound E (15 mg) (4-(hydroxymethyl)b enzoic acid) | F0L233 | 3006-96-0 | N/A | ||
1239005 | Ergocalciferol (30 mg/ampule; 5 ampules) (Vitamin D2) | Y028Q0 | R0K341 (31-AUG-2016) | 50-14-6 | N/A | |
1239504 | Ergoloid Mesylates (300 mg) | J0J384 | I (30-JUN-2012) | 8067-24-1 | N/A | |
1240004 | Ergonovine Maleate (150 mg) (List Chemical) | R045R0 | N (31-MAY-2017) | 129-51-1 | N/A | List Chemical |
1241007 | Ergosterol (50 mg) | I0G053 | H (31-MAY-2008) | 57-87-4 | N/A | |
1241506 | Ergotamine Tartrate (150 mg) (List Chemical) | R02200 | J0F349 (31-MAY-2016) | 379-79-3 | N/A | List Chemical |
1241550 | Ergotaminine (100 mg) (List Chemical) | H0H017 | G0B177 (31-MAR-2009) | 639-81-6 | N/A | List Chemical |
1241823 | Erythorbic Acid (50 mg) | F0G391 | 89-65-6 | N/A | ||
1241903 | Erythritol (200 mg) | F1F295 | F0E313 | 149-32-6 | N/A | |
(30-NOV-2009) | ||||||
1242000 | Erythromycin (250 mg) | R013R0 | N0G117 (31-AUG-2015) | 114-07-8 | N/A | |
1242010 | Erythromycin B (100 mg) | R05250 | R002J0 (31-JAN-2018) | 527-75-3 | N/A | |
1242021 | Erythromycin C (50 mg) | F4L354 | F-3 (28-FEB-2014) | N/A | N/A | |
1242032 | Erythromycin Related Compound N (50 mg) (N-Demethylerythro mycin A) | R030K0 | H0L401 (31-MAR-2017) | N/A | N/A | |
1243002 | Erythromycin Estolate (200 mg) | H | G (31-JAN-2003) | 3521-62-8 | N/A | |
1245008 | Erythromycin Ethylsuccinate (200 mg) | R064T0 | H (30-SEP-2017) | 1264-62-6 | N/A | |
1246000 | Erythromycin Gluceptate (200 mg) | H | G (31-JUL-2003) | 23067-13-2 | N/A | |
1247003 | Erythromycin Lactobionate (200 mg) | H-1 | H (31-JAN-2002) | 3847-29-8 | N/A | |
1248006 | Erythromycin Stearate (200 mg) | R01900 | H0B187 (31-MAY-2016) | 643-22-1 | N/A | |
1248200 | Erythropoietin for | F0M430 | 113427-24-0 | N/A | ||
Bioassays | ||||||
1249202 | Escin (350 mg) | R023G0 | G0J158 (31-OCT-2015) | 11072-93-8 | N/A | |
1249406 | Escitalopram Oxalate (200 mg) | G0M272 | F0I224 (31-OCT-2014) | 219861-08-2 | N/A | |
1249417 | Escitalopram Related Compound A (10 mg) ((S)-4-[4-dimethylam i-(4-fluoropheny )-1-hydroxy-1-butyl]- 3-hydroxymethylben zonitrile hemi(+)-di-toluoyltart rate) | R028B0 | F0I112 (28-FEB-2017) | 128173-53-5 | N/A | |
1249701 | Esmolol Hydrochloride (100 mg) | F0K112 | 81161-17-3 | N/A | ||
1249789 | Esomeprazole Magnesium (25 mg) | R00830 | G0I290 (30-SEP-2015) | 217087-09-7 | N/A | |
1249803 | Esomeprazole Strontium (20 mg) | F047S0 | 934714-36-0 | N/A | ||
1249905 | Estazolam CIV (100 mg) | F0J370 | 29975-16-4 | 0021605010 1 | Controlled | |
1249916 | Estazolam Related | F0K064 | 37945-06-5 | N/A | ||
Compound A (10 mg) (5-Chloro-2-(3-chlor omethyl-4H-1,2,4-tri azol-4-yl)-benzophe none) | ||||||
1250008 | Estradiol (500 mg) | R025F0 | N0J191 (31-DEC-2016) | 35380-71-3 | N/A | |
1250020 | Estradiol Related Compound B (10 mg) (1,3,5(10),6-estratetr aen-3,17beta-diol) | F0H263 | 7291-41-0 | N/A | ||
1250041 | Estradiol Related Compound C (15 mg) (1,3,5(10)-estratrien- 3,17beta-diol-6-one) | F0H282 | 571-92-6 | N/A | ||
1251000 | Estradiol Benzoate (250 mg) | H2L542 | H1L542 (31-OCT-2017) | 50-50-0 | N/A | |
1252003 | Estradiol Cypionate (200 mg) | H0H309 | G-1 (31-DEC-2009) | 313-06-4 | N/A | |
1252193 | Estradiol Cypionate System Suitability Mixture (10 mg) | F00760 | N/A | N/A | ||
1254009 | Estradiol Valerate | M0M467 | L2L009 | 979-32-8 | N/A | |
(100 mg) | (30-APR-2015) | |||||
1254508 | Estriol (100 mg) | R007R0 | L0K175 (30-NOV-2016) | 50-27-1 | N/A | |
1255001 | Estrone (200 mg) | R030H0 | L0F119 (31-AUG-2017) | 53-16-7 | N/A | |
1255500 | Estropipate (500 mg) | J0B262 | I (31-DEC-2003) | 7280-37-7 | N/A | |
1255850 | Eszopiclone CIV (100 mg) | F0K158 | 138729-47-2 | 0021605030 1 | Controlled | |
1255861 | Eszopiclone Related Compound A (10 mg) (6-(5-Chloropyridin-2 -yl)-7-oxo-6,7-dihydr o-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine- 1-carboxylate 4-oxide) | F0L285 | 43200-96-0 | N/A | ||
1256004 | Ethacrynic Acid (200 mg) | H0L537 | G0I168 (30-APR-2014) | 58-54-8 | N/A | |
1257007 | Ethambutol Hydrochloride (200 mg) | H2M489 | H1J063 (30-JUN-2015) | 1070-11-7 | N/A | |
1257018 | Ethambutol Related Compound A (15 | F0J050 | 10054-06-5 | N/A | ||
mg) ((2R,2'S)-2,2'-[ethan e-1,2-diylbis(azanedi yl)]dibutan-1-ol) | ||||||
1257029 | Ethambutol Related Compound B (15 mg) (((2R,2'R)-2,2'-[etha ne-1,2-diylbis(azane diyl)]dibutan-1-ol) hydrochloride) | F0J051 | 134566-79-3 | N/A | ||
1258305 | Ethchlorvynol CIV (0.7 mL) | F0B011 | 113-18-8 | 0021625400 2 | Controlled | |
1260001 | Ethinyl Estradiol (150 mg) | R0M195 | Q0C162 (31-JUL-2014) | 57-63-6 | N/A | |
1260012 | Ethinyl Estradiol Related Compound A (20 mg) (6-Keto-ethinyl estradiol) | R035D0 | J0K316 (31-AUG-2017) | N/A | N/A | |
1260023 | Ethinyl Estradiol Related Compound B (20 mg) (19-Nor-17alpha-pre gna-1,3,5(10),9(11)-t etraen-20-yne-3,17- diol) | R03960 | G0M193 (31-JAN-2017) | 1231-96-5 | N/A | |
1261004 | Ethionamide (200 mg) | H0B148 | G (31-MAR-2003) | 536-33-4 | N/A | |
1262801 | Ethopabate (125 mg) | F | 59-06-3 | N/A | ||
1262823 | Ethopabate Related Compound A (25 mg) (Methyl-4-acetamido -2-hydroxybenzoate) | F | N/A | N/A | ||
1264002 | Ethosuximide (500 mg) | I0F301 | H (31-MAY-2008) | 77-67-8 | N/A | |
1264501 | Ethotoin (500 mg) | F036M1 | F (30-NOV-2016) | 86-35-1 | N/A | |
1265005 | Ethoxzolamide (200 mg) | F | 452-35-7 | N/A | ||
1265300 | Ethyl 4-nitrobenzoate (40 mg) | F01510 | 99-77-4 | N/A | ||
1265402 | Ethyl Acetate (1.2 mL/ampule; 3 ampules) | R032S0 | H0K396 (30-NOV-2017) | 141-78-6 | N/A | |
1265424 | Ethyl Acrylate and Methyl Methacrylate Copolymer Dispersion (1.5 g) (Poly(ethyl | R054Y0 | F0F189 (31-OCT-2017) | N/A | N/A | |
acrylate-co-methyl methacrylate)) | ||||||
1265457 | Ethylbenzene (0.5 mL/ampule; 3 ampules) | F0F060 | 100-41-4 | N/A | ||
1265504 | Ethylcellulose (1 g) | R024J0 | J0L385 (30-APR-2016) | 9004-57-3 | N/A | |
1265515 | Ethylene Glycol (0.5 mL) | G1L121 | G0K011 (30-APR-2017) | 107-21-1 | N/A | |
1265526 | 2-Ethylhexan-1-ol (1.5 mL) | F0G192 | 104-76-7 | N/A | ||
1265537 | Ethylhexyl Triazone (200 mg) | F0H178 | 88122-99-0 | N/A | ||
1265548 | Ethylhexyl Triazone Related Compound A (20 mg) (2-ethylhexyl 4-aminobenzoate) | R007D0 | F0H136 (31-MAR-2016) | 26218-04-2 | N/A | |
1265559 | Ethylhexyl Triazone Related Compound B (20 mg) (4-[(4,6-Bis[(4-{[(2-et hylhexyl)oxy]carbon yl}phenyl)amino]-1,3 ,5-triazin-2-yl)amino] benzoic acid) | F1H137 | F0H137 (31-MAR-2016) | N/A | N/A | |
1265560 | Ethylhexyl Triazone Related Compound C (20 mg) (Bis(2-ethylhexyl) 4,4'-[(6--1,3,5-triazine-2,4- diyl)bis(azanediyl)]di benzoate) | F1H139 | F0H139 (31-MAR-2016) | N/A | N/A | |
1265592 | Ethylene Glycol and Vinyl Alcohol Graft Copolymer (1 g) | F0I360 | 121786-16-1 | N/A | ||
1265606 | Ethyl Formate (1.2 mL/ampule; 3 ampules) | F0E193 | 109-94-4 | N/A | ||
1265752 | Ethyl Laurate (500 mg) | F0J039 | 106-33-2 | N/A | ||
1265800 | Ethyl Lauroyl Arginate (200 mg) | F0K422 | 60372-77-2 | N/A | ||
1265843 | Ethyl Linoleate (1 mL) | F024K0 | 544-35-4 | N/A | ||
1266008 | Ethyl Maltol (1 g) | I0I142 | H (31-OCT-2010) | 4940-11-8 | N/A | |
1266507 | Ethylnorepinephrine Hydrochloride (200 mg) | F | 3198-07-0 | N/A | ||
1266609 | Ethyl Oleate (1 mL) | F024L0 | 111-62-6 | N/A | ||
1266802 | N-Ethylpiperazine (0.5 mL) | F0H382 | 5308-25-8 | N/A | ||
1266868 | Ethyl Palmitate (500 mg) | F024N0 | 628-97-7 | N/A | ||
1267000 | Ethylparaben (200 mg) | I2L094 | I1F039 (30-SEP-2013) | 120-47-8 | N/A | |
1267102 | Ethyl Stearate (100 mg) | F024M0 | 111-61-5 | N/A | ||
1267500 | Ethyl Vanillin (200 mg) | G0I398 | F2B134 (29-FEB-2012) | 121-32-4 | N/A | |
1268003 | Ethynodiol Diacetate (200 mg) | I2G236 | I1G236 (30-NOV-2017) | 297-76-7 | N/A | |
1268502 | Etidronate Disodium (200 mg) | G | F-2 (28-FEB-2003) | 7414-83-7 | N/A | |
1268513 | Etidronate Disodium Related Compound A (300 mg) (Sodium phosphite dibasic pentahydrate) | F0E227 | 13517-23-2 | N/A | ||
1268604 | Etidronic Acid Monohydrate (1 g) | G1G218 | G (31-OCT-2008) | 25211-86-3 | N/A | |
1268706 | Etodolac (400 mg) | G | F (31-OCT-2001) | 41340-25-4 | N/A | |
1268728 | Etodolac Related Compound A (25 mg) ((+/-)-8-ethyl-1-meth | F4L074 | F3L074 (28-FEB-2018) | 109518-50-5 | N/A | |
yl-1,3,4,9-tetrahydro pyrano [3,4-b]-indole-1-aceti c acid) | ||||||
1268750 | Etomidate (200 mg) | F1J222 | F0J222 (31-OCT-2015) | 33125-97-2 | N/A | |
1268772 | Metomidate Hydrochloride (50 mg) (methyl 1-(1-phenylethyl)-1H -imidazole-5-carbox ylate hydrochloride) | F1J186 | F0J186 (30-NOV-2017) | 35944-74-2; 36557-22-9 | N/A | |
1268783 | Etonogestrel (100 mg) | R061G0 | F0M257 (31-DEC-2017) | 54048-10-1 | N/A | |
1268794 | Etonogestrel Related Compound A (10 mg) (13Beta-Ethyl-11-me thylenegon-4-ene-3, 17-dione) | F0M258 | 54024-17-8 | N/A | ||
1268808 | Etoposide (300 mg) | R049U0 | H1K394 (30-NOV-2017) | 33419-42-0 | N/A | |
1268852 | Etoposide Resolution Mixture (30 mg) | F1M482 | F0B209 (31-MAY-2015) | 33419-42-0 | N/A | |
1268896 | Etoricoxib Related Compound C (50 | F0L323 | 249561-98-6 | N/A | ||
mg) (2-chloro-1,3-bis(dim ethylamino)trimethini um hexafluorophosphat e) | ||||||
1268900 | Eucalyptol (200 mg) | R017H0 | F0K046 (30-APR-2017) | 470-82-6 | N/A | |
1268919 | Eucalyptus Oil (1 g) | F0M379 | 8000-48-4 | N/A | ||
1268965 | Eugenol (500 mg) | F1J388 | F0D303 (31-MAR-2012) | 97-53-0 | N/A | |
1268998 | [Glu13]-Exenatide (1 mg) | F04770 | N/A | N/A | ||
1269009 | [Met(O)14]-Exenatid e (1 mg) | F04790 | 1678417-38-3 | N/A | ||
1269017 | Evening Primrose Oil (1 g) | F0M167 | 308064-97-3 | N/A | ||
1269028 | Ezetimibe (250 mg) | F028D0 | 163222-33-1 | N/A | ||
1269039 | Ezetimibe System Suitability Mixture (20 mg) | R042J0 | F028E0 (31-MAR-2017) | Mixture | N/A | |
1269045 | [N-Acetyl-His1]-Exe natide (1 mg) | F04780 | N/A | N/A | ||
1269050 | Exemestane (150 mg) | G0M518 | F0J313 (31-JAN-2015) | 107868-30-4 | N/A | |
1269061 | Exemestane | F0J314 | 19457-55-7 | N/A | ||
Related Compound A (15 mg) (6-Methyleneandrost a-4-ene-3,17-dione) | ||||||
1269072 | Exemestane Related Compound B (15 mg) (6-hydroxymethylan drostra-1,4-diene-3, 17-dione) | F0J315 | 184972-09-6 | N/A | ||
1269083 | Exemestane Related Compound C CIII (15 mg) (androsta-1,4-diene- 3,17-dione) | F0J316 | 897-06-3 | 0021605020 1 | Controlled | |
1269094 | Exemestane System Suitability Mixture (25 mg) | F0J317 | N/A | N/A | ||
1269105 | Exenatide (2.73 mg) | F052N0 | 141758-74-9 | N/A | ||
1269119 | FAME Standard Mixture (100 mg) | R02730 | R014E0 (30-SEP-2016) | 71076-49-8 | N/A | |
1269130 | Famciclovir Related Compound E (25 mg) (2-aminopurine) | F0L077 | N/A | N/A | ||
1269141 | Famciclovir Related Compound F (25 mg) (2-Amino-6-chloropu rine) | F0L061 | 10310-21-1 | N/A | ||
1269152 | Famciclovir (200 mg) | F1J072 | F0J072 (31-AUG-2016) | 104227-87-4 | N/A | |
1269163 | Famciclovir System Suitability Mixture (20 mg) (Mixture of Famciclovir, Propionyl famciclovir and 6-Chloro famciclovir) | F0J076 | N/A | N/A | ||
1269174 | Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-p urin-9-yl)ethyl]propa ne-1,3-diol hydrochloride) | F0J126 | 246021-75-0; 104227-86-3 (base | N/A | ||
1269185 | Famciclovir Related Compound B (20 mg) [4-(2-Amino-9H-puri n-9-yl)-2-(hydroxym ethyl)butyl acetate] | F0J077 | 104227-88-5 | N/A | ||
1269196 | Famciclovir Related Compound C (20 mg) (4-(2-amino-9H-puri n-9-yl)-2-methylbutyl acetate) | F0L099 | 174155-70-5 | N/A | ||
1269200 | Famotidine (125 mg) | R048S0 | I0E063 (31-JUL-2017) | 76824-35-6 | N/A | |
1269221 | Famotidine Related Compound B (25 mg) (3,5-bis[2-[[[2-[(diami nomethylene)amino] thiazol-4-yl]methyl]s ulphany]ethyl]-4H-1, 2,4,6-thiatriazine1,1- dioxide) | R05620 | F0G182 (31-JAN-2018) | 89268-62-2 | N/A | |
1269232 | Famotidine Related Compound C (25 mg) (3-[[2-(diaminomethy leneamino)thiazol-4- yl]methylthio]-N-sulf amoylprop* hydrochloride) | F0K160 | 76824-17-4 | N/A | ||
1269243 | Famotidine Related Compound D (25 | F1K058 | F0K058 (30-NOV-2016) | 76824-16-3 | N/A | |
mg) (3-[[2-(diaminomethy leneamino)thiazol-4- yl]methylthio]propan amide) | ||||||
1269254 | Famotidine Related Compound E (25 mg) (2,2'-[4,4'-disulfanedi ylbis(methylene)bis(t hiazole-4,2-diyl)]digu anidine) | F0K059 | 129083-44-9 | N/A | ||
1269265 | Famotidine Related Compound F (25 mg) (3-[[2-(diaminomethy leneamino)thiazol-4- yl]methylthio]propan oic acid) | F0K060 | 107880-74-0 | N/A | ||
1269298 | Famotidine Sulfoxide (25 mg) (3-[[2-(diaminomethy leneamino)thiazol-4- yl]methylsulfinyl]-N'- sulfamoylpropanimid amide) | F0K116 | N/A | N/A | ||
1269312 | Felbamate (250 mg) | F1K169 | F0K169 | 25451-15-4 | N/A | |
(30-JUN-2017) | ||||||
1269323 | Felbamate Related Compound A (25 mg) (3-Hydroxy-2-phenyl propyl carbamate) | F0K170 | N/A | N/A | ||
1269334 | Felbamate Related Compound B (25 mg) (Phenethyl carbamate) | F0K171 | 6326-19-8 | N/A | ||
1269356 | Feban (200 mg) | F033H0 | 58306-30-2 | N/A | ||
1269367 | Feban Related Compound A (15 mg) (Methyl [[2-[(methoxyacetyl) amino]-4-(phenylthio )phenyl]carbamimid oyl]carbamate) | F033J0 | 92088-58-9 | N/A | ||
1269378 | Feban Related Compound B (15 mg) (2-(Methoxymethyl)- 5-(phenylthio)-1H-be nzimidazole) | F033K0 | 92114-71-1 | N/A | ||
1269389 | Felodipine (300 mg) | H0I178 | G0D065 (30-APR-2011) | 72509-76-3 | N/A | |
1269390 | Felodipine Related Compound A (15 mg) (ethyl methyl 4-(2,3-dichloropheny l)-2,6-dimethylpyridi ne-3,5-dicarboxylate ) | R003P0 | H0L149 (31-JUL-2015) | 96302-71-7 | N/A | |
1269403 | Fenbendazole (100 mg) | R03700 | F (31-DEC-2016) | 43210-67-9 | N/A | |
1269414 | Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2 -yl)carbamate) | F0D009 | 10605-21-7 | N/A | ||
1269425 | Fenbendazole Related Compound B (30 mg) (Methyl [5(6)-chlorobenzimid azole-2-yl]carbamat e) | F0D008 | 20367-38-8 | N/A | ||
1269447 | Fenofibrate (200 mg) | R002C0 | G0I241 (31-AUG-2016) | 49562-28-9 | N/A | |
1269458 | Fenoldopam Mesylate (200 mg) | F0C125 | 67227-57-0 | N/A | ||
1269469 | Fenoldopam Related Compound A (20 mg) | F0C124 | N/A | N/A | ||
(N-Methyl-6-chloro-2 ,3,4,5-tetrahydro-1-( 4-hydroxyphenyl)-1 H-3-benzazepine-7, 8-diol hydrochloride) | ||||||
1269470 | Fenoldopam Related Compound B (20 mg) (1H-3-Benzazapine- 7,8-diol, 2,3,4,5-tetrahydro-1- (4-hydroxyphenyl)-, methanesulfonate) | F0C126 | N/A | N/A | ||
1269505 | Fenoprofen Calcium (500 mg) | H0I310 | G-1 (31-JAN-2012) | 53746-45-5 | N/A | |
1269550 | Fenoprofen Sodium (500 mg) | R00270 | G (30-SEP-2015) | 66424-46-2 | N/A | |
1269607 | Fenofibrate Related Compound A (25 mg) ((4-chlorophenyl)(4- hydroxyphenyl)meth anone) | R04400 | F0F021 (30-NOV-2017) | 42019-78-3 | N/A | |
1269618 | Fenofibrate Related Compound B (25 mg) | R044H0 | R00630 (31-DEC-2017) | 42017-89-0 | N/A | |
(2-(4-(4-chlorobenzo yl)phenoxy)-2-methy lpropanoic acid) | ||||||
1269629 | Fenofibrate Related Compound C (25 mg) (1-methylethyl 2-[[2-[4-(4-chloroben zoyl)phenoxy]-2-met hylpropanoyl]oxy]-2- methylpropanoate) | G1J387 | G0J387 (31-OCT-2016) | 217636-48-1 | N/A | |
1269902 | * CII (100 mg) | F0H364 | * | 0021606030 1 | Controlled | |
1269913 | * Related Compound A (100 mg) ((2-bromoethyl)benz ene) | R00620 | F0H141 (31-MAY-2016) | 103-63-9 | N/A | |
1269924 | * Related Compound B (10 mg) (4-Anilinopiperidine) | F0H397 | 23056-29-3 | N/A | ||
1269946 | * Related Compound D (10 mg) (N-Phenyl-1-(phenyl methyl)-4-piperidina | F0H406 | 1155-56-2 | N/A | ||
mine) | ||||||
1269957 | * Related Compound E CII (10 mg) (N-Phenyl-1-(2-phen ylethyl)-4-piperidina mine) | F0H419 | 21409-26-7 | 0021606040 1 | Controlled | |
1269979 | * Related Compound G CI (10 mg) (Acetyl *; N-(1-Phenethylpiperi din-4-yl)-N-phenylac etamide) | F0H407 | 3258-84-2 | 0021698192 0 | Controlled | |
1270005 | * Citrate CII (100 mg) | M0L328 | L0G319 (28-FEB-2014) | 990-73-8 | 0021606010 7 | Controlled |
1270231 | Trigonella Foenum-graecum Seed Dry Extract (1 g) | F004B0 | N/A | N/A | ||
1270311 | Ferulic Acid (25 mg) (trans-4-hydroxy-3- methoxycinnamic acid) | F0J193 | 1135-24-6 | N/A | ||
1270355 | Ferrous Sulfate (2 x 1 g) | R05970 | F1K388 (31-OCT-2017) | 7782-63-0 | N/A | |
1270377 | Fexofenadine | R032H0 | G0K308 | 153439-40-8 | N/A | |
Hydrochloride (200 mg) | (28-FEB-2017) | |||||
1270388 | Fexofenadine Related Compound A (25 mg) (4-[1-oxy-4-[4-(hydro xydiphenylmethyl)-1- piperidinyl]butyl]-alp ha,alpha-dimethyl benzeneacetic acid) | H0M213 | G0I292 (31-JAN-2015) | 76811-98-8 | N/A | |
1270399 | Fexofenadine Related Compound B (25 mg) (3-[1-hydroxy-4-[4-(h ydroxydiphenylmeth yl)-1-piperidinyl]butyl ]-alpha,alpha-dimeth yl benzeneacetic acid hydrochloride) | G0L338 | F0D246 (31-JAN-2014) | N/A | N/A | |
1270402 | Finasteride (200 mg) | R027L0 | G0K072 (29-FEB-2016) | 98319-26-7 | N/A | |
1270424 | Fish Oil (1 g) | F0G015 | 8016-13-5 | N/A | ||
1270435 | Filgrastim (0.98 mg) (COLD SHIPMENT REQUIRED) | F0L526 | N/A | N/A | ||
1270446 | Fexofenadine Related Compound C (15 mg) ((+/-)-4-[1-hydroxy-4 -[4-(hydroxydiphenyl methyl)-1-piperidinyl ]-butyl]-isopropylben zene hydrochloride) | R032J0 | G0I059 (30-SEP-2016) | N/A | N/A | |
1270457 | High Molecular Weight Filgrastim (0.7 mg) (COLD SHIPMENT REQUIRED) | F017E0 | N/A | N/A | Cold Shipment Required | |
1270480 | Fingolimod Hydrochloride (300 mg) | F062E0 | 162359-56-0 | N/A | ||
1270526 | Fingolimod System Suitability Mixture (40 mg) | F062F0 | N/A | N/A | ||
1270548 | Fetal Bovine Serum (10 mL) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | F0L450 | N/A | N/A | International Cold Chain Shipment Required | |
1270708 | Flavoxate | F0H157 | 3717-88-2 | N/A | ||
Hydrochloride (200 mg) | ||||||
1270719 | Flavoxate Related Compound A (25 mg) (3-methylflavone-8-c arboxylic acid) | F0H158 | 3468-01-7 | N/A | ||
1270720 | Flavoxate Related Compound B (20 mg) (3-Methylflavone-8-c arboxylic acid methyl ester) | F0I350 | 90101-87-4 | N/A | ||
1270731 | Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-c arboxylic acid ethyl ester) | F0I351 | 35888-94-9 | N/A | ||
1270774 | Flax Seed Oil (1 g) | F0M179 | 8001-26-1 | N/A | ||
1270800 | Flecainide Acetate (200 mg) | G0K124 | F2A022 (31-JUL-2012) | 54143-56-5 | N/A | |
1270821 | Flecainide Related Compound A (75 mg) (3-[2,5-bis(2,2,2-trifl | R047E0 | F (30-JUN-2017) | N/A | N/A | |
uoroethoxy)phenyl]- 1,5,6,7,8,8a-hexahy droimidazo-[1,5a]pyr idine hydrochloride) | ||||||
1271008 | Floxuridine (250 mg) | G0F207 | F-2 (30-SEP-2007) | 50-91-9 | N/A | |
1271700 | Fluconazole (200 mg) | R021F0 | H1L308 (30-NOV-2016) | 86386-73-4 | N/A | |
1271711 | Fluconazole Related Compound A (10 mg) (2-[2-fluoro-4-(1H-1, 2,4-triazol-1-yl)phen yl]-1,3-bis(1H-1,2,4-t riazol-1-yl)-propan-2 -ol) | I0M038 | H0H246 (31-JUL-2014) | N/A | N/A | |
1271722 | Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1 ,3-bis(1H-1,2,4-triaz ol-1-yl)-propan-2-ol) | R05370 | I0L387 (31-DEC-2017) | 81886-51-3 | N/A | |
1271733 | Fluconazole Related Compound C (10 mg) (1,1'-(1,3-phenylene | I0M050 | H0H124 (31-JUL-2014) | N/A | N/A | |
)di(1H-1,2,4-triazole) ) | ||||||
1272000 | Flucytosine (200 mg) | R03100 | H0J113 (31-AUG-2016) | 2022-85-7 | N/A | |
1272204 | Fludarabine Phosphate (300 mg) | H0K220 | G0E247 (31-OCT-2012) | 75607-67-9 | N/A | |
1272907 | Fludeoxyglucose (100 mg) | F0E100 | 29702-43-0 | N/A | ||
1272918 | Fludeoxyglucose Related Compound A (15 mg) (4,7,13,16,21,24-hex aoxa-1,10-diazabicy clo[8.8.8]hexacosan e) | F0D119 | 23978-09-8 | N/A | ||
1272929 | Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D- glucose) | F0H343 | 14685-79-1 | N/A | ||
1273003 | Fludrocortisone Acetate (200 mg) | R006U0 | I0L284 (30-SEP-2016) | 514-36-3 | N/A | |
1273808 | Flumazenil (200 mg) | R02080 | G0J035 (29-FEB-2016) | 78755-81-4 | N/A | |
1273819 | Flumazenil Related | F0E147 | N/A | N/A | ||
Compound A (20 mg) (8-fluoro-5,6-dihydro -5-methyl-6-oxo-4H-i midazol-[1,5-alpha][ 1,4]benzodiazepine- 3-carboxylic acid) | ||||||
1273820 | Flumazenil Related Compound B (20 mg) (Ethyl 8-hydroxy-5,6-dihydr o-5-methyl-6-oxo-4H -imidazol-[1,5-alpha] [1,4]benzodiazepine -3-carboxylate) | F0E148 | N/A | N/A | ||
1273841 | Flumazenil Related Compound C (500 mg) (N,N-Dimethylforma mide diethyl acetal) | F0F300 | 1188-33-6 | N/A | ||
1274006 | Flumethasone Pivalate (200 mg) | I | H (31-JAN-2002) | 2002-29-1 | N/A | |
1274505 | Flunisolide (200 mg) | I1L312 | I (31-OCT-2014) | 77326-96-6 | N/A | |
1274607 | Flunixin Meglumine (300 mg) | H0E241 | G (30-NOV-2006) | 42461-84-7 | N/A | |
1274629 | Flunixin Related | F0M446 | 2942-59-8 | N/A | ||
Compound A (15 mg) (2-Chloronicotinic acid) | ||||||
1274630 | Flunixin Related Compound B (25 mg) (2-Methyl-3-(trifluoro methyl)aniline) | F0M470 | 54396-44-0 | N/A | ||
1274631 | Flunixin Related Compound C (50 mg) (Ethyl 2-chloronicotinate) | F0L475 | 1452-94-4 | N/A | ||
1275009 | Fluocinolone Acetonide (200 mg) | R041G0 | K0K185 (31-MAY-2017) | 67-73-2 | N/A | |
1276001 | Fluocinonide (100 mg) | J0M477 | I (31-DEC-2014) | 356-12-7 | N/A | |
1277004 | Fluorescein (200 mg) | G0B171 | F-1 (28-FEB-2003) | 2321-07-5 | N/A | |
1277037 | Fluorescein Related Compound C (25 mg) (2-(2,4-Dihydroxybe nzoyl)benzoic acid) | F022H0 | 2513-33-9 | N/A | ||
1277252 | Fluoride Dentifrice: Sodium Fluoride/Silica (4.6 | L0J093 | K0F055 (30-JUN-2011) | N/A | N/A | |
oz) | ||||||
1277274 | Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder (4 oz) | G0D270 | F (30-JUN-2005) | N/A | N/A | |
1277300 | Fluoride Dentifrice: Sodium Monofluorophosphat e-Calcium Carbonate (4.6 oz) | G | N/A | N/A | ||
1277354 | Fluoride Dentifrice: Sodium Monofluorophosphat e/Dicalcium Phosphate (4.6 oz) | G | N/A | N/A | ||
1277401 | Fluoride Dentifrice: Sodium Monofluorophosphat e (1000 ppm)/Silica (5.25 oz) | G-1 | G (31-AUG-1999) | N/A | N/A | |
1277423 | Fluoride Dentifrice: Sodium Monofluorophosphat e (1500 ppm)/Silica (5.25 oz) | F-1 | F (31-JUL-1999) | N/A | N/A | |
1277456 | Fluoride Dentifrice: Stannous Fluoride-Silica (4 oz) | H0B105 | G (30-NOV-2002) | N/A | N/A | |
1278007 | Fluorometholone (200 mg) | R032K0 | K0M523 (31-JAN-2017) | 426-13-1 | N/A | |
1278018 | Fluorometholone Related Compound A (15 mg) (11Beta,17alpha-Dih ydroxy-6alpha-meth ylpregna-1,4-diene-3 ,20-dione) | F001X0 | 6870-94-6 | N/A | ||
1278109 | Fluorometholone Acetate (200 mg) | G0M520 | F1G190 (31-DEC-2014) | 3801-06-7 | N/A | |
1278302 | Fluoroquinolonic Acid (150 mg) | H2H402 | H1H402 (31-JAN-2016) | 86393-33-1 | N/A | |
1279000 | Fluorouracil (250 mg) | R009T0 | I0G371 (29-FEB-2016) | 51-21-8 | N/A | |
1279019 | Fluorouracil Related Compound A (25 mg) (Pyrimidine-2,4,6(1H ,3H,5H)-trione) | F0M370 | 67-52-7 | N/A | ||
1279021 | Fluorouracil Related Compound B (25 mg) | F0M373 | 496-76-4 | N/A | ||
(Dihydropyrimidine-2 ,4,5(3H)-trione) | ||||||
1279054 | Fluorouracil Related Compound E (25 mg) (5-Chloropyrimidine- 2,4(1H,3H)-dione) | F0M276 | 1820-81-1 | N/A | ||
1279065 | Fluorouracil Related Compound F (25 mg) (2-Ethoxy-5-fluoropy rimidin-4(1H)-one) | F0M375 | 56177-80-1 | N/A | ||
1279804 | Fluoxetine Hydrochloride (200 mg) | H0L518 | G0F085 (30-JUN-2014) | 56296-78-7 | N/A | |
1279815 | Fluoxetine Related Compound A (15 mg) (N-methyl-3-phenyl- 3-[(alpha, alpha, alpha-trifluoro-m-toly l)oxy]propylamine hydrochloride) | H2M433 | H1J248 (31-OCT-2015) | 79088-29-2 | N/A | |
1279826 | Fluoxetine Related Compound B (5 mL of a 0.01N HCl Solution, approx. 2 | R04500 | G1I129 (31-JAN-2018) | 23580-89-4 | N/A | |
mg/mL) (N-Methyl-3-phenylp ropylamine) | ||||||
1279837 | Fluoxetine Related Compound C (15 mg) (4-(methylami no)-4-oxobutanoic acid) | F0C352 | N/A | N/A | ||
1280009 | Fluoxymesterone CIII (200 mg) | G4F292 | G3F292 (31-AUG-2015) | 76-43-7 | 0021640000 5 | Controlled |
1280803 | Fluphenazine Decanoate Dihydrochloride (300 mg) | R02100 | G (31-OCT-2015) | 2376-65-0 | N/A | |
1281001 | Fluphenazine Enanthate Dihydrochloride (125 mg) | H | G (28-FEB-1999) | 3105-68-8 | N/A | |
1282004 | Fluphenazine Hydrochloride (125 mg) | I0G294 | H (30-SEP-2008) | 146-56-5 | N/A | |
1282591 | Foeniculin (4 x 50 mg) | F049S0 | 78259-41-3 | N/A | ||
1282707 | Fondaparinux | R065E0 | F0M178 | 114870-03-0 | N/A | Cold Shipment |
Sodium for Assay (0.6 mL) (COLD SHIPMENT REQUIRED) | (30-SEP-2017) | Required | ||||
1282718 | Fondaparinux Sodium Identification (30 mg) | F0M501 | 114870-03-0 | N/A | ||
1282729 | Fondaparinux Sodium System Suitability Mixture A (2.5 mg) | F0M176 | N/A | N/A | ||
1282730 | Fondaparinux Sodium System Suitability Mixture B (2.5 mg) | F0M177 | N/A | N/A | ||
1283200 | Formic Acid (1.2 mL/ampule; 3 ampules) | R016R0 | F0E217 (31-JAN-2017) | 64-18-6 | N/A | |
1283244 | Forskolin (40 mg) (7Beta-acetoxy-8,13 -epoxy-1alpha,6Beta ,9alpha-trihydroxy-la bd-14-en-11-one) | F0J260 | 66575-29-9 | N/A | ||
1283255 | Powdered Forskohlii Extract (500 mg) | F0J268 | N/A | N/A | ||
1283302 | Foscarnet Sodium | F0H118 | 34156-56-4 | N/A | ||
(50 mg) | ||||||
1283313 | Foscarnet Related Compound B (10 mg) (disodium (ethoxyoxidophosph anyl)formate) | R069F0 | F0H254 (30-NOV-2017) | N/A | N/A | |
1283324 | Foscarnet Related Compound D (0.27 mL) (O,O-diethyl ethoxycarbonylphos phonate) | F0G331 | 1474-78-8 | N/A | ||
1283404 | Fosinopril Sodium (200 mg) | G0M206 | F0F336 (28-FEB-2015) | 88889-14-9 | N/A | |
1283415 | Fosinopril Related Compound A (25 mg) ((4S)-4-cyclohexyl-[( 4-phenylbutyl)phosp hinyl]acetyl-L-proline ) | R003W0 | F0G019 (31-JAN-2016) | 95399-71-6 | N/A | |
1283426 | Fosinopril Related Compound B (25 mg) ((4S)-4-Cyclohexyl-1 -[(R)-[(S)-1-hydroxy- 2-methylpropoxy](4- phenylbutyl)phosphi | R036H0 | F0F337 (31-AUG-2016) | N/A | N/A | |
nyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) | ||||||
1283437 | Fosinopril Related Compound C (15 mg) ((4S)-4-cyclohexyl-1 -[(RS)-1-hydroxy-2- methylpropoxy](4-ph enylbutyl)phosphinyl ]-acetyl-L-proline propionate (ester), sodium salt) | F0F339 | N/A | N/A | ||
1283448 | Fosinopril Related Compound D (15 mg) ((4R)-4-cyclohexyl-1 -[(R)-[(S)-1-hydroxy- 2-methylpropoxy](4- phenylbutyl)phosphi nyl]acetyl-L-proline propionate (ester), sodium salt) | F0F340 | N/A | N/A | ||
1283459 | Fosinopril Related Compound E (15 mg) | F0F341 | N/A | N/A | ||
((4S)-4-phenyl-1-[(R )-[(S)-1-hydroxy-2-m ethyl-propoxy](4-phe nylbutyl)phospinyl]a cetyl-L-proline propionate (ester), sodium salt) | ||||||
1283460 | Fosinopril Related Compound F (15 mg) ((4S)-4-cyclohexyl-1 -[(R)-[(S)-1-hydroxyp ropoxy](4-phenylbut yl)phosphinyl]acetyl- L-proline propionate(ester), sodium salt) | F0F344 | N/A | N/A | ||
1283470 | Fosinopril Related Compound G (15 mg) ((4-phenylbutyl)phos phinyl acetic acid, disodium salt) | F0F345 | N/A | N/A | ||
1283481 | Fosinopril Related Compound H (25 mg) (4-phenylbutyl phosphonic acid) | F0F346 | 46348-61-2 | N/A | ||
1284000 | Flurandrenolide (100 mg) | J0M002 | I0B245 (31-MAR-2014) | 1524-88-5 | N/A | |
1285002 | Flurazepam Hydrochloride CIV (200 mg) | R005A0 | J0C365 (30-JUN-2015) | 1172-18-5 | 0021606020 5 | Controlled |
1285308 | Flurazepam Related Compound C (50 mg) (5-chloro-2-(2-diethy laminoethylamino)-2' -fluorobenzophenon e hydrochloride) | I0D361 | H-1 (30-APR-2006) | N/A | N/A | |
1285603 | Flurazepam Related Compound F (50 mg) (7-chloro-5-(2-fluoro phenyl)-1,3-dihydro- 2H-1,4-benzodiazepi n-2-one) | J0M396 | I0C092 (31-AUG-2014) | 2886-65-9 | N/A | |
1285750 | Flurbiprofen (200 mg) | I0L341 | H0D349 (30-APR-2014) | 5104-49-4 | N/A | |
1285760 | Flurbiprofen Related Compound A (100 mg) (2-(4-Biphenylyl)pro pionic Acid) | I0G406 | H (31-DEC-2009) | N/A | N/A | |
1285807 | Flurbiprofen Sodium | G0G056 | F (31-OCT-2008) | 56767-76-1 | N/A | |
(200 mg) | ||||||
1285818 | Fluticasone Propionate Related Compound J (15 mg) (6alpha, 9alpha-difluoro-11be ta,17alpha-dihydrox y-16alpha-methyl-3- oxoandrosta-1,4-die ne-17beta-carboxyli c acid) | F019N0 | 28416-82-2 | N/A | ||
1285829 | Fluticasone Propionate Related Compound D (15 mg) (S-methyl 6alpha, 9alpha-difluoro-11be ta-hydroxy-16alpha- methyl-3-oxo-17alph a-propionyloxyandro sta-1,4-diene-17beta -carbothioate) | F019M0 | 73205-13-7 | N/A | ||
1285840 | Fluticasone Propionate Related Compounds Mixture (25 mg) | F0G058 | N/A | N/A | ||
1285851 | Flutamide (200 mg) | H1E297 | H0B278 | 13311-84-7 | N/A | |
(30-SEP-2007) | ||||||
1285862 | o-Flutamide (50 mg) | H0I306 | G0G325 (30-JUN-2011) | N/A | N/A | |
1285873 | Fluticasone Propionate (100 mg) | H0L509 | G0K029 (30-APR-2014) | 80474-14-2 | N/A | |
1285884 | Fluticasone Propionate Resolution Mixture (25 mg) | F0E123 | N/A | N/A | ||
1285895 | Fluticasone Propionate System Suitability Mixture (25 mg) (Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D) | F0E122 | N/A | N/A | ||
1285909 | Fluvoxamine Maleate (200 mg) | G0L125 | F0E016 (31-AUG-2015) | 61718-82-9 | N/A | |
1285910 | Fluticasone Propionate Nasal Spray Resolution Mixture (25 mg) | F0G060 | N/A | N/A | ||
1285931 | Fluvastatin Sodium | R061P0 | I0K242 | 93957-55-2 | N/A | |
(2 x 350 mg) | (31-JAN-2018) | |||||
1285942 | Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3- (4-Fluorophenyl)-1-( methylethyl)-1H-indo l-2-yl]-3,5-dihydroxy- 6-heptenoic acid monosodium salt)) | G0I230 | F0F016 (30-APR-2011) | N/A | N/A | |
1285964 | Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3- (4-fluorophenyl)-1-m ethylethyl-1H-indol-2 -yl]-3,5-dihydroxy-6- heptenoic acid 1,1, dimethylethyl ester) | G0M042 | F0F017 (31-AUG-2014) | 129332-29-2 | N/A | |
1285986 | Flutamide Related Compound B (20 mg) (N-[4-nitro-3-(trifluor omethyl)phenyl]acet | F0L511 | 393-12-4 | N/A | ||
amide) | ||||||
1285997 | Flutamide Related Compound A (20 mg) (4-nitro-3-(trifluorom ethyl)aniline) | F0L502 | 393-11-3 | N/A | ||
1286005 | Folic Acid (500 mg) (Vitamin M or Vitamin Bc) | Q0G151 | P (31-AUG-2008) | 59-30-3 | N/A | |
1286027 | Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofola te) | I1I097 | I0B176 (30-JUN-2010) | 1492-18-8 | N/A | |
1286060 | Formononetin (50 mg) | R029F0 | F0C196 (30-APR-2016) | 485-72-3 | N/A | |
1286107 | Formoterol Fumarate (100 mg) | F1H187 | F0H187 (31-JUL-2015) | 183814-30-4 | N/A | |
1286118 | Formoterol Fumarate System Suitability Mixture (20 mg) | F0H166 | N/A | N/A | ||
1286129 | Formoterol Fumarate Resolution Mixture (20 mg) | F0H168 | N/A | N/A | ||
1286209 | Mafenide Related Compound A (50 mg) (4-Formylbenzenesu lfonamide) | G0C351 | F (31-AUG-2005) | N/A | N/A | |
1286300 | 10-Formylfolic Acid (25 mg) | R02850 | F2B226 (31-JAN-2017) | 134-05-4 | N/A | |
1286322 | Fosfomycin Tromethamine (800 mg) | F0J414 | 78964-85-9 | N/A | ||
1286366 | Fosphenytoin Sodium (350 mg) | R012C0 | G0E124 (31-AUG-2015) | 92134-98-0 | N/A | |
1286402 | Frovatriptan Racemate (15 mg) | F004Q0 | 147009-08-3 | N/A | ||
1286413 | Frovatriptan Succinate (200 mg) | F010H0 | 158930-17-7 | N/A | ||
1286424 | Frovatriptan Related Compound A (20 mg) ((R)-3-Amino-2,3,4,9 -tetrahydro-1H-carb azole-6-carboxamid e) | F010W0 | N/A | N/A | ||
1286504 | Fructose (125 mg) | J1M205 | J0J006 (31-OCT-2015) | 57-48-7 | N/A | |
1286606 | L-Fucose (200 mg) | G0L330 | F0E007 | 2438-80-4 | N/A | |
(30-SEP-2013) | ||||||
1286650 | Fulvestrant (200 mg) | R036R0 | F0H065 (30-NOV-2016) | 129453-61-8 | N/A | |
1286661 | Fulvestrant System Suitability Mixture (30 mg) | R049J0 | F1M180 (31-JUL-2017) | N/A | N/A | |
1286708 | Fumaric Acid (200 mg) | H1E328 | H0E328 (31-MAY-2015) | 110-17-8 | N/A | |
1286800 | Furazolidone (200 mg) | R021X0 | H0I140 (31-JUL-2017) | 67-45-8 | N/A | |
1287008 | Furosemide (200 mg) | M0M043 | L0H311 (31-MAY-2014) | 54-31-9 | N/A | |
1287020 | Furosemide Related Compound A (50 mg) (2-Chloro-4-N-furfur ylamino-5-sulfamoyl benzoic Acid) | R04570 | K0I004 (31-JUL-2017) | N/A | N/A | |
1287030 | Furosemide Related Compound B (100 mg) (4-Chloro-5-sulfamo ylanthranilic Acid) | R00750 | K0H287 (30-APR-2016) | 3086-91-7 | N/A | |
1287303 | Gabapentin (250 mg) | R020J0 | I0K190 (31-OCT-2016) | 60142-96-3 | N/A | |
1287325 | Gabapentin Related | R01130 | I0K238 | 64744-50-9 | N/A | |
Compound A (50 mg) (2-Azaspiro[4.5]deca n-3-one) | (31-AUG-2016) | |||||
1287347 | Gabapentin Related Compound B (30 mg) ((1-cyanocyclohexyl) acetic acid) (COLD SHIPMENT REQUIRED) | G0K192 | F0F232 (31-DEC-2012) | 133481-09-1 | N/A | |
1287358 | Gabapentin Related Compound D (10 mg) ((1-(3-oxo-2-aza-spir o[4.5]dec-2-ylmethyl )-cyclohexyl)acetic acid) | R01920 | G1K279 (28-FEB-2017) | N/A | N/A | |
1287369 | Gabapentin Related Compound E (25 mg) (carboxymethyl-cycl ohexanecarboxylic acid) | G0K277 | F1J405 (30-NOV-2013) | 67950-95-2 | N/A | |
1287507 | Gadodiamide (500 mg) | R04000 | G0M395 (31-MAY-2017) | 131410-48-5 | N/A | |
1287518 | Gadodiamide | F | N/A | N/A | ||
Related Compound A (50 mg) (gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide) | ||||||
1287529 | Gadodiamide Related Compound B (50 mg) (gadolinium disodium diethylenetriamine pentaacetic acid) | F | N/A | N/A | ||
1287609 | Gadopentetate Monomeglumine (250 mg) | H1M158 | H0K203 (31-JUL-2015) | 92923-57-4 | N/A | |
1287631 | Gadoteridol (500 mg) | F | 120066-54-8 | N/A | ||
1287642 | Gadoteridol Related Compound A (50 mg) (10-(2-hydroxypropyl )-1,4,7,10-tetraazacy clododecane-1,4,7-tr iacetic acid) | F0A002 | 120041-08-9 | N/A | ||
1287653 | Gadoteridol Related Compound B (50 | F0B198 | 112188-16-6 | N/A | ||
mg) (1,4,7,10-Tetraazacy clododecane-1,4,7-tr iacetic acid, monogadolinium salt) | ||||||
1287664 | Gadoteridol Related Compound C (50 mg) (1,4,7,10-Tetraaza-1 1-oxo-bicyclo[8.2.2]t etradecane-4,7-diac etic acid) | F0B199 | 220182-19-4 | N/A | ||
1287675 | Gadoversetamide (200 mg) | F0C172 | 131069-91-5 | N/A | ||
1287686 | Gadoversetamide Related Compound A (200 mg) (Hydrogen[8,11,14-tr is(carboxymethyl)-6- oxo-2-oxa-5,8,11,14 -tetraazahexadecan- 16-oato(4-)]gadoliniu m) | F0C173 | N/A | N/A | ||
1287700 | Galactose (200 mg) | R047C0 | G0F252 (31-OCT-2017) | 59-23-4 | N/A | |
1287711 | Galactitol (500 mg) | F0D376 | 608-66-2 | N/A | ||
1287722 | Galactosamine Hydrochloride (50 mg) | G1L378 | G0L378 (30-APR-2017) | 1772-03-8 | N/A | |
1287755 | Galantamine Hydrobromide (200 mg) | R036S0 | F1K075 (31-MAR-2017) | 1953-04-4; 69353-21-5 | N/A | |
1287766 | Galantamine Hydrobromide Racemic (15 mg) | F0G344 | 193146-85-9 | N/A | ||
1287777 | Galantamine Hydrobromide Related Compounds Mixture (25 mg) | F0G350 | N/A | N/A | ||
1288000 | Gallamine Triethiodide (200 mg) | G0M284 | F (31-MAY-2014) | 65-29-2 | N/A | |
1288306 | Ganciclovir (200 mg) | G1L169 | G0J026 (30-APR-2014) | 82410-32-0 | N/A | |
1288317 | Ganciclovir Related Compound A (15 mg) ((RS)-2-Amino-9-(2, 3-dihydroxy-propoxy methyl)-1,9-dihydro- purin-6-one) | G1L421 | G0J294 (30-JUN-2014) | N/A | N/A | |
1288339 | Ganciclovir Mono-N-methyl | F0I023 | N/A | N/A | ||
Valinate (10 mg) (2-(RS)-[(guanin-9-yl )methoxy]-3-hydroxy propyl N-methyl-L-valinate hydrochloride) | ||||||
1288340 | Powdered Garcinia Hydroxycitrate Extract (500 mg) | F0J391 | N/A | N/A | ||
1288372 | Ganoderma lucidum Fruiting Body Dry Extract (1 g) | F012B0 | N/A | N/A | ||
1288383 | Ganoderic Acid A (50 mg) | F01200 | 81907-62-2 | N/A | ||
1288408 | Gatifloxacin (300 mg) | F0J187 | 180200-66-2 | N/A | ||
1288452 | Gatifloxacin Related Compound E (15 mg) (1-Cyclopropyl-6-flu oro-8-methoxy-7-(2- methylpiperazin-1-yl )-4-oxo-1,4-dihydroq uinoline-3-carboxylic acid monohydrochloride) | F045U0 | 1219097-41-2 | N/A | ||
1288463 | Gemcitabine Hydrochloride (200 mg) | H0I101 | G0G083 (31-DEC-2010) | 122111-03-9 | N/A | |
1288500 | Gemfibrozil (200 mg) | H1F285 | H (30-NOV-2007) | 25812-30-0 | N/A | |
1288510 | Gemfibrozil Related Compound A (20 mg) ((E,Z)-2,2-dimethyl-5 -[2,5-dimethyl-4-(pro pene-1-yl)phenoxy]v aleric acid) | H0H180 | G0D369 (30-JUN-2009) | N/A | N/A | |
1288805 | Genistin (30 mg) | R06200 | F0H345 (31-MAY-2017) | 529-59-9 | N/A | |
1288816 | Genistein (15 mg) | R030E0 | F1K131 (31-MAR-2016) | 446-72-0 | N/A | |
1289003 | Gentamicin Sulfate (200 mg) | M1J001 | M0D314 (30-JUN-2011) | 1405-41-0 | N/A | |
1290002 | Gentian Violet (650 mg) | G1K417 | G0E112 (31-OCT-2013) | 548-62-9 | N/A | |
1291005 | Gibberellic Acid (200 mg) | G | F (30-APR-2001) | 77-06-5 | N/A | |
1291446 | Ginger Constituent Mixture (0.2 mg) (6-gingerol and 6-shogaol) | F0E129 | N/A | N/A | ||
1291504 | Powdered Ginger (500 mg) | F04221 | F (31-AUG-2016) | N/A | N/A | |
1291548 | Ginkgolic Acids (20 mg) (Mixture of ginkgolic acid C13:0, ginkgolic acid C15:1 and ginkgolic acid C17:1) | R024B0 | G0J291 (31-JAN-2017) | N/A | N/A | |
1291559 | Ginkgo Terpene Lactones (50 mg) | I0K042 | H0I309 (30-NOV-2011) | N/A | N/A | |
1291672 | Ginsenoside Rg1 (20 mg) | F013D0 | 22427-39-0 | N/A | ||
1291683 | Powdered American Ginseng Extract (1.5 g) | F0F323 | 90045-38-8 | N/A | ||
1291708 | Powdered Asian Ginseng Extract (1.5 g) | G0F321 | F0B289 (31-MAR-2008) | 50647-08-0 | N/A | |
1291719 | Panax Notoginseng Root and Rhizome Dry Extract (1 g) | F01280 | N/A | N/A | ||
1292303 | Glimepiride (200 mg) | G0K135 | F1H150 (30-JUN-2012) | 93479-97-1 | N/A | |
1292314 | Glimepiride Related Compound A (20 mg) (glimepiride | G0M157 | F1H269 (31-AUG-2014) | N/A | N/A | |
cis-isomer) | ||||||
1 |